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Abstract 
 
Enabling technologies have emerged in the past decade and have made an impact on the way 
organic synthesis is conducted to a very great extent. Flow chemistry is one of the key 
enabling technologies for organic chemists and its benefits have been appreciated and 
described by numerous publications and reviews. As more flow equipment and software is 
developed, more diverse chemical transformations and multi-step syntheses are being 
successfully adapted into flow processes. This dissertation describes the utilisation of flow 
chemistry as a versatile option to develop new chemistries in the preparation of biologically 
active compounds and in methodologies employing hazardous reagents. 
 
In the first chapter, an introduction into flow chemistry is provided, as well as highlights of 
the advantages, current challenges and future prospects in the field. 
 
The second chapter describes the integration of machine-assisted methods with batch process 
to access two active pharmaceutical ingredients, a precursor to sacubitril and OZ439 
respectively. Some representative gas-liquid reactions using enabling technologies have been 
demonstrated in these syntheses. 
 
The third chapter follows which contains the development of two new preparations of diazo 
compounds with organoboron compounds. The first preparation involves the 
diastereoselective synthesis of anti homoallylic alcohol via an in situ generation of transient 
allylic boronic species. The second methodology involves the preparation of an 
organodimetallic compound, α-trimethylsilyl benzylboronic acid pinacol esters and the 
development of their applications as bifunctional building blocks for further derivatisation. 
 
It should be emphasised that the aim of this thesis is to demonstrate the utility of flow 
chemistry as a tool for synthetic organic chemists, and not to advocate replacing all batch 
processes with flow procedures. The most powerful strategy lies in the appropriate 
combination of the two methods and is driven by a deep knowledge of the requirements of the 
particular chemical transformation and the overall end goal.  
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Abbreviations 
 
Δ  heat  
δ  chemical shift in parts per million  
λmax  wavelength at peak maximum  
µ  micro  
νmax  frequency at peak maximum  
[α]  specific rotation  
°C  degrees Celsius  
Å  angstrom(s)  
Ac  acetyl  
acac  acetylacetonate  
API active pharmaceutical ingredient (s) 
approx.  approximately  
aq.  aqueous  
Ar  aryl  
atm  atmosphere  
AU  absorbance unit(s)  
B  base  
Bn  benzyl  
Boc  tert-butoxycarbonyl  
BPR  back pressure regulator  
br  broad (NMR spectroscopy and IR spectroscopy)  
nBu  butyl  
tBu tert-butyl 
cat. catalytic 
c  centi  
c  concentration  
ca.  circa  
cat. catalytic 
Cbz  carboxybenzyl  
cm-1  wavenumber  
cod  1,5-cyclooctadiene  
conv.  conversion  
COSY  correlation spectroscopy  
Cp  cyclopentadienyl  
CPME  cyclopentyl methyl ether  
CSA  camphorsulfonic acid  
Cy  cyclohexyl  
CyDMEDA Trans-N,N'-dimethyl-1.2-cyclohexanediamine 
δ chemical shift in parts per million downfield from 
tetramethylsilane 
d  day(s) or doublet (NMR spectroscopy)  
dba  dibenzylideneacetone  
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene  
DCE  1,2-dichloroethane  
de  diastereomeric excess  
dec.  decomposed  
DEPT  distortionless enhacement by polarisation transfer  
DIPEA  N,N-diisopropylethylamine  
DMA  N,N-dimethylacetamide  
DMAP  4-dimethylaminopyridine  
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DME  1,2-dimethoxyethane  
DMF  N,N-dimethylformamide  
DMSO  dimethylsulfoxide  
dr  diastereomeric ratio  
E  electrophile  
ee  enantiomeric excess  
equiv.  equivalent(s)  
es  enantiospecificity  
ESI  electrospray ionisation  
Et  ethyl  
et al.  et alia  
EWG  electron-withdrawing group  
FEP  fluorinated ethylene propylene  
FT  Fourier transform  
g  gram(s)  
h  hour(s)  
Hex  hexyl  
HMBC  heteronuclear multiple bond correlation  
HOMO  highest occupied molecular orbital  
HPLC  high-performance liquid chromatography  
HRMS  high-resolution mass spectroscopy  
HSQC  heteronuclear single quantum correlation  
Hz  Hertz  
i  iso  
i.d.  inner diameter  
IR  infrared  
k kilo 
L  litre(s) or unspecified ligand  
lit.  literature value  
M  mega or unspecified metal  
M  molar  
m  medium (IR spectroscopy), metre(s), milli or multiplet 
(NMR spectroscopy)  
m  meta  
m-CPBA  meta-chloroperoxybenzoic acid  
Me  methyl  
min  minute(s)  
mmHg  millimetre(s) of mercury  
mol  mole(s)  
MOM  methoxymethyl  
m.p.  melting point  
MS  molecular sieves  
m/z  mass-to-charge ratio  
n  nano  
nbd  norbornadiene  
n.d.  not determined  
NMI  N-methylimidazole  
NMP  N-methyl-2-pyrrolidone  
NMR  nuclear magnetic resonance  
NOESY  nuclear Overhauser spectroscopy  
Nu  nucleophile  
o  ortho  
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oct  octanoate or octet (NMR spectroscopy)  
p  para  
Pent  pentyl  
Ph  phenyl  
pin  pinacol  
ppm  parts per million  
Pr  propyl  
PS  polymer-supported  
Py  pyridine  
q  quartet (NMR spectroscopy)  
qn  quintet (NMR spectroscopy)  
R  undefined substituent  
rac  racemic  
Rf  retention factor  
r.t.  room temperature  
s  singlet (NMR spectroscopy) or strong (IR spectroscopy)  
sept  septet (NMR spectroscopy)  
SN2'  bimolecular nucleophilic substitution with allylic 
rearrangement  
sublim.  sublimed  
T  temperature  
t  triplet (NMR spectroscopy)  
t  tertiary  
TBAF  tetrabutylammonium fluoride  
TBS  tert-butyldimethylsilyl  
TC  thiophene-2-carboxylate  
tert  tertiary  
Tf  trifluoromethanesulfonyl  
TFA  trifluoroacetyl  
THF  tetrahydrofuran  
TLC  thin layer chromatography  
TMEDA  N,N,N′,N′-tetramethyl-1,2-ethylenediamine  
TMS  trimethylsilyl  
tR  residence time or retention time  
Ts  tosyl  
UV  ultraviolet  
W  watt(s)  
w  weak (IR spectroscopy)  
w.r.t.  with respect to  
w/w  weight-to-weight ratio  
X  undefined heteroatom  
Xantphos  4,5-bis(diphenylphosphino)-9,9-dimethylxanthene  
Structure representation 
*	H. Maehr J. Chem. Ed. 1985, 62, 1140-120.	 	 	 x	
Structure representation 
 
 
This thesis uses the graphical representation of chemical structures based on the convention 
proposed by Maehr.* Solid and broken lines represent relative configuration and indicate 
compounds that are racemic, whereas solid and broken wedges are used to assign absolute 
configuration. Normal bond lines are used to describe stereocentres where the configuration 
is unspecified. 
 
 
racemic single enantiomer unspecified
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Polymer-supported reagents abbreviations 
 
PS-DMAP 4-(Dimethylamino)pyridine, polymer-bound 
 
   
PS-NCO Isocyanate, polymer-supported 
 
   
PS-PPh3 Triphenylphosphine, polymer-supported 
 
   
PS-thiosulfate 
 
Thiosulfate, polymer-bound 
  
   
QP-BZA QuadraPure
® Benzylamine 
 
 
   
QP-DMA QuadraPure® Dimethylbenzylamine 
 
   
QP-SA QuadraPure® p-Toluenesulfonic acid 
 
   
QP-TU QuadraPure
® Thiourea 
 
 
N
N
NCO
P
Ph
Ph
NMe3
S2O32- Na
NH2
NMe2
SO3H
N
H
S
NH2
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Flow technology diagrams 
 
 
HPLC, peristaltic or syringe pump 
 
T-piece 
 
Column containing polymer-supported reagents or solid reagents 
 
Coiled flow reactor 
 
Tube-in-tube reactor 
 Back pressure regulator 
 
Sample loop 
 
Liquid-liquid separator 
 
Microfluidic reactor 
 
Mettler Toledo FlowIR® in-line IR spectrometer 
GPR
BPR
FlowIR
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Flow technology equipment 
Vapourtec R2+/R4 
Vapourtec Ltd. 
http://www.vapourtec.com 
 
Uniqsis FlowSyn 
Uniqsis Ltd. 
http://www.uniqsis. com 
 
Vapourtec E-series with UV-150  
Photochemical Reactor 
Vapourtec Ltd. 
 
FlowCAT 
HEL Group 
http://www.helgroup.com 
FlowIR® 
Mettler-Toledo Autochem Inc. 
http://www.mt.com 
Knauer Smartline Pump 100 
Wissenschaftliche Gerätebau Dr. 
Ing. Herbert Knauer GmbH 
http://www.knauer.net 
 
Tube-in-tube	reactor	Cambridge	Reactor	Design	http://www.cambridgereactordesign.com		
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1.1 Introduction 
 
Recent advances in flow chemistry have received significant attention not only in the field of 
synthetic organic chemistry but also as they pave the way to the development of more 
sustainable processes.1 By recognising synthesis as a holistic system, chemistry can be 
integrated with engineering and informatics to create a new paradigm for organic synthesis.  
 
Flow reactors have been widely applied in chemistry, from the microfluidic preparation of 
quantum dots2 and nano-particles3 to the synthesis of active pharmaceutical ingredients 
(APIs) in drug discovery4 and process5 laboratories. This thesis describes the application of 
flow chemistry, integrated with batch techniques, to the construction of complex molecules in 
a research laboratory environment. Moreover, the combination of reactor engineering and a 
physicist's understanding in fluid dynamics allows greater safety and enhanced efficiencies as 
well as the opportunity to discover new chemical transformations. It is also a testimony to the 
rapid development of the field that during the course of this work many items of flow 
equipment, including several commercial available bench-top reactor systems, gas-liquid 
reactors and automation software, have become readily accessible.6 
 
The advantages of flow technologies in organic synthesis have been extensively reviewed in 
the literature.7 In this section, these advantages will be summarised along with some of the 
remaining challenges for the future direction of next generation technological development.  
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1.1.1 Key features of flow chemistry 
 
Flow chemistry, in the context of this work, is defined as a solution-phase chemical reaction 
that is typical carried out in pressurised coiled reactors made from fluorinated tubing, with an 
internal diameter generally of the order of 0.5 − 1.0 mm. Reagents are combined through a 
connector into a single reaction stream which could then be passed through reactor coils 
subjecting the solution to the reaction conditions, such as heating, cooling, exposure to light, 
heterogeneous catalyst, etc. By dividing the reactor volume by the total flow rate through the 
reactor system, "residence time" is obtained which is equivalent to the reaction time. Next, 
the exiting stream of the crude product could be passed through a series of down-stream 
processes, for example, polymer supported reagents which can quench, scavenge and purify 
the stream, to provide a out-put of pure product in an ideal scenario. The modular features of 
flow equipment provide the flexibility in the design and construction of the overall 
continuous process and it is feasible to incorporate in-line monitoring system at any stage of 
the process or combine a number of flow processes for the purpose of multistep synthesis.    
 
 Large surface area-to-volume ratio 
 
Tubing-based reactors have a larger surface area-to-volume ratio compared to the round 
bottomed flask, providing more efficient thermal transfer.8 Efficient heating and cooling can 
avoid dangerous, unexpected exothermic runaways which can be a significant issue for 
reactions that are performed at scale. Since heat can be effectively removed from the reacting 
solution, exothermic processes can be performed more safely and degradation or byproducts 
could also be avoided or minimised under the flow conditions. In addition, with accurate 
temperature control and a homogeneous temperature distribution within the reaction stream, 
mass transfer properties in flow are fundamentally different than in batch. Due to the highly 
characterised nature of mixing in flow, flow processes can be readily numbered up, which is 
often not a straightforward operation in batch mode. Moreover, reactions requiring a specific 
degree of penetration into the reaction medium, such as photochemical and microwave-
induced reactions, would be operated more efficiently using a coiled reactor that has a large 
surface area-to-volume ratio.  
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 Pressurisation 
 
Many flow setups can be operated as a pressurised system of low volume through the 
incorporation of a back pressure regulator (BPR). Performing flow processes under pressure 
allows superheating of solvents beyond their boiling points, providing a greater range of 
solvents and temperatures for optimisation.9 Furthermore, the ability to operate under 
pressure gas-liquid reactions is often problematic in batch mode and this could be achieved 
safely in a flow system. There are several formats of flow equipment for gas-liquid reactions, 
such as Thales Nanos' H-Cube hydrogenation reactor, tube-in-tube reactor and the HEL 
FlowCAT reactor.     
 
 Reactive intermediates 
 
Reactions involving highly reactive intermediates can be difficult to handle, and the use of 
hazardous reagents, such as phosgene and diazomethane, are associated with specific safety 
concerns.10 Recent literature examples have demonstrated the advantages of employing flow 
reactor technologies for conducting chemical reactions that were previously referred to as 
forbidden. In a flow process, a reactive intermediate generated in situ can immediately be 
trapped with reagents to provide the desired product.11 Mixing and mass transfer properties of 
continuous flow processes leads to a uniform concentration of product at a specific point in 
the reactor over time, and only small quantities of potentially hazardous reactive 
intermediates remain in the flow stream.  
 
 In-line-monitoring 
 
Incorporation of detectors into the setup for monitoring the reaction stream in-line has been 
one of the most attractive features in flow chemistry. These detectors provide instant, 
quantitative information with regards to the levels of product.12 Moreover, mechanistic 
studies13 and kinetic studies14 can also be conducted with the aid of these enabling tools.  
 
 Multistep synthesis 
 
1.1 Introduction 
	 			 5	
In recent decades, many chemical transformations under batch conditions have been 
translated into single-step flow processes and gradually these processes are combined to 
generate more complex, multistep sequences.15 Telescoping reactions into multistep 
processes can significantly reduce the number of necessary unit operations, such as washing, 
quenching, extraction, separation and drying, and consequently the time and the labour 
required to perform a reaction sequence. However, the accurate addition of sequential 
reagents, in terms of concentration, with a disperse product stream is often problematic when 
developing a multistep plug flow process. One of the possible solutions is to employ in-line 
infra-red monitoring with software feedback control, controlling an additional pumps to 
dispense sequential reagents in real time based upon the concentration of reaction 
intermediates.   
 
 Automation 
 
Advances in software for automation and control assists flow chemists to have better 
equipment control, which accelerates the development of multistep flow processes.16 
Performing multistep synthesis in flow still requires a number of manual operations such as 
sample loading, programming of reaction parameters, control of pumps. Having automated 
control of these operations would lead to a better management of the system even when a 
single researcher is performing continuous multistage processes.  It would not only release 
more time for the synthetic chemists for more advanced synthesis and reaction planning but 
also allows processes to be remotely controlled with the safe 24/7 operation of machinery. 
Automation can also be employed for library generation17 and is considered as a important 
element in the development of self-optimising reactor systems.18  
 
 1.1.2 Challenges in flow chemistry 
 
Clogging of the reactor due to precipitation of solids is a specific issue to a flow system that 
leads to system blockage. For very fine solids and slurries, there are a number of examples 
using reactors and peristaltic pumps to deal with slurries.19 Other approaches, such as 
sonication baths20, piezoelectricity21 and the addition of solubilising stream have shown some 
promise in circumventing this issue. However, the formation or the use of insoluble chemical 
compounds should be considered carefully at the experimental design stage.  
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Currently, commercially available flow reactors are still relatively expensive. Although a 
number of flow reactors that are developed in-house by a number of research groups have 
shown to be more economically affordable, it is still one of the major limitations for 
widespread adoption of flow chemistry. Training of flow chemistry is often considered as an 
additional skill supplementary to traditional batch chemistry, which requires a significant 
investment of resources and time before any benefits are realised. 
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2.1 Literature examples of API synthesis in flow 
 
Active pharmaceutical ingredients are the biologically active components in a drug which are 
generally structurally more complex and more valuable than commodity chemicals and 
usually require highly diverse multistep syntheses (typically 6 to 10 synthetic steps). Before 
the concept of continuous flow processes became popular in the pharmaceutical industry, the 
versatile and configurable multipurpose batch reactor dominated the production of APIs. The 
ability of batch reactor in handling multiple reaction steps in comparatively low production 
volumes as well as the ease of operation is a satisfying tool for this purpose.  In the last 20 
years, application of the enabling technologies for the preparation of fine chemicals, such as 
active pharmaceutical ingredients23, 15a or natural products24, has gained much attention in 
both academia and pharmaceutical industry. For example, the fine-chemical industry has 
gradually transformed its existing infrastructure of multipurpose batch or semi-batch reactors 
to continuous flow reactors; there is also a growing number scientists who move from 
research chemists in academia to process chemists and chemical engineers in pharmaceutical 
companies who are now contributing in this field of research. This is reflected by the 
development of a continuous end-to-end manufacturing plant for an API, alishiren 
hemifumarate VII, at the Novartis-MIT Center for Continuous Manufacturing (Scheme 1).25 
Starting from a chemical intermediate I, all operational steps involved including reactions, 
separation, purification, crystallisation, drying and formulation are all integrated in one 
single, fully automated continuous process (Figure 1).  
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Scheme 1 Synthesis of alishiren hemifumarate VII 
	
Figure	1	Process	flow	diagram	of	production	of	alishiren	hemifumarate	including	the	major	unit	operations.	R	=	reactor,	S	=	separation,	Cr	=	crystallisation,	W	=	filter	/	wash,	D	=	dilution	tank,	E	=	extruder,	MD	=	mold.	(Image	taken	from	ref.	25a) 
With precise control of many parameters such as fast heat and mass transfer, mixing and 
residence times, performing certain transformations in a flow reactor are more reliable and 
reproducible compared to equivalent batch reactions. The construction of a flow reactor is 
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modular, providing flexibility to the process design with the integration of various 
components, for instance, heating and cooling zones, separators, residence tubing coils, 
photochemical reactors, and diagnostic/analysis units.  Automation and continuous operation 
as well as operational safety can be accomplished with these small footprint reactor units, 
allowing chemist to conduct more potentially hazardous reactions or extreme process 
windows with reduced inventories of reactive chemicals.26 Furthermore, the real time 
monitoring of the system and the ability to connect with the Internet of things (IoT)* such as 
camera or thermostats connected to computer and internet network provides a rapid response 
of the process status with the incorporation of automated safe shutdown protocols which can 
be administrated even in far distance from the process site. Despite the optimisation of the 
chemical transformation itself, each practical step in the entire processing sequence, 
including quenching, workup, extraction and purification, become essential elements of the 
synthesis planning.12a, 23d, 27 With such consideration happening at an early stage of a API 
development pipeline, the scaling from a milligram to multi-kilogram and eventually multi-
tonnes scale manufacturing can be achieved more efficiently. This also helps meet the 
specific demand of materials for different stages of biological and regulatory testing and 
production of marketed drug. In recent years, numerous literature reviews in this research 
area have been published.28 Selected representative examples are described below. 
 
Gleevec (Imatinib meslate) 1 is tyrosine kinase inhibitor for the treatment of chronic myeloid 
leukaemia. Although a number of batch protocol have been previously described, Ley et al. 
developed a flow-based protocol to demonstrate some significant improvements for handing 
poorly soluble and complex molecules with the use of in-line solvent switching technique and 
polymer supported reagents (Scheme 2).29 Formation of the amide core 4 was performed via 
the reaction between acid chloride 2 and aniline 3. After a solvent switching from CH2Cl2 to 
DMF, nucleophilic substitution of the chloride in 4 with N-methylpiperazine, followed by 
subsequent Buchwald-Hartwig coupling with 5 was used to yield the crude product 1. 
Purification using an automated chromatography system provided the desired Imatinib 1 in 
32% overall yield.  
 
*Internet of Things (IoT): A network of internet-connected objects able to collect and exchange data using embedded 
sensors. 
Internet of Thing device: Any stand-alone internet-connected device that can be monitored and/or controlled from a 
remote location. 
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Scheme 2 Telescoped flow synthesis of Imatinib (Gleevec). 
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In 2013, Ley et al. reported a telescoped process for the preparation of the anti-inflammatory 
agent fanetizole 6 on a mulitgram scale using a tube-in-tube reactor (Scheme 3).30 The flow 
process began with the addition of ammonia to isothiocyanate 7 to generate the 
corresponding thiourea, followed by condensation with 2-bromoacetophenone 7a to provide a 
mixture of  2-aminothiazole fanetizole 6 and its salt form 8 in 99% combined yield. An inline 
titration may also be integrated to the flow system for on-demand check of the ammonia 
concentration, ensuring the safety and reproducibility of the process. 
 
 
Scheme 3 Telescoped process of fanetizole. 
 
Artemisinin is a key antimarlarial agent and its preparation is challenging due to its complex 
molecular structure. Seeberger et al. reported a one-pot photochemical continuous-flow 
process for the semisynthesis of artemisinin 9 from dihydroartemisinic acid 10 (Scheme 4). 31 
Employing 60 high-powered LEDs created a high photon flux (420 nm, 72W), allowing an 
efficient and safe generation of singlet oxygen, which is the key reagent in the photochemical 
ene reaction. There are a number of advantages of this flow protocol over the corresponding 
batch reaction. Firstly, the generation and immediate consumption of reactive singlet oxygen 
in continuous flow enhanced operational safety over the batch conditions. Secondly, the high 
surface: volume ratio of fluid traveling through the flow system allowed evenly distributed 
light penetration to the reaction stream. This flow synthesis of artemisinin 9 has an excellent 
throughput at 8.33 g h-1, affording a potential scale up route to this life saving medicine. 
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Scheme 4 Photochemical ene reaction using singlet oxygen in the flow preparation of artemisinin. (approx. total residence 
time is less than 11.5 min).  
Meclinertant (SR-48692) is a nuerotensin receptor-1 antagonist can be prepared using 
machine-assisted protocol. The multistep machined-assisted synthesis of SR-48692 11, 
developed by Ley et al., has illustrated the utilisation of a wide range of enabling 
technologies at different stages of the flow processes.32 Ketone intermediate 17 was first 
prepared continuously from a telescoped acylation and rearrangement in flow using a 
monolithic DMAP reactor, in which employing polymer-supported reagents simplified the 
downstream processing of the reaction stream (Scheme 5). With the use of an in-house 
designed back-pressure regulator for handling chemical slurries, the flow Claisen 
condensation reaction of ketone 17 with diethyl oxalyl ester 18 in the presence of sodium 
ethoxide provided the 1,3-dicarbonyl product 19 (Scheme 6a). The Knorr pyrazole 
condensation of 1,3-dicarbonyl product 19 and hydrazine 20 gave the pyrazole 21 (Scheme 
6b). In addition, a semipermeable membrane system was employed for the automated work-
up. Flow hydrolysis of pyrazole 21 using potassium hydroxide afforded the corresponding 
acid 22 (Scheme 7). Amide coupling reaction of acid 22 and amine 24 using triphosgene 23 
was performed to yield the protected SR-48692 25. Subsequent batch deprotection with 
QuadraPure® sulfonic acid (QP-SA) provides the SR48692 11.  
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Scheme 5 Telescoped flow synthesis of ketone 17. 
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Scheme 6 a) Claisen condensation of ketone 17. b) Knorr pyrazole condensation of ketone 19 and hydrazine 20. 
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Scheme 7 Machine-assisted flow synthesis of SR48692 11. 
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Ley et al. developed a telescoped synthesis of (E/Z)-tamoxifen 26 using continuous-flow 
organometallic reagent-mediated transformations.33 Air-sensitive organometallic reagents 
such as nBuLi, Grignard reagents and DIBAL-H, were pumped using chemically resistant, 
peristaltic pumping system. This process provided tamoxifen 26 in 84% yield with a E/Z ratio 
of 25:75 (Scheme 8). The flow process began with the lithiation of 27 using nBuLi, followed 
by an addition to ketone 28 to generate a lithium intermediate 29. Trifluoroacetylation of the 
lithium intermediate 29 with trifluoroacetic anhydride (TFAA) gave ester 30 at ambient 
temperature. Subsequent treatment of the ester 30 at 100 °C with triethylamine allow the 
elimination reaction to occur and provide the (E/Z)-tamoxifen 26.  
 
 
Scheme 8 Continuous-flow telescoped synthesis of (E/Z)-tamoxifen 26. 
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Modified from the work by the McQuade group, Jamison et al. developed a improved 
continuous-flow process of ibuprofen 27 requiring only three minutes residence time and 
provided 83% at 8.09 g h-1 with >98% determined by 1H NMR analysis.34 This process 
involves five stages, including 3 bond-forming reactions, one work-up and one in-line liquid-
liquid separation (Scheme 9).  
 
 
Scheme 9 Three-minute ibuprofen synthesis in continuous-flow. 
 
Efavirenz is a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV. There 
was no efficient synthesis of this drug to meet the demand of millions of people worldwide. 
Seeberger et al. developed a semi-continuous process to produce rac-Efavirenz 31 in an 
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key propargyl alcohol intermediate 36, followed by an one-step flow process of the copper-
catalysed cyclisation of an in situ generated aryl isocyante to provide the cyclic carbamate 
core of Efavirenz (Scheme 10). In the telescoped process, the first step was the ortho 
lithiation of 1,4-dichlorobenzene 32 and subsequent trifluoroacylation with 
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yield of 73% over two steps. Taking advantage of the high heat/mass transfer, in the flow 
reactor enabled good control of the temperature avoiding the decomposition and clogging 
caused by the organolithium intermediates. In addition, using a partitioned cold bath with a 
submerged passage prevented exposure of the reaction mixture to ambient conditions and 
gave better control of reaction temperature in different reaction zones.  Alcohol 36 was 
subjected to copper-catalysed carbamate formation in flow using an optimised packed-bed 
reactor, affording the final rac-Efavirenz 31 with 62% isolated yield. Employing the 
optimised packed-bed reactor allowed the reaction to be performed with a lower catalyst 
loading and for a shorter reaction time (1 h), representing a significant improvement 
compared with batch process (16 h).  
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Scheme 10 Flow synthesis of Efavirenz. 
Lapkin et al. developed the synthesis of the antimalarial API artemether from artemisinin 9 in 
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significant advantages over the optimised literature batch reactions, especially for enabling 
small solvent inventories.  
 
 
Scheme 11 Flow process for a tandem conversion of Artemisinin 9 into artemeter 38. 
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Scheme 12 Racemic synthesis and enzymatic resolution towards nonpeptidal bis-THF moiety 39 of Darunavir 44 in 
continuous-flow. 
Sedelmeier et al. developed a two-step telescoped flow process of ribociclib with integrated 
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crude 48.HCl as a solution. The acidic aqueous phase containing 48.HCl was then combined 
with an aqueous NaOH stream, followed by a 2nd in-line liquid-liquid extraction to afford an 
organic phase containing 48 as free base. Subsequent salt formation with succinic acid 
provided the desired product ribociclib 45. With a total residence time of 90 minutes, the 
flow process delivered the desired product 45 in 92.5% yield and 95% purity with a 
throughput of 51.0 g/h. 
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Scheme 13 Telescoped continuous-flow synthesis of ribociclib 45. 
 
Baumann et al. described a continuous synthesis of ibuprofen 27 based on a photo-Favorskii 
rearrangement reaction of a readily available α-chloropropiophenone precursor 49 (Scheme 
14).39 This flow process was performed using a photo-reactor that can be linked to a photo-
spectrometer in order to allow real time analysis and reaction profiling. In addition, various 
filters were studied for the screening of reaction wavelength. 
 
 
Scheme 14 Flow synthesis of ibuprofen via a photo-Favorskii rearrangement. 
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Recently, Cole et al. reported a kilogram-scale synthesis of prexasertib monolactate 
monohydrate 50 under continuous-flow cGMP (current good manufacturing practices) 
conditions.40 This small-volume continuous (SVC) process contains eight unit operations, 
producing the pure target compound 50 at roughly 3 kilograms per day using a series of small 
continuous reactors, extractors, evaporators, crystallisers and filters.40 This production begins 
with the four-step synthesis of nitrile 56 under batch conditions (Scheme 15). Nitrile 56, 
employed as the starting material in the continuous flow processes, was converted to pyrazole 
57 under high temperature and pressure conditions using a stainless steel plug flow reactor 
(PFR). Subsequent continuous counter current extraction and inline concentration under 
reduced pressure provided the intermediate solution of 59. An SNAr reaction of 59 and 
pyrazine 58 was performed using a PFR, followed by the addition of methanol which 
afforded a viscous slurry. A continuous crystallisation process using two mixed-suspension, 
mixed-product removal vessels (MSMPR) in series and intermittent flow filters minimised 
the solids fouling in the process and provided the crystallised solids 59 in excess of 99.8 % 
HPLC purity. The dissolution of 59 in formic acid promoted removal of the Boc protecting 
group with controlled gas evolution of carbon dioxide and iso-butylene using a custom made 
vertically oriented PFR reactor to handle these gaseous by-products. Solution of 60 was 
treated with excess lactic acid, subsequent inline rotary evaporator concentration of the crude 
solution and batch recrystallisation, the product was filtered as a lactate salt 50. This SVC 
manufacturing production, as a successful example, has demonstrated the usefulness and real 
world applications of integrated continuous processes for productions of APIs.  
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Scheme 15 Continuous-manufacturing production for prexasertib monolactate monohydrate 50. 
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2.2 Precursor to Sacubitril AHU-377 
 
2.2.1 Introduction 
  
The preceding chapter has described the recent developments in the field of API syntheses 
using enabling technologies. In this chapter, another example of integrated flow and batch-
based synthesis of an API for heart failure treatment is described.    
 
2.2.1.1 Target molecule 
 
The α-methyl-β-amino-γ-biphenyl valeric acid derivative sacubitril 62 (Figure 2) is a prodrug 
neprilysin inhibitor identified by Ksander et al. in 1995.41 Sacubitril 62 has shown 
antihypertensive effect and its mode of action in humans has been studied. In combination of 
sacubitril with the angiotensin II receptor antagonist valsartan 61 (Figure 2) by co-
crystallisation, a first-in-class dual acting drug LCZ696 was developed to reduce the risk of 
cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) and reduced 
ejection fraction. LCZ696 (marketed under the brand name Entresto) was granted approval in 
2015 under the FDA’s priority review process for its use in heart failure.42  
 
In the synthesis of sacubitril 62, the main challenge lies in the assembly of the two 
stereocentres. Several synthetic strategies to this precursor 63 have been reported and four of 
the most interesting of these are reviewed in the following section.  
 
 
Figure 2 Active components in Entresto. 
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2.2.1.2 Selected literature syntheses 
 
The first synthesis of sacubitril was reported in 1995 by Ksander et al., in the same paper as 
its discovery, and was performed during the identification of novel neprilysin inhibitors with 
superior pharmacologic properties.41 Their eight-step route proceeded from the reaction of an 
unnatural N-Boc-D-tyrosine methyl ester 64 with triflic anhydride followed by a Suzuki 
coupling reaction with phenylboronic acid to give ester 65 (Scheme 16). Saponification of the 
ester 65 followed by the formation of the Weinreb amide and subsequent lithium aluminium 
hydride reduction provided aldehyde 66. Treatment with a Wittig reagent 
(carbethoxyethylidene)triphenylphosphorane gave the (E)-olefin 67 as a single geometric 
isomer. Palladium-catalysed hydrogenation of olefin 67 yielded a 6:1 threo:erythro mixture 
of ester 67. The Boc protecting group was removed with hydrochloric acid to provide the 
sacubitril precursor 63. 
  
 
Scheme 16 Ksander's route to sacubitril. 
 
Therein, the stereochemistry of amine was inherited from 64 and the stereocentre at the α-
position was installed via a Wittig reaction between biphenyl amino aldehyde and 
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(carbethoxyethylidene)triphenylphosphorane followed by a stereoselective hydrogenation of 
the resulting internal double bond of acrylic ester 67 (Scheme 16).  
 
An alternative route to the precursor 63, by Hook et al., started with L-pyroglutamic acid 
methyl ester 69 and was completed in seven linear synthetic steps (Scheme 17).43 Amide 
formation from acid 69 followed by treatment with 4-biphenyl magnesium bromide to 
provide ketone 70. Reduction of ketone 70 under catalytic hydrogenation conditions in the 
presence of 5% Pd/C followed by Piv protection gave lactam 71. Enantioselective 
methylation of lactam 71 with dimethyl sulfate provided (3R, 5S)-72 in a 91:9 diastereomeric 
ratio. Piv deprotection with tosic acid followed by lactam ring opening reaction under acidic 
reflux conditions afforded amine salt 63.  
 
 
Scheme 17 Hook's route to sacubitril (yields were not reported). 
 
Another example route to 62, by Xu et al., was a six-step route starting from chiral (4R, 1S)-
4,5-dihydro-2-(1-methyl-3-butenyl)-4-(1,1-dimethylethyl)oxazole 74 (Scheme 18).44 
Hydrolysis of oxazoline 74 followed by ozonolysis gave acid 75. Lactamisation followed by 
O-cyclisation with a chiral Betti base 76 provided lactam 77 as a single diastereomer. Ring 
opening reaction of lactam 77 with 4-biphenyl magnesium bromide followed by catalytic 
hydrogenation using 10% Pd/C afforded enantiomerically pure lactam 79 after 
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recrystallisation. Subsequent lactam ring opening under acidic ethanolic conditions afforded 
ester 63.  
 
 
Scheme 18 Xu's route to Sacubitril (yields were not reported). 
 
Most recently, a multi-gram scale synthesis of sacubitril, by Tian et al., was developed based 
on a stereodefined building block approach.45 Their synthesis started with the treatment of 
mono-protected triol 80 with nonafluorobutanesulfonyl fluoride and DBU to give chiral 
epoxide 81 (Scheme 19). Employing a catalytic amount of copper(I) bromide dimethyl 
sulfide complex in the Grignard reaction with 4-biphenyl magnesium bromide led to epoxide 
opening with exclusive regioselectivity to give 82. A two-step process involving meslyation 
followed by substitution of the resulting mesylate with sodium azide converted the R-
configured hydroxyl group 82 to the S-configured azide 83. After the removal of the acid-
sensitive TBS group of 83 and alcohol oxidation in a one-pot process using Jones reagent, the 
crude acid was then reacted with thionyl chloride to provide ethyl ester 84. The azide 
reduction of 84 to 63 was attempted using catalytic hydrogenation in the presence of Pd/C in 
MeOH. Instead, lactam 73 was produced exclusively with the NMR data of 73 matching with 
previously reported literature. In order to synthesise sacubitril, the Staudinger reduction with 
triphenylphosphine was performed to convert azide 84 to crude aza-yilde, followed by 
treatment of aza-ylide with succinic anhydride, known as the Staudinger ligation, afforded 
sacubitril 62.  
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Scheme 19 Tian's route to sacubitril. (yield of prepartion of 73 was not reported). 
 
2.2.1.3 Synthetic approach to 63 
 
The proposed retrosynthesis of enantiopure 63 incorporating asymmetric addition to an imine 
and stereoselective hydrogenation as the key steps is shown below (Scheme 20). It was 
envisaged that substrate 85 could be synthesised from commercially available 4-
biphenylacetic acid 90. Esterification followed by DIBAL reduction would provide 4-
biphenylacetaldehyde 89. Imine formation to give chiral tert-butylsulfinimine 87, and 
subsequent metal mediated Barbier-type carbethoxyallylation with bromide 86 would furnish 
85. Stereoselective hydrogenation of 85 followed by deprotection should then lead directly to 
the sacubitril precursor 63.  
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Scheme 20 Retrosynthetic analysis of sacubitril. 
 
In order to assess the potential benefits that could be offered through the application of the 
enabling technologies, the route would first need to be developed under batch conditions 
before its modification into flow.   
 
2.2.2 Result and discussion 
 
2.2.2.1 Synthesis of biphenylacetaldehyde 89 
 
The target synthesis of 63 commenced with the esterification of 4-biphenylacetic acid 90 with 
thionyl chloride in methanol under reflux conditions. Subsequent DIBAL reduction at -78 °C 
gave aldehyde 89 in 98% yield over two steps under batch conditions (Scheme 21).  
 
 
Scheme 21 Preparation of aldehyde 89. 
 
Inspired by the previous work by Ley et al., a flow synthesis of 89 was also developed from 
the commercially available 4-biphenyl iodide 91 via two heterogeneous catalytic gas/liquid 
reactions: the ethylene Heck reaction and anti-Markovnikov Wacker reaction respectively.46 
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could be effectively catalysed by 1 mol% palladium(II) acetate with the use of monodentate 
ligands, tri-tert-butylphosphonium tetrafluoroborate, and base, N,N-
dicyclohexylmethylamine, in MeOH/PhMe (1:9) at 120 °C under 15 bar of ethylene gas. This 
flow reaction was complete in a residence time of 20 minutes. Polymer-supported thiourea 
(QP-TU) and polymer-supported sulfonic acid (QP-SA) scavenged the palladium catalyst and 
base respectively so that solvent removal was the only necessary manual handling required to 
isolate the product.  
 
 
Scheme 22 Flow preparation of aldehyde 89.^ 
 
The preparation of 4-biphenylacetaldehyde 89 from styrene 92 commenced with flow anti-
Markovnikov Wacker oxidation, once again, using the tube-in-tube reactor.47 Treatment of 
styrene 92 with 5 mol% bis(acetonitrile)dichloropalladium(II), 5 mol% copper(II) chloride 
and water (1.5 equiv.) in PhMe/tBuOH (1:6) under 8 bar oxygen at 60 °C gave aldehyde 89 in 
80% yield after flash column chromatography.  The starting material was fully consumed 
with 86 % selectivity towards the desired acetaldehyde 89 over formation of the 
corresponding benzaldehyde and methyl ketone by-products. 
Pd(OAc)2 (5 mol%)
Cy2NMe (1.1 equiv.)
PhMe/MeOH (9:1)
1.0 mLmin-1
I
tBu3PH.BF4 (2 mol%)
1.5 m
H2C CH2 (15 bar)
GPR
5 mL, 0.30 M
20 mL
120 °C
QP-SA and QP-TU 300 PSI
92
99 % yield
PhMe/tBuOH (1:6)
0.25 mLmin-1
2 mL, 0.20 M
30 mL
60 °C
QP-TU300 PSI
PhMe/tBuOH (1:6)
0.25 mLmin-1
2 mL, 0.20 M
(MeCN)2PdCl2 (5 mo%)
CuCl2 (5 mol%)
H2O (1.4 equiv.)
GPR
O2 (8 bar)
1.5 m
O
H
89
80 % yield
after column chromatography
91
0.42 mL
0.42 mL
5 g
5 g
^This work was conducted in collaboration with Dr Samuel Bourne 
2. Synthesis of API using flow chemistry 
	 			 37	
2.2.2.2 Synthesis of N-tert-butanesulfinimine 88 
 
 
Scheme 23 Preparation of chiral sulfinamide (S)-88 and (R)-88. 
 
In order to investigate the desired stereochemistry of chiral sulfinimine required for the key   
asymmetric addition reaction in the next step, both enantiopure R-(+)- and S-(-)-2-methyl-2-
propanesulfinamide (R)-88 and (S)-88 were prepared separately in gram scale in batch 
(Scheme 23). According to previously described procedures, S-(-)-2-methyl-2-
propanesulfinamide (S)-88 can be synthesised from di-tert-disulfide 93 via catalytic 
asymmetric mono-oxidation and subsequent nucleophilic substitution reaction with lithium 
amide.48 Treatment of di-tert-disulfide 93 with hydrogen peroxide solution in acetone 0 °C in 
the presence of vanadyl bis-acetylacetonate and chiral tridentate ligand (R, S)-95 gave the 
desired mono-oxidised product (R)-94 in 96 % conversion with 86 % enantiomeric excess 
respectively. Slow addition of hydrogen peroxide solution over 18 hours and continuous 
monitoring by 1H NMR and/or chiral HPLC prevented over-oxidation and enhanced the 
enantioselectivity of the product.  
 
 
Scheme 24 Asymmetric oxidation of di-tert-disulfide 93. 
 
Regarding the stereochemistry control in the mechanism, previous studies described that VO 
(acac)2 reacted with ligand (R, S)-95 under aerobic conditions in acetonitrile to give a 2:1 
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was confirmed by X-ray diffraction crystallography. Moreover, the square pyramidal 
geometry of the vanadium complex was exposed, where the oxo ligand and tert-butyl group 
of the tridentate ligands were located on opposite sides of the plane of the square pyramid, 
due to steric hindrance. At high concentrations of hydrogen peroxide in the reaction mixture, 
the non-stereoselective catalytic pathway is dominant, involving complete or partial 
displacement of ligand (R, S)-95 from the vanadium complex A by excess hydrogen peroxide 
to give a non-selective intermediate B. Slow addition of hydrogen peroxide avoided high 
concentrations of hydrogen peroxide in the reaction mixture, and therefore allowed formation 
of the selective oxidant allowing di-tert-butylsulfide to be oxidised selectively to afford the 
desired product (R)-94. A nucleophilic substitution reaction of sulfinyl sulfide (R)-94 with 
lithium amide (generated in situ from lithium metal and ammonia in the presence of iron(III) 
nitrate at -78 oC) in ammonia at -78 °C afforded (R)-tert-butylsulfinamide (R)-88 in 52 % 
yield with 99 % enantiomeric excess after recrystallisation over two steps. Enantiopure S-(+)-
2-methyl-2-propanesulfinamide (S)-88 was prepared in a similar approach, however, using an 
alternate tridenate ligand (S, R)-95  instead in the asymmetric mono-oxidation. 
 
Condensation of (S)-tert-butylsulfinamide (S)-88 with acetaldehyde 89 in flow in the 
presence of 5 mol% pyridinium p-toluenesulfonate through a column of magnesium sulfate 
heated at 70 °C was completed in less than 10 minutes to afford (S)-imine (S)-87 in 
quantitative yield. QuadraPure® benzylamine (QP-BZA) and QP-SA scavenged the acid 
catalyst and unreacted sulfinamide respectively. The crude product (S)-87 was of excellent 
purity and so could be used in the next step without further purification. Similarly, (R)-imine 
(R)-87 was prepared under the same conditions (Scheme 25).  
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Scheme 25 Flow condensation of (S)-tert-butylsulfinamide (S)-88 with acetaldehyde 89. 
3.2.2.3 Stereoselective allylation of sulfinyl aldimine 87 
 
Adopted the protocol reported by Yus,49 a diastereoseletive aza-Barbier-type 
carbethoxyallylation reaction for asymmetric synthesis of chiral amine was investigated.  
Treatment of (R)-imine (R)-87 with bromide 86 and indium metal in saturated aqueous 
sodium bromide at room temperature gave the desired (RS, R)-diastereomer (RS, R)-85 in 38 
% yield after flash column chromatography with an excellent diastereoisomeric ratio (dr 93:7 
determined by crude 1H NMR analysis). A few observations were made in this experiment: 1) 
the conversion of imine was incomplete; 2) the stirring was stopped after a few hours due to 
the aggregation of solid residue on the magnetic stirrer bar; 3) yields were improved 
significantly but were still variably when the experiment was repeated a few times with 
vigorous stirring. It was suspected that the hydrophobic biphenyl group of imine 87 caused 
limited solubility in saturated aqueous sodium bromide, leading to poor mixing and hence a 
very slow rate of reaction.  
 
Optimisations of relevant reaction parameters are summarised in Table 1. Hydrolysis of the 
imine (R)-87 occurred in THF, yielding the corresponding aldehyde and other reaction 
products derived from it (Table 1, entry 4). These results aligned with the literature that the 
formation of an allylindium intermediate was facilitated in aqueous media. Hence, a number 
of biphasic solvent systems were screened. It was found that when the reaction was 
performed in a mixture of CH2Cl2 and saturated sodium bromide solution (Rs, R)-85 was 
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isolated in 85 % yield with high diastereoisomeric ratio (dr 90:10 determined by crude 1H 
NMR analysis) (Table 1, entries 10).  
 
Table 1 Optimisation of metal-mediated carbethyoxyallylation of (R)-sulfinimine (R)-87 with bromide 86. 
 
Entrya Metalb Additive Solventc Conversion (%)d 
1H NMR 
Yield (%)d 
Selectivity 
(RS, R)-85 : 
(RS, S)-85  
(dr)d 
1 In NaBr H2O 60 38e 95:5 
2 In - EtOAc  0 0 n.d. 
3 In - CH2Cl2 0 0 n.d. 
4 In - THF 100 0 n.d. 
5 In - MeOH 100 54 91:9 
6 In NaBr Acetone : H2O 22 22 85:15 
7 In NaBr MeCN : H2O 55 54 90:10 
8 In NaBr DMSO : H2O 75 63 90:10 
9 In NaBr MeOH : H2O 100 61 94:6 
10 In NaBr CH2Cl2 : H2O 100 85e 90:10 
11 In NaBr iPrOH : H2O 100 75e 93:7 
12 Zn NaBr H2O 55 26e 52:48 
13 Zn LiCl DMF 100 78e 19:81 
14 Zn - DMF 100 82 53:47 
15 Zn LiCl iPrOH 100 68e 1:99 
a 0.1 mmol scale, imine (R)-87, metal (3.0 equiv.), bromide 86 (1.5 equiv.), additive (LiCl 5.0 equiv. or 
saturated solution of NaBr), solvent (0.10 M), room temperature, reaction time = 48 h. b Indium metal powder 
(99.9% metal basis) and activated zinc metal were used. c The ratio of biphasic solvent system was 1:1 d 
Determined by crude 1H NMR. e Isolated yield.  
 
Zinc metal was also investigated as an alternative metal source.50 Compared to reactions 
using indium metal in saturated sodium bromide solution, the yield was similar, however, 
with disappointing diastereoisomeric ratio (dr 52:48 determined by crude 1H NMR analysis). 
However, after optimisation of the reaction conditions, it was found that treatment of imine 
(R)-87 and bromide 86 with zinc metal and lithium chloride in isopropanol gave ester (RS, 
S)-85 in 68 % isolated yield with reverse diastereoisomeric ratio (dr 1:99 determined by 
crude 1H NMR analysis and HPLC). Since the stereochemistry at the C-4 position was 
undesired when using R-imine (R)-87, the stereochemistry at the C-4 position could be 
corrected if S-imine (S)-87 was employed instead. Pleasingly, ester (SS, R)-85 with the 
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desired stereochemistry at the C-4 position was obtained in 70% yield with dr 99:1 when 
treatment of imine (S)-87 and bromide 86 with zinc metal and lithium chloride in isopropanol 
(Scheme 26).  
 
 
Scheme 26 Zinc-mediated carbethyoxyallylation of (S)-sulfinimine (S)-87 with bromide 86. 
 
We adopted the above optimised protocol for the flow generation of organozinc species, the 
diastereoseletive aza-Barbier-type carbethoxyallylation reaction was also successfully 
transferred to a flow process.51 The reaction mixture containing imine (S)-87, bromide 86 and 
LiCl as additive, was passed through a column of activated zinc dust. Less then 5 min 
residence time was sufficient to generate the reactive organozinc intermediate, and followed 
by a reaction coil at room temperature for further 30 min residence time provided ester (SS, 
R)-85 in 70% yield (Scheme 27). 
 
 
Scheme 27 Flow preparation of allyl ester (SS, R)-85. 
 
The mechanism of the Barbier reaction is similar to the Grignard reaction, however, the 
former reaction is performed in a one-pot synthesis whereas in the later reaction the Grignard 
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reagent is prepared separately before addition of the electrophile. When organoindium is 
treated with (R)-imine (R)-87, the (RS, R)-diastereomer (RS, R)-85 was provided exclusively. 
This result is consistent with previously reported findings, which suggest an approach of an 
allylindium sesquihalide intermediate 96 as the nucleophilic species through proceeding a 
six-membered ring model TS-I and TS-II.49 In these transition states, a four-membered 
metallacycle is created, in which the metal is chelated with both the oxygen and the nitrogen 
atoms of the imine moiety (Figure 3). In addition, it was assumed that the nucleophilic attack 
occurs predominantly to the Si-face of the imine unit for (RS, R)-diastereomer (RS, R)-85.  
 
 
 
Figure 3 Proposed transition states of indium-mediated carbethyoxyallylation of (R)-sulfinimine (R)-87 with bromide 86. 
 
In the zinc-mediated carbethoxyallylation reaction, a high level of stereocontrol towards (RS, 
S)-diastereomer (RS, S)-85 was observed when the treatment of (R)-imine (R)-87 with 
organozinc reagent and lithium chloride used as an additive in either an N,N-
dimethylformamide or isopropanol. Knochel et al. discovered that oxidative addition of 
lithium chloride to metallic zinc produces a soluble bimetallic intermediate RZnX.LiCl which 
enhance the reactivity of the organozinc reagent. Recent studies by Blum et al. further 
examined the mechanistic role of lithium chloride in enabling such insertion using 
fluorescence microscopy.52 Since the (RS, S)-diastereomer (RS, S)-85 is the major product, it 
is speculated that the nucleophilic attack occurs predominantly to the Re-face of the (R)-
imine unit. Moreover, it is proposed that the dramatic effect of lithium chloride in 
stereocontrol could be related to the chelation of lithium metal to both the oxygen and the 
nitrogen atoms of the imine moiety, which forms a four-membered metallacycle. In such 
transition state, the Si-face addition is more favourable due to minimal steric hindrance 
(Figure 4). 
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Figure 4 Proposed transition states of zinc-mediated carbethyoxyallylation of (S)-sulfinimine (S)-87 with bromide 86. 
  
2.2.2.4 Asymmetric hydrogenation of allyl acid 98 
 
With the allyl ester (SS, R)-85 in hand, asymmetric hydrogenation was investigated. In 2003, 
Börner et al. reported the development of a chiral bisphospholane-Rh(I) catalyst, (-)-4,5-
bis[(2R,5R)-2,5-dimethylphospholanyl](1,2-dimethyl-1,2-dihydropyridazine-3,6-dione)(1,5-
cyclooctadiene)(1,5-cyclooctadiene) rhodium(I) tetrafluoroborate 
[Rh(COD)catASium®M]BF4, for enantioselective hydrogenation of isomeric β-acylamido 
acrylates.53 It was also reported that this catalyst was characterised by a larger bit-angle 
compared to Me-DuPHOS Rh(I) complex and its electronic property of the bridging unit. In 
the following year, the same group published further work on this catalyst for asymmetric 
hydrogenation of non-substituted itaconates in good to excellent enantioselectivities and high 
turnover frequencies.54 Furthermore, this Rh(I) catalyst has also been screened by Novartis 
AG in the investigation of asymmetric hydrogenation of Boc-protected allyl acid Boc-98 and 
gave the Boc-protected acid Boc-99 in excellent yield and enantioselectivity. Pleasingly, 
hydrolysis of allyl ester (SS, R)-85 in batch using a tetrahydrofuran/water (1:1) solution of 
lithium hydroxide, and subsequent treatment of allyl acid 98 with 0.1 mol% 
[Rh(COD)catASium®M]BF4 catalyst 100 and 0.9 equiv. diisopropylethylamine in ethanol 
under 20 bar H2 afforded the acid 99 in quantitative yield and excellent diastereoselectivity 
(95:5) (Scheme 28).  
 
Zn
Cl
Li
Br
97
EtO
O
N
Zn
R
H CO2Et
S
(R)
++
TS III (Re-face addition)
O
Li
N
Zn
CO2Et
H
R
S
(R)
O
++
TS IV (Si-face addition)
Li
2. Synthesis of API using flow chemistry 
	 			 44	
 
Scheme 28 Asymmetric hydrogenation of allyl acid 98. 
 
Regarding the mechanism of Rh-catalysed stereoselective hydrogenation, intermediate III can 
be formed through two possible mechanistic pathways, which are the unsaturated mechanism 
and dihyride mechanism respectively (Scheme 29).55  Solvate complex I can first undergo 
ligand association to give the catalyst-substrate complex IIa, followed by oxidative addition 
with H2 to produce dihydride intermediate III, which is known as unsaturated mechanism. 
Alternatively, oxidative addition with H2 to the solvate complex I generates solvate dihydride 
complex IIb, with subsequent ligand association leading to the dihydride intermediate III, 
which is known as dihydride mechanism. The stereocontrol is determined in the insertion of a 
hydride to form the monohydride intermediate IV, possessing a five-membered ring. When 
the Rh complex III is generated with a C2-chiral diphosphine ligand it forms a mixture of two 
diastereomeric substrate complexes IIIa and IIIb, depending on the Re/Si face selection at C-2 
position, which lead to the S or R hydrogenation product. The enantioselectivity is 
determined by reactivity and the relative equilibrium ratio of these two diastereomeric 
substrate complexes IIIa and IIIb (Figure 5).  
 
 
(R)HN CO2H
S(S)
O
LiOH, THF/H2O, 0 °C
(R)HN CO2Et
S(S)
O
99 % yield
(S)HN (R) CO2H
S(S)
O
(SS, R)-85 98
99
cat. 100 (0.5 mol%),
H2 (20 bar),
DIPEA (0.9 equiv.),
EtOH
99%
dr 97:3
Rh
P
P
O
O
O
catASium M(R)Rh 
100
2. Synthesis of API using flow chemistry 
	 			 45	
 
Scheme 29 Proposed mechanism of asymmetric hydrogenation of allyl acid 98. 
Since the (R)-acid 99 was obtained as the exclusive product, it is suspected that the hydride 
was inserted on the Si face, and hence the diasteromeric substrate complex IIIa should be 
favoured.56 However, the actual transition state of the insertion is not clear. According to the 
previously reported mechanism of the rhodium-catalysed asymmetric hydrogenation reaction, 
a plausible mechanism and possible enantio-determining transition model is proposed.57 The 
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steric hindrance between methyl group on the diphosphine ligand with the biphenyl group of 
the substrate could be determining factor of the selectivity.  
 
 
 
Figure 5 Proposed di-hydride intermediates for diastereoselectivity. 
 
The reaction rate of enantioselective hydrogenation of acrylic acid 98 was relatively slow in 
batch, requiring 20 bar H2 with stirring for 20 hours. With the use of tube-in-tube gas-
reactors, the gas-liquid mixing should be improved and continuous hydrogenation can be 
achieved without the need for installing a high-pressure autoclave. Flow hydrogenation of 
acrylic acid 98 with a tube-in-tube gas-reactor was first attempted, however, only starting 
material was recovered with no conversion to product observed. It was found that H2 has 
been permeated through the fluoropolymers, such as polytetrafluoroethylene (PTFE) and 
perfluoroalkoxy alkane (PFA). After replacement with a stainless steel reactor, the reaction 
showed 33 % conversion to acid 99. It was also found that reducing the concentration of the 
solution and increasing the residence further improved conversion to acid 99. However, an 
additional stainless steel reactor only slightly improves the conversion, hence it was 
suspected that there was a depletion of H2 in the reaction stream.58  
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Table 2 Optimisation of flow asymmetric hydrogenation of allyl acid 98.  
 
Entrya 
Flow rate 
(mL min-1) 
Concentration 
(M) 
Hydrogen 
pressure (bar) 
Conversion to 99 
(%)b 
drc 
1d 0.50 0.10 20 0 - 
2e 0.10 0.10 20 33 93:7 
3e 0.10 0.05 20 78 93:7 
4e 0.10 0.05 30 76 93:7 
5e 0.15 0.05 20 52 93:7 
6 e,f 0.10 0.05 20 82 93:7 
a All reactions performed on a 0.1 mmol scale. b Determined by analysis of the crude reaction product with 1H-
NMR spectroscopy. c Determined by chiral HPLC. d PTFE reactor. e Stainless steel reactor. f Two 20 mL 
reactors. 
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Table 3 Optimisation of modified flow setup for asymmetric hydrogenation of allyl acid 98. 
 
Entrya Concentration (M) Conversion (%)b Isolated yield (%) drc 
1 0.10 100 99 93:7 
2 0.20 99 99 93:7 
3 0.30 85 82 93:7 
4 0.20 83 83 93:7 
5d 0.075 100 99 93:7 
a All reactions performed on a 0.1 mmol scale with a residence time of 200 min. b Determined by analysis of the 
crude reaction product with 1H-NMR spectroscopy. c Determined by chiral HPLC. d Reaction performed on a 
5.2 mmol scale. 
 
Modification of the flow system with the addition of a second tube-in-tube reactor and a 20 
mL stainless steel reactor led to full conversion to the acid 99 under the optimised conditions 
(Table 3). It was found that a 0.2 M solution of acrylic acid 98 with 1 mol% catalyst 100 
under 25 bar of H2 with a residence time of 3.5 hours produced acid 99 in 99% isolated yield 
and 93:7 d.r. (Table 3, entry 5). Moreover, 2 g of allyl acid 98 was processed at slightly lower 
concentration (0.075 M of allyl acid 98) with a throughput of 0.45 g h-1. Diastereomerically 
and enantiomerically pure material of acid 99 was obtained by crystallisation, however, the 
material was of sufficient purity to carry through to the next step. The correct absolute and 
relative configuration of the two stereogenic centers in acid 99 was confirmed by single 
crystal X-ray crystallography (Figure 6). 
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Figure 6 Crystal structure of acid 99. 
Esterification of acid 99 to the corresponding ethyl ester using thionyl chloride in ethanol and 
concomitant cleavage of the sulfinyl group in batch provided the desired product 63·HCl in 
essentially quantitative yield (99%) without further purification. The stereoisomeric purity (dr 
93:7) was confirmed by comparison to known standards by chiral HPLC analysis (Scheme 
30).  
 
 
Scheme 30 Synthesis of precursor to sacubitril 63. 
 
2.2.3 Conclusions and outlook 
 
In summary, (2R,4S)-5-(4-biphenylyl)-4-amino-2-methylpentanoic acid ethyl ester 63.HCl 
was successfully prepared via a machine assisted process in 6 steps (longest linear sequence) 
in 54 % overall yield. Two asymmetric synthetic steps, namely diastereoseletive aza-Barbier-
type carbethoxyallylation reaction and asymmetric hydrogenation, were employed as the key 
transformations to control the stereochemistry of the C-2 and C-4 atoms respectively. A 
number of gas-liquid reactions, such as ethylene Heck reaction, Wacker oxidation and 
asymmetric hydrogenation, were performed using the tube-in-tube flow reactor, enhancing 
the high safety and more efficient mixing with the handling of hazardous gases. The flow 
generation of organzinc species using a column of acitivated zinc dust has demonstrated 
significant advantages, for instance, efficient dissipation of heat compared to the traditional 
batch protocol. This process was performed at gram scale and has the potential to be further 
developed for industrial scale up.  
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2.2.4 Experimental details 
 
2.2.4.1 General Experimental 
 
Unless stated otherwise, reagents were obtained from commercial sources and used without 
purification. New compounds have been fully characterized. NMR characterization was 
performed on reported ones.  1H-NMR spectra were recorded on Bruker Avance DPX-400 or 
DPX-600 (600 MHz), with the residual solvent peak as the internal reference (CDCl3 = 7.26 
ppm). 1H resonances are reported to the nearest 0.01 ppm. 13C-NMR spectra were recorded 
on the same spectrometer with proton decoupling, with the solvent peak as the internal 
reference (CDCl3 = 77.00 ppm). All 13C resonances are reported to the nearest 0.01 ppm. 
DEPT 135, COSY, HMQC, and HMBC experiments were used to aid structural 
determination and spectral assignment. The multiplicity of 1H signals are indicated as: s 
=singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublets of doublets, t = 
triplet, q = quadruplet, sext = sextet, m = multiplet, br = broad, or combinations of thereof. 
Coupling constants (J) are quoted in Hz and reported to the nearest 0.1 Hz. Where 
appropriate, measures of the same coupling constant are averaged. The removal of solvent 
under reduced pressure was carried out on a standard rotary evaporator. High resolution mass 
spectrometry (HRMS) was performed using a Waters Micromass LCT Premier™ 
spectrometer using time of flight with positive ESI, or a Bruker BioApex 47e FTICR 
spectrometer using (positive or negative) ESI or EI at 70 eV to within a tolerance of 5 ppm of 
the theoretically calculated value. Infrared spectra were recorded on a Perkin-Elmer 
Spectrum RX One FT-IR ATR (Attenuated Total Reflectance) spectrometer. The samples 
were prepared as thin films deposited on the ATR, unless otherwise specified. Only 
structurally important absorptions are quoted. Absorption maxima (νmax) are reported in 
wavenumbers (cm-1). Optical rotations were measured on a Perkin-Elmer Polarimeter 343 at 
589 nm (Na D-line) with a path length of 10 cm path length. Concentration (c) are quoted in 
g per 100 mL and specific rotations, [α]D24 are reported in units of 10-1cm2g-1 at 24 oC. 
Melting points were using an OptiMelt automated melting point system available from 
Standford Research Systems. High pressure liquid chromatography (HPLC) was run on an 
Agilent Technologies 1100 Series HPLC with wavelength monitoring at 210 and 254 nm, 
using a Daicel Chiralpak AD-H column (250 mm x 4.6 mm I.D.; pore size: 50 µm).  The 
flow experiments were performed on Uniqsis FlowSyn module1 or a Vapourtec R2+R4 
module.2 All gas-flow reactions were performed with a tube-in-tube reactor as described to 
introduce gases into a continuous flow stream. For the design of the tube-in-tube reactor see 
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previous publications.3 Teflon® AF-2400 (0.6 mm i.d., 0.8 mm o.d.) was used as supplied by 
Biogeneral inc. (9925 Mesa Rim Road, San Diego, California, USA. www.biogeneral.com). 
Omnifit® columns4 were used for the containment of polymer-supported reagent or other 
solid reagents.   
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2.2.4.2 Experimental Procedure 
Flow synthesis of 4-phenylstyrene 92 
 
4-Iodobiphenyl 91 (420 mg, 1.50 mmol), Cy2NMe (0.39 mL, 1.8 mmol), Pd(OAc)2 (3 mg, 1 
mol%) and tBu3PH.BF4 (9 mg, 2 mol%) were dissolved in PhMe/MeOH (5 mL, 9:1). The 
reaction mixture was injected into a Uniqsis Flowsyn reactor via a 5 mL PEEK injection 
loop. The reaction plug was pumped at 1.0 mL min−1 [using PhMe/MeOH (9:1) as stock 
solvent] through a tube-in-tube gas reactor pressurized with ethylene (15 bar) followed by a 
20 mL PTFE reaction coil at 120 °C. The exiting reaction stream passed through an Omnifit 
column containing a mixture of QP-TU and QP-SA followed by a 300 psi BPR. The output 
was directed into a pre-weighed flask and flushed with argon. The solvent was removed in 
vacuo to provide the title compound (268 mg, 1.49 mmol, 99 %) as a white crystalline solid. 
Data are consistent with a reported example.i 
 
1H NMR (400 MHz, CDCl3): δ 7.64 (d, J = 7.4 Hz, 2 H, H3), 7.61 (d, J = 8.3 Hz, 2 H, H6), 
7.52 (d, J = 8.3 Hz, 2 H, H7), 7.48 (t, J = 7.4 Hz, 2 H, H2), 7.38 (t, J = 7.4 Hz, 1 H, H1), 6.78 
(dd, J = 17.6, 11.0 Hz, 1 H, H9), 5.83 (d, J = 17.6 Hz, 1 H, H10), 5.31 (d, J = 11.0 Hz, 1 H, 
H10').  
13C NMR (100 MHz, CDCl3): δ 140.7 (C4), 140.6 (C5), 136.6 (C8), 136.4 (C9), 128.7 (C2), 
127.3 (C1), 127.2 (C6), 126.9 (C3), 126.6 (C7), 114.0 (C10).  
FTIR (νmax, cm-1): 3164 (br w, OH), 1617 (w, C=C), 1581 (w), 1509 (w), 1426 (w), 1325 (s), 
1164 (w), 1122 (m), 1068 (m), 1018 (w), 924 (w), 831 (w). 
HRMS (ESI): calculated for C16H15F3NO [M+H]+ 294.1100, found 294.1104.  
Rf = 0.32 (hexane). 
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Flow synthesis of (4-biphenylyl)acetaldehyde 89 
 
4-Phenylstyrene 92 (72 mg, 0.4 mmol) was dissolved in PhMe/tBuOH (1:6, 2 mL) and loaded 
into injection loop A (2 mL). (MeCN)2PdCl2 (5 mg, 5 mol%), CuCl2 (3 mg, 5 mol%) and 
H2O (0.01 mL, 0.56 mmol) were dissolved in PhMe/tBuOH (1:6, 2 mL) and loaded into 
injection loop B (2 mL). Both reagents were then pumped using a Uniqsis Flowsyn reactor 
via the 2 mL PEEK injection loops A and B at a combined flow rate of 0.5 mL min−1 (using 
PhMe/tBuOH (1:6) as stock solvent). The combined reagent stream was the passed through a 
tube-in-tube reactor pressurized with dry O2 (8 bar) followed by a 30 mL stainless steel 
reaction coil at 60 °C. The output stream then passed through an Omnifit column containing 
QP-TU and a 300 psi BPR, directed into a round-bottom flask. The flask was purged 
throughout the reaction with a stream of argon. The solvent was removed under vacuum and 
the crude residue purified by silica gel column chromatography (20 % EtOAc/Hexane) to 
yield the title compound (63 mg, 0.32 mmol, 80 %) as a white crystalline solid. Data are 
consistent with a reported example.ii 
 
1H NMR (400 MHz, CDCl3): δ = 9.81 (t, J = 2.5 Hz, 1 H, H10), 7.63 (d, J = 7.8 Hz, 4 H, 
H7, H3), 7.48 (t, J = 7.4 Hz, 2 H, H2), 7.39 (t, 7.4 Hz, 1 H, H1), 7.32 (d, J = 7.8 Hz, 2 H, 
H6), 3.75 (d, J = 1.6 Hz, 2 H, H9). 
13C NMR (101 MHz, CDCl3): δ 191.4 (C10), 140.6 (C4), 140.4 (C5), 130.9 (C7), 130.1 (C4, 
C8), 128.9 (C6), 127.7 (C3), 127.4 (C1), 127.1 (C2), 50.0 (C9). 
m.p.: 54.8–58.2 °C (recrystallised in hexane) 
FTIR (νmax, cm-1): 3032 (w), 1721 (s, CO), 1488 (w), 1509 (w), 1426 (w), 1325 (s), 1164 (w), 
1122 (m), 1068 (m), 1018 (w), 924 (w), 831 (w). 
HRMS (ESI): calculated for C14H12O [M+H]+ 197.0958, found 197.0961.  
Rf = 0.27 (20 % EtOAc/hexane). 
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Flow synthesis of [2-(4-biphenylyl)ethylidene]((S)-tert-butylsulfinyl)amine (S)-87 
 
(4-Biphenyl)acetaldehyde 89 (392 mg, 2.0 mmol) was dissolved in PhMe/tBuOH (1:9, 2 mL) 
and loaded into injection loop A (2 mL). (S)-tert-Butylsulfinamide (S)-88 (266 mg, 2.2 
mmol) and PPTS (25 mg, 5 mol%) were dissolved in iPrOH (2 mL) and loaded into injection 
loop B (2 mL). The reagents are pumped using a Uniqsis Flowsyn reactor via the 2 mL PEEK 
injection loops A and B. The two sample loops were switched inline into streams of 
PhMe/tBuOH each flowing at 0.15 mL min−1 and mixed in a T-piece. The output of the T-
piece was directed to an Omnifit column containing MgSO4 (6 g) held at 70 °C, followed by 
a column containing a mixture of QP-SA and QP-BZA, followed by a 150 psi BPR. The 
output stream was collected in a 25 mL round bottom flask and the solvent was removed in 
vacuo to afford analytical pure title compound (595 mg, 1.99 mmol, 99 %) as an orange 
solid. Data are consistent with a reported example.iii 
 
1H NMR (400 MHz, CDCl3): δ 8.17 (t, J = 5.2 Hz, 1 H, H10), 7.58 (m, H3, 4 H, H7), 7.44 
(t, J = 7.4 Hz, 2 H, H2), 7.35 (t, J = 7.4 Hz, 1 H, H1), 7.31 (d, J = 8.0 Hz, 2 H, H6), 3.88 (m, 
2 H, H9), 1.21 (s, 9 H, H12). 
13C NMR (101 MHz, CDCl3): δ 167.3 (C10), 140.7 (C4), 140.1 (C5), 133.8 (C8), 129.6 
(C7), 128.8 (C6), 127.6 (C3), 127.3 (C1), 127.0 (C2), 56.9 (C11), 42.3 (C9), 22.4 (C12). 
m.p.: 48.1–50.0 °C (recrystallised in hexane) 
[α]D24 : +195.8 (c 1.0, CHCl3)  
FTIR (νmax, cm-1):  3726 (w), 2969 (w), 2327 (s), 1620 (s, CN), 1487 (m), 1364 (w, SO), 
1081 (s), 1078 (w), 829 (m), 763 (m). 
HRMS (ESI): calculated for C18H22NOS [M+H]+ 300.1422; found 300.1417. 
HPLC: 97% ee (Daicel Chiralpak AD-H column; 90:10 hexanes/isopropanol; flow rate = 0.9 
mL min-1; 25 oC; λ = 254 nm; run time = 35 min; tR (S) = 14.6 min, tR (R) = 8.9 min). 
Rf = 0.54 (20 % EtOAc/hexane) 
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Flow synthesis of (4R)-5-(4-biphenylyl)-4-[(S)-tert-butylsulfinylamino]-2-
methylenepentanoic acid ethyl ester (SS, R)-85 
 
[2-(4-Biphenylyl)ethylidene]((S)-tert-butylsulfinyl)amine (S)-87 (595 mg, 2.0 mmol) was 
dissolved in iPrOH (2 mL) and loaded into injection loop A (2 mL). 2-
(Bromomethyl)propenoic acid ethyl ester 86 (460 mg, 2.4 mmol) and LiCl (339 mg, 8 mmol) 
dissolved in iPrOH (2 mL) and loaded into injection loop B (2 mL). The reagents are pumped 
using a Uniqsis Flowsyn reactor via the 2 mL PEEK injection loops A and B. The two 
sample loops were switched inline into streams of iPrOH each flowing at 0.15 mL min−1. The 
output stream of the T-piece was directed to an Ominfit column (3 mm i.d. x 100 mm) 
containing activated zinc dust (1.35 g) followed by a 10 mL PFA reactor coil. The output was 
then pumped through an Omnifit column containing QP-SA and QP-TU, followed by a 150 
psi BPR. The exiting stream containing the reaction mixture was directed into a 25 mL round 
bottom flask and the solvent was removed under vacuum. Purification of the crude residue by 
silica gel column chromatography (40 % EtOAc-Hexane) provided the title compound (579 
mg, 1.39 mmol, 70 %) as colourless oil. 
 
1H NMR (600 MHz, CDCl3): δ 7.60 (d, J = 8.4 Hz, 2 H, H3), 7.57 (d, J = 8.2 Hz, 2 H, H6), 
7.45 (t, J = 7.5 Hz, 2 H, H2), 7.35 (m, 3 H, H1, H7), 6.26 (s, 1 H, H13), 5.60 (s, 1 H, H13), 
4.19 (q, J = 7.1 Hz, 2 H, H15), 3.80 (m, 1 H, H10), 3.35 (d, J = 8.3 Hz, 1 H, NH), 3.14 (dd , J 
= 13.7, 5.1 Hz, 1 H, H9), 3.02 (dd, J = 13.7, 7.1 Hz, 1 H,  H9'), 2.57 (dd, J = 14.1, 4.3 Hz, 1 
H, H11), 2.44 (dd, J = 14.1, 9.5 Hz, 1 H, H11), 1.28 (t, J = 7.1 Hz, 3 H, H16), 1.16 (s, 9 H, 
H18) 
13C NMR (101 MHz, CDCl3): δ 167.0 (C14), 140.8 (C4), 139.5 (C5), 137.7 (C8), 136.1 
(C7), 130.4, 128.7 (C2), 127.7 (C6), 127.1 (C1), 127.0 (C13), 127.0 (C3), 61.0 (C15), 57.0 
(C17), 56.2 (C10), 42.6 (C9), 38.0 (C11), 22.6 (C18), 14.2 (C16) 
FTIR (νmax, cm-1):  3234 (w), 2958 (w), 1713 (s, CO), 1628 (w), 1487 (m), 1182 (w), 1366 
(w), 1313 (w), 1181 (s), 1143 (m), 1053 (s), 949 (w), 845 (w), 764 (m). 
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HRMS (ESI): calculated for C24H32NO3S [M+H]+ 414.2103, found 414.2097  
HPLC: 98:2 d.r. (Daicel Chiralpak AD-H column; 90:10 hexanes/isopropanol; flow rate  = 
0.9 mL min-1; 25 oC; λ = 254 nm; run time = 35 min; tR (4R,SS) = 12.4 min, tR (4S,SS)  = 17.0 
min). 
Rf = 0.18 (40 % EtOAc/hexane) 
 
Batch synthesis of (4R)-5-(4-biphenylyl)-4-[(S)-tert-butylsulfinylamino]-2-
methylenepentanoic acid 98 
 
To a stirred solution of (4R)-5-(4-biphenylyl)-4-[(S)-tert-butylsulfinylamino]-2-
methylenepentanoic acid ethyl ester (SS, R)-85 (28.0 g, 68.0 mmol) in THF (500 mL) at 0 °C 
was added a solution of lithium hydroxide (9 g) in H2O (300 mL). The reaction mixture was 
allowed to warm to room temperature and stirred for 6 h. The reaction was quenched by 
addition of phosphoric acid (85% v/v) until pH 3-4 was obtained. Et2O (500 mL) was added 
and the aqueous layer removed. The remaining organic layer was washed with brine (100 
mL), dried with MgSO4 and the solvent removed under vacuum. The residue was dissolved 
in the minimum amount of CH2Cl2 followed by slow addition of hexane to precipitate the 
titled compound (25.9 g, 67.1 mmol, 99 %) as a white amorphous solid.  
 
1H NMR (400 MHz, CDCl3): δ 7.58 (d, J = 7.4 Hz, 2 H, H3), 7.54 (d, J = 8.1 Hz, 2 H, H6), 
7.43 (t, J = 7.4 Hz, 2 H, H2), 7.33 (t, J = 7.4 Hz, 1 H, H1), 7.33 (d, J = 8.1 Hz, 2 H, H7), 6.34 
(s, 1 H, H13), 5.66 (s, 1 H, H13), 3.85 (m, 1 H, H10), 3.65 (d, J = 7.8 Hz, 1 H, NH), 3.10 (dd, 
J = 13.8, 5.6 Hz, 1 H, H9), 3.03 (dd, J = 13.8, 6.9 Hz, 1 H, H9'), 2.51 (m, H112 H,), 1.16 (s, 9 
H, H16).  
13C NMR (100 MHz, CDCl3): δ 170.4 (C14), 140.8 (C4), 139.5 (C5), 137.7 (C8), 136.2 
(C12), 130.3 (C7), 128.8 (C1), 128.8 (C2), 127.2 (C13), 127.0 (C3, C6), 57.1 (C15), 56.6 
(C10), 42.5 (C9), 37.5 (C11), 22.7 (C16).  
m.p.: 59.6 °C  
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FTIR (νmax, cm-1):  2925 (w), 2326 (s), 1694 (s, CO), 1626 (w), 1487 (w), 1365 (w), 1292 
(w), 1185 (m), 1007 (m, SO), 824 (w), 762 (m).  
HRMS (ESI): calculated for C22H28NO3S [M+H]+ 386.1790; found 386.1780. 
HPLC: 95:5 d.r. (Daicel Chiralpak AD-H column; 90:10 hexanes/isopropanol; 25 oC; flow 
rate = 0.9 mL min-1; λ = 254 nm; run time = 30 min; tR (4R,SS) = 16.9 min, tR (4S,SS) = 8.9, 
21.3 min). 
Rf = 0.00 (20% EtOAc/hexane) 
 
Flow synthesis of (2R,4S)-5-(4-biphenylyl)-4-[(S)-tert-butylsulfinylamino]-2-
methylpentanoic acid 99 
 
(4R)-5-(4-Biphenylyl)-4-[(S)-tert-butylsulfinylamino]-2-methylenepentanoic acid 98 (2.0 g, 
5.2 mmol), (−)-2,3-Bis[(2R,5R)-2,5-dimethylphospholano] maleicanhydride(1,5-
cyclooctadiene)rhodium(I) tetrafluoroborate (324 mg, 519 µmol) and N,N-
diisopropylethylamine (0.06 mL, 4.67 mmol) were dissolved in EtOH (69 mL). The reaction 
mixture was injected into a Vapourtec R2+/R4, flowing at 0.2 mL min−1 through a tube-in-
tube gas reactor pressurized with H2 (20 bar) followed by a 20 mL stainless steel reaction 
coils at room temperature. The output reaction stream passed through another tube-in-tube 
gas reactor pressurized with H2 (20 bar) by a 20 mL stainless steel reaction coils at room 
temperature. The output was directed through a 300 psi BPR and a variable BPR into a pre-
weighed flask and flushed with argon. The reaction mixture was filtered through celite and 
the solvent removed in vacuo to provide 1.99 g (99%) of the title compound as a yellow solid. 
 
1H NMR (600 MHz, CDCl3): δ 7.58 (d, J = 7.5 Hz, 2 H, H3), 7.54 (2 H, d, J = 8.1 Hz, 2 H, 
H6), 7.42 (t, J = 7.5 Hz, 2 H, H2), 7.33 (t, J = 8.1 Hz, 1 H, H1), 7.22 (d, J = 8.2 Hz, 2 H, H7), 
3.68 – 3.75 (m, 1 H, H10), 3.37 (d, J = 9.0 Hz, 1 H, NH), 3.10 (dd, J = 13.7, 4.6 Hz, 1 H, 
H9), 3.04 (dd, J = 13.7, 6.9 Hz, 1 H, H9'), 2.72 (m, 1 H, H12), 1.91 (ddd, J = 14.0, 10.4, 3.5 
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Hz, 1 H, H11), 1.51 (ddd, J = 14.0, 10.4, 3.5 Hz, 1 H, H11'), 1.23 (d, J = 6.8 Hz, 3 H, H13), 
1.10 (s, 9 H, H16). 
13C NMR (151 MHz, CDCl3): δ 180.9 (C14), 140.8 (C4), 139.4 (C5), 135.8 (C8), 130.6 
(C7), 128.7 (C1), 127.2 (C2), 127.1 (C6), 127.0 (C3), 56.4 (C15), 55.8 (C10), 42.4 (C12), 
39.0 (C9), 36.2 (C11), 22.7 (C16), 17.9 (C13). 
m.p.: 120.1 °C 
FTIR (νmax, cm-1):  3352 (br w, COOH), 3316 (w), 3288 (w), 2986 (w), 2917 (w), 1640 (w), 
1582 (s), 1563 (m), 1488 (w), 1474 (w), 1439 (m), 1407 (m), 1338 (m), 1367 (w), 1327 (w), 
1222 (w), 1201 (w), 1177 (w), 1080 (w), 1049 (s), 959 (w), 928 (m), 868 (w), 847 (m), 839 
(m),758 (s), 731 (m). 
[α]D20 : (c 1.0, CHCl3) −15.8 
HRMS (ESI): calculated for C22H30NO3S [M+H]+ 388.1946, found 388.1958. 
HPLC: 97:3 d.r. (Daicel Chiralpak AD-H column; 90:10 hexanes/isopropanol; 25 oC; flow 
rate = 0.9 mL min-1; λ = 210 nm; run time = 45 min; tR (2R,4S) = 16.1 min, tR (2R,4R) = 23.6 
min). 
 
Figure 7 X-ray Crystal Structure of 99. 
CCDC: 1427794 
Summary of Data CCDC 1427794 
Compound Name: Formula: 2(C22 H29 N1 O3 S1),C4 H10 O1,(C1)n 
Unit Cell Parameters: a 6.5483(2) b 14.2646(5) c 25.3389(9) P21 
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Batch Synthesis of (2R,4S)-5-(4-biphenylyl)-4-amino-2-methylpentanoic acid ethyl ester 
hydrochloride 63.HCl 
 
To a stirred solution of (2R,4S)-5-(4-biphenylyl)-4-[(S)-tert-butylsulfinylamino]-2-
methylpentanoic acid 99 (50.0 mg, 134 µmol) in absolute ethanol (0.4 mL) at 0 °C was added 
thionyl chloride (20 µL, 268 µmol). The reaction mixture was stirred at room temperature for 
3 h. The solvent was removed to yield 46.0 mg (99%) of titled compound as a white solid. 
Data are consistent with a reported example.iv 
 
1H NMR (600 MHz, DMSO-d6): δ 8.17 (br. s, 3 H, NH), 7.66 (dd, J = 8.0, 7.4 Hz, 4 H, H3, 
H6), 7.47 (t, J = 7.7 Hz, 2 H, H2), 7.36 (t, J = 7.4 Hz, 2 H, H1), 7.36 (d, J = 8.0 Hz, 1 H, H7), 
3.99 (q, J = 7.1 Hz, 1 H, H15), 3.42 – 3.36 (m, 1 H, H10), 3.04 (dd, J = 13.8, 5.5 Hz, 1 H, 
H9), 2.81 (dd, J = 13.8, 8.1 Hz, 1 H, H9'), 2.77 – 2.70 (m, 1 H, H12), 1.86 (ddd, J = 14.3, 9.1, 
5.0 Hz, 1 H, H11), 1.59 (ddd, J = 13.8, 8.1, 5.4 Hz, 1 H, H11'), 1.10 (t, J = 7.1 Hz, 3 H, H16), 
1.07 (d, J = 7.1 Hz, 3 H, H13). 
13C NMR (151 MHz, CDCl3): δ 174.7 (C14), 139.7 (C4), 138.7 (C5), 135.5 (C8), 130.0 
(C7), 129.0 (C1), 127.4 (C2), 126.8 (C6), 126.5 (C3), 60.1 (C15), 50.4 (C10), 38.1 (C5), 35.5 
(C11), 35.0 (C12), 17.5 (13), 13.9 (C16). 
FTIR (νmax, cm-1):  3234 (w), 2925 (w), 1694 (s, CO), 1626 (w), 1487 (w), 1185 (s), 1367 
(w), 1180 (m), 1143 (m), 1007 (s, SO), 949 (w), 845 (w), 765 (m). 
HRMS (ESI): calculated for C20H26NO2 [M+H]+ 312.1964; found 312.1967.  
HPLC: 97:3 d.r. (Daicel Chiralpak AD-H column; isocratic n-
hexane/ethanol/methanol/trimethylamine 80/10/10/0.2; 40 oC; flow rate = 0.8 mL min-1; λ = 
254 nm; run time = 23 mins; tR (2R, 4S) 97.07%; tR (2S,4R) 0.21%; tR  (2S, 4S) 2.32%; tR 
(2R,4R) 0.40%) 
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2.3 Production of an antimalarial drug OZ439 
 
2.3.1 Introduction 
 
In this chapter, a synthesis of an antimalarial drug OZ439 using enabling technologies in 
handling hazardous chemicals, for instance, ozone gas and hydrogen gas, is described. With 
modified flow systems that have fine control in reaction conditions to suppress side products 
formation, these gas-liquid reactions can be performed continuously to provide desired 
product in gram scale, demonstrating the potential of further scale up.  
 
2.3.1.1 Target molecule 
 
Despite significant scientific advancements, malaria is still a global health problem that 
causes the deaths of more than half a million people with a further quarter billion being 
infected, particularly in sub-Saharan African populations.59 Through the bites of infected 
female Anopheles mosquitoes, this life-threatening disease was infected in most cases by 
Plasmodium falciparum and Plasmodium vivax. Despite the development of a number of 
classical antimalarial agents such as artemisinin and its derivatives (Figure 8), the widespread 
use of these agents has led to drug resistance and is therefore diminishing their effectiveness. 
In light of this, new antimalarial chemotherapy is still needed.60 In addition, it is imperative 
to seek more highly potent anti-malarial drugs at low cost in order to match the economies 
that are most afflicted by this disease. 
 
 
Figure 8 Structures of artemisinin derivatives and synthetic ozonides.  (A) Artemisinin  (ART), dihydroartemisinin (DHA), 
artemether (AM) and artesunate (AS); (B) OZ277. 
 
Recent investigations61 focused on the design and optimisation of a completely synthetic 
ozonide antimalarial based upon the 1,2,4-trioxolane pharmacophore, which displays very 
high efficacy against all blood stages of Plasmodium falciparum and Plasmodium vivax, high 
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oral bioavailability, good safety profile, low projected cost of goods, and most importantly, 
the potential for a single-dose oral cure.60a,62 In particular, ozonide OZ277 102, also known as 
arterolane, was the first synthetic ozonide to be evaluated clinically and was granted approval 
in 2012 as a combination drug with piperaquine in India. Further studies directed to improve 
the pharmacokinetic and pharmacodynamic properties resulted in the identification of the 
more potent analogue OZ439 103, also known as artefenomel (Figure 9).63 The important 
property of 103 is that it provides a single oral dose treatment for the total eradication of the 
parasite in humans, especially children, and it is currently undergoing phase IIb trials.64 Like 
its predecessor, next-generation ozonide OZ439 contains a pharmacophoric peroxide bond 
and three stereocentres, which poses significant synthetic challenges.  
 
 
Figure 9 Structure of OZ439 
 
2.3.1.2 Previous synthesis from literature 
 
In 2004, the synthesis of OZ439 for medicinal chemistry studies was first described by 
Vennerstrom et al. using Griesbaum co-ozonolysis and post-ozonolysis reactions.63a 
Employing previous reported conditions by the same group, treatment of oxime 104 and 
ketone 105 with ozone in a 1:4 mixture of cyclohexane and CH2Cl2 at 0 °C gave ozonide 106 
in 70 % yield with cis-trans selectivity of 20:1 (Scheme 31). Ozonide 106 then underwent 
hydrolysis followed by nucleophilic substitution reaction with N-(2-chloroethyl)morpholine 
hydrochloride to provide OZ439 free base 103 in 93 % yield. Final salt formation with 
methanesulfonic acid in ether resulted in the precipitation of the desired OZ439 103 in 98 % 
yield. X-ray crystallography of OZ439 was also reported by the authors. 
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Scheme 31 Vennerstrom's route to OZ439. 
 
Despite its success, there are a number of issues that need to be addressed with this synthesis. 
Firstly, the preparation of ketone 105 was not reported by the authors and is not an 
economical starting material, as it requires multistep chemical synthesis. Secondly, gas liquid 
reactions such as Griesbaum co-ozonolysis can be performed using flow chemistry in order to 
enhance safety and mixing. In addition, the use of large quantities of cyclohexane and 
CH2Cl2 is undesirable in industrial application. Lastly, N-(2-chloroethyl)morpholine is 
potentially genotoxic. In light of this, an alternative route to OZ439 that addresses these 
issues should be developed.  
 
2.3.1.3 Synthetic approach to OZ439 
 
By integrating new technologies with traditional batch methods, an alternate synthetic route 
of ozonide OZ439 would be developed (Scheme 32). By using flow chemistry, the flexibility 
of continuous processing of material is highly amenable to later scale-up, thereby making this 
an attractive approach for industrial production. Key transformations in this new strategy 
include the partial reduction of readily available biphenol 109 to selectively afford 4-(4-
hydroxyphenyl)cyclohexan-1-one 105 and the subsequent Griesbaum co-ozonolysis reaction 
with the O-methyl oxime 104 to provide ozonide 106. Instead of N-(2-
chloroethyl)morpholine, amide substituent 108 was installed to reveal the OZ439 free base 
via an amide reduction process, followed by mesylate salt formation to furnish the final 
product OZ439 103. 
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Scheme 32 Retrosynthetic analysis of OZ439 free base. 
 
2.3.2 Result and discussions 
 
2.3.2.1 Selective reduction of biphenyl in flow 
 
The synthesis of ozonide OZ439 103 began with the selective phenol hydrogenation of 
commercially available biphenol 109. In 2001, Kiya et al. reported a batch process for 
producing hydroxyphenylcyclohexanone from biphenol in the presence of a palladium 
catalyst in an autoclave.65 Building on previous work from the Ley group regarding the HEL 
FlowCAT platform66, it was envisioned that this chemical methodology would be beneficial 
for the proposed synthesis of OZ439.67 This is because this small footprint platform has 
precise control of system parameter for liquid/gas reactions under trickle heterogeneous 
catalysis conditions. Investigation for the selective reduction of 109 to 110 focused on the 
screening of relevant parameters, including catalyst, temperature, hydrogen gas feed, liquid 
feed, substrate concentration and solvent, which can all be conveniently regulated on this 
machinery. 
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Figure 10 Flow setup for selective hydrogenation using HEL FlowCat platform. 
Table 4 Optimisation of flow selective hydrogenation of biphenol.  
 
Entry Solvent Conc. (M) 
Gas 
Feed 
(L/min) 
T 
(°C) 
Flow rate 
(mL/min) 
Catalyst 
(wt. %) 
Ratio by 1H NMR (%) 
109 110 111 112 
1 EtOH 0.25 0.2 50 1 5 % Pd/C 100 0 0 0 
2 EtOH 0.05 0.2 100 1 5 % Pd/C 50 16 26 8 
3 EtOH 0.05 0.2 100 1 10 % Pd/C 31 4 33 32 
4 EtOH:H2O (1:1) 0.05 0.2 100 1 10 % Pd/C 47 26 20 7 
5 EtOH:H2O (1:1) 0.05 0.2 100 1 5% Pd/Al2O3 99 trace trace 0 
6 EtOH:H2O (1:1) 0.05 0.2 100 1 5% Rh/Al2O3 99 trace trace 0 
7 EtOH:H2O (1:1) 0.05 0.2 100 1 20 % Pd/C 8 41 14 37 
8 EtOH:H2O (1:1) 0.05 0.1 100 1 20 % Pd/C 13 58 18 10 
9 EtOH:H2O (1:1) 0.05 0.1 110 1 20 % Pd/C 11 63 16 10 
10 EtOH:H2O (1:1) 0.05 0.1 120 1 20 % Pd/C 43 34 17 7 
11 EtOH:MeOH:H2O (5:1:4) 0.05 0.1 100 1 20 % Pd/C 44 42 12 2 
12 EtOH:MeOH:H2O (2:1:2) 0.05 0.1 100 1 20 % Pd/C 27 42 22 9 
13 EtOH:MeOH:H2O (1:2:2) 0.05 0.1 100 1 20 % Pd/C 13 61 20 6 
14 iPrOH 0.05 0.1 100 1 20 % Pd/C 37 26 20 17 
15 iPrOH:H2O (1:1) 0.05 0.1 100 1 20 % Pd/C 50 38 11 1 
16 iPrOH:H2O (4:1) 0.05 0.1 100 1 20 % Pd/C 55 33 12 0 
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A range of palladium catalysts have been screened and Pd/C 20 wt. % was identified as the 
most suitable catalyst for this transformation. Other metal catalysts, such as Rh or Pd/C with 
lower loading (5–10 wt. %), resulted in reduced conversion and selectivity. In addition, the 
use of Pd/Al2O3 instead of Pd/C resulted in only traces amount of desired product (Table 4, 
entries 5). Moreover, EtOH was found to be the solvent of choice in terms of conversion and 
using EtOH/H2O (1:1, v/v) as solvent mixture improved the selectivity towards the desired 
product. However, due to the limited solubility of starting material 109 or product 110, 
reaction concentration must be kept below 0.05 M. In addition, the reaction’s conversion and 
selectivity is highly sensitive to the temperature. The lowered selectivity led to the formation 
of the otherwise minor by-products 111 and 112 (Table 4). Similarly, deviation from the flow 
rate of hydrogen gas (the amount of hydrogen fed into the system) at 0.1 L min-1 resulted in 
decrease in reaction’s conversion and selectivity. With a packed bed reactor (3 mL internal 
volume) and system pressure of 5 bar, pure product 110 was obtained in 63% NMR yield 
(58% isolated yield) under optimized conditions (Table 4, entry 9). The product mixture was 
purified by recrystallization with purity >95% as determined by NMR. In order to scale up 
the reaction, the reaction run time was simply extended, providing 2 g of pure 110 in 5 hours 
with the same reactor set-up. These results clearly demonstrate the advantages of continuous 
processing compared to the batch protocol.65  
 
2.3.2.2 Acetylation in flow 
 
With an optimised protocol for the preparation of phenol 110 in hand, flow acetylation of 
phenol 110 to acetate 105 was then developed. It was found that when a solution of phenol 
110, DMAP (5 mol %) and Et3N (4.5 equiv.) in CH2Cl2 was combined at a T-piece with a 
stream of acetic anhydride (1.5 equiv.) in CH2Cl2 with a combined flow rate 0.8 mL min-1 
and reacted in 10 mL PFA coil at room temperature provided acetate 105 in quantitative 
yield. The crude product’s analytical purity was confirmed by 1H NMR after a filtration 
through silica and solvent evaporation (Scheme 33). 
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Scheme 33 Flow preparation of acetate 105. 
 
2.3.2.3 Griesbaum co-ozonolysis in flow 
 
Followed by flow acetylation of phenol 110, Griesbaum co-ozonolysis was then investigated 
under flow conditions. Co-ozonolysis reaction between O-methyl oximes and a carbonyl 
compound in the presence of ozone has been demonstrated as an efficient methodology for 
the preparation of 1,2,4-trioxolane.68, 69 The postulated mechanism first involves the reaction 
between dipolarophile N-methyl oxime 104 with ozone via a 1,3-dipolar cycloaddition to 
generate the five-membered ring intermediate 113 (Scheme 34). A retro-1,3-dipolar 
cycloaddition of this intermediate then leads to the formation of the carbonyl oxide 114 and 
methyl nitrite. The reactive carbonyl oxide 114 then undergoes a 1,3-cycloaddition with the 
carbonyl compound to provide desired 1,2,4-trioxolane derivative 115. However, this reactive 
intermediate 115 could also undergo dimerisation to fashion 1,2,4,5-tetraoxane or decompose 
to the corresponding ketone 117. 
DMAP (5 mol%)
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Scheme 34 Postulated mechanism of Griesbaum coozonolysis.  
 
Initial investigation of reaction conditions was carried out using cyclohexanone 118 as a 
commercially available model substrate, and O-methyl 2-adamantatone oxime 104. The flow 
setup employed for the optimisation reactions is shown in Table 5. A solution containing the 
oxime 104 and ketone 118 was combined with a stream of ozone at a Y-piece connector and 
directly passed through a PTFE tube reactor. The exiting solution stream was then collected 
in a round bottomed flask under a constant flow of argon to remove unreacted ozone. In 
comparison to other solvents, ethyl acetate was identified as the optimal solvent, which is 
relatively environmental benign (compared to other solvents) and provided the desired 
product in reasonable yield (Table 5, entry 9).  
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Table 5 Optimisation of flow co-ozonolysis using ketone 118 and oxime 104.^ 
 
Entry Solvent Flow rate (mL min-1) 
O2 
(L min-1) 
Conc. of 
104 
(M) 
Oxime 
104 
(equiv.) 
Ketone 
118 
(equiv.) 
Yield of 
115 
(%) 
1 Cyclohexane 2.0 1 0.2 1 1 nd* 
2 Cyclohexane 2.0 2 0.2 1 1 nd* 
3 Cyclohexane 2.0 2 0.2 1 1.5 nd* 
4 Cyclohexane 1.0 1 0.2 1 1 nd* 
5 Cyclohexane 1.0 1 0.2 1 1.2 27% 
6 Cyclohexane 1.0 1 0.2 1 1.5 42% 
7 Cyclohexane 1.0 1 0.2 1 2.0 35% 
8 Heptane 1.0 1 0.2 1 1.5 39% 
9 Ethyl acetate 1.0 1 0.2 1 1.5 40% 
10 Acetonitrile 1.0 1 0.2 1 1.5 5% 
11 Toluene 1.0 1 0.2 1 1.5 5% 
12 Trifluorotol. 1.0 1 0.2 1 1.5 2% 
13 Ethanol 1.0 1 0.2 1 1.5 0% 
 
Unfortunately, this flow setup was not optimal due to the lack of reproducibility. Despite the 
same defined parameters, different results were obtained for independent experiments. In 
light of this, a modified setup was employed (Scheme 35), where a solution containing the 
ketone 118 (1.5 equiv.) and the oxime 104 (1.0 equiv.) in EtOAc was combined with a stream 
of ozone at a T piece connector and entered a 2 mL reactor coil (255 mm, 1.0 mm i.d.).  The 
reactor output was collected directly in a round bottom flask under a constant flow of argon 
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^This work was conducted in collaboration with Dr Alicia Galván and Dr José Souto 
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for ozone removal. Under these reaction conditions, the desired product 115 was obtained in 
47 % isolated yield. Moreover, the reaction was repeated three times and similar results were 
obtained, demonstrating the reproducibility of the system.  
 
 
Scheme 35 Modified flow setup for co-ozonolysis of ketone 118 and oxime 104. 
 
Having optimised the flow setup for co-ozonolysis, 4-phenyl cyclohexanone 119 was next 
used as an alternative commercially available model substrate. Vennerstrom et al. reported 
that when O-methyl 2-adamantanone oxime 104 and para-substituted cyclohexanones 119 
undergoes Griesbaum co-ozonolysis, the major tetrasubstituted ozonide isomers possess cis 
configurations, suggesting a preferred axial attack of the carbonyl oxide on the 
cyclohexanone dipolarophiles. Neither modifying the residence time or the gas flow rate of 
ozone led to an improvement of the reaction yield (Table 6, entries 2 and 3). Pleasingly, it 
was found that reacting excess oxime 104 with respect to the ketone afforded a great 
improvement to the reaction yield, resulting in the desired compound 120 in 76% isolated 
yield after purification (Table 6, entry 4). Although the reaction yield can be improved further 
if 3 equiv. of oxime 104 are used, it was not an ideal condition against the objective of this 
project. Performing this reaction at 0 °C did not result in an increase in reaction yield (Table 
6, entry 6). Switching to a Y-piece connector was attempted to maximise mixing but no 
improvement in yield was observed. Under these optimised reaction conditions, the process 
proceeded continuously for 45 min without issue (Table 6, entry 7). Unfortunately, partial 
blockage of the reactor coil was observed under longer reaction times due to the slow 
evaporation of organic solvents by rapid gaseous stream, leading to subsequent product 
precipitation. This was avoided easily by conducting the experiment with a more diluted 
solution while increasing both solution (oxime and ketone) and gas (ozone) flow rates in 
order to maintain identical throughput for the flow system.  As expected, the reaction 
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successfully proceeded continuously for three hours without any observed blockages and 
afforded model product 120 in 78% yield with a calculated throughput of 1.6 g·h-1 (equating 
to 38.2 g·d-1). 
 
Table 6 Optimisation of flow co-ozonolysis of ketone 119 and oxime 104. 
 
Entry Flow rate (mL min-1) 
O2 
(L min-1) 
Oxime 104 
(equiv.) / [C] 
Ketone 119 
(equiv.) / [C] 
Isolated yield of 120 
(%) 
1 0.5 0.5 1.0 / 0.2 M 1.5 / 0.3 M 40 
2 0.5 1.0 1.0 / 0.2 M 1.5 / 0.3 M 33 
3 0.35 0.5 1.0 / 0.2 M 1.5 / 0.3 M 40 
4 0.5 0.5 2.0 / 0.4 M 1.0 / 0.2 M 76 
5b 0.5 0.5 2.0 / 0.4 M 1.0 / 0.2 M 66 
6 0.5 0.5 3.0 / 0.6 M 1.0 / 0.2 M 91 
7c 0.5 0.5 2.0 / 0.4 M 1.0 / 0.2 M Coil blockage after 45 min 
8c 1.0 1.0 2.0 / 0.2 M 1.0 / 0.1 M 70 3 hours of reaction 
a Compounds observed in the crude 13C NMR analysis. b Reaction was performed at 0 °C. c Continuous process 
without using loop. 
 
Using this modified flow setup with optimised conditions, the flow Griesbaum co-ozonolysis 
of previously prepared ketone 105 and oxime 104 was performed (Scheme 36). Under 
previous optimised conditions, blockage was once again observed after 30 min reaction time. 
By further optimising the reaction conditions, the flow co-ozonolysis proceeded smoothly for 
3.5 h, providing desired 1,2,4-trioxolane 106 in 70% yield (9:1 cis-trans selectivity towards 
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the desired product) after crystallisation in ether, which equates to a production rate of 1.67 
g·h-1 (40.2 g·d-1).  
 
Scheme 36 Continuous flow coozonolysis of ketone 105 and oxime 104. 
 
2.3.2.4 Synthesis of OZ439 
 
Following the reaction conditions previously reported in the literature,63 the cleavage of the 
acetyl group of the key fragment 106 was performed to provide phenoxide anion in situ, 
which underwent subsequent nucleophilic substitution with 4-(2-chloroethyl)morpholine 121 
in one pot to afford OZ439 free base 103 in 95% yield under batch conditions (Scheme 37). 
However, due to the genotoxicity of 4-(2-chloroethyl)morpholine 121, an alternative route to 
OZ439 was developed. 
 
 
Scheme 37 Synthesis of OZ439 via coupling reaction of ozonide 106 with 4-(2-chloroethyl)morpholine 121. 
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2.3.2.5 Alternative synthesis of OZ439 from acetylated phenol 106 
 
 
Two synthetic approaches were attempted to avoid the use of 4-(2-chloroethyl)morpholine 
121. The first approach involved the generation of an imine intermediate, followed by 
reduction to afford the product OZ439 free base. The second approach consisted of the 
formation of amide intermediate, and subsequent amide reduction to furnish OZ439 free 
base.   
 
 2.3.2.5.1 via reductive amination 
 
Removal of acetyl group of the ozonide 106 under basic condition, followed by a 
nucleophilic substitution reaction with allyl bromide, gave crude alkene 122. The crude 
alkene intermediate 122 was then subjected to ozonoloysis, where subsequent reductive 
amination with sodium cyanoborohydride and salt formation with methanesulfonic acid 
provided OZ439 103 in 27% isolated yield (over 5 steps, Scheme 38). Although OZ439 was 
successfully synthesised via this route without the use of genotoxic 4-(2-
chloroethyl)morpholine 121, the number of redox reactions required and low overall yield did 
not lead to significant improvement compared to the previous route.  
 
 
Scheme 38 Synthesis of OZ439 via reductive amination. 
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 2.3.2.5.2 via selective reduction of amide  
 
Similar to the route described above, the acetyl group of ozonide 106 was removed under 
basic conditions and subsequent nucleophilic substitution with 4-(chloroacetyl)-morphine 
108 afforded the amide intermediate 107 in 99% yield (Scheme 39).  
 
 
Scheme 39 Preparation of amide 107. 
In order to selectively reduce the amide, a wide range of reducing reagents, including 
BH3·THF, BH3·DMS, Superhydride, NaBH4/TFA, LiAlH4 and NaBH4/Tf2O, were attempted 
but minimal trace of the desired product was observed (Table 7). The sensitivity associated 
with the trioxolane ring was problematic, which resulted in both reduction of the amide group 
and cleavage of the trioxolane moiety when it was treated with these reducing reagents. To 
our delight, when the ozonide 107 was subjected to a Zn-catalysed amide reduction in the 
presence of triethoxysilane,70 it was found that OZ439 free base 103 could be obtained in 
86% isolated yield without disruption of the trioxolane system (Table 7, entry 14). 
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Table 7 Optimisation of reduction of amide 103. 
 
Entry Reducing agent (equiv.) 
Conc. of 107 
(M) 
T 
(ºC) 
t 
(h) 
Resulta 
1 BH3·THF (1.3) 0.05 rt 3 s.m. 
2 BH3·THF (1.3) 0.05 50 3 s.m. 
3 BH3·THF (3.0) 0.05 50 15 s.m. 
4 BH3·THF (3.0) 0.3 rt 15 decom. 
5 BH3·THF (3.0) 0.3 -78 2 s.m. 
6 BH3·DMS (3.0) 0.3 rt 15 117 +decom. 
7 BH3·DMS (1.5) 0.3 rt 15 117 +decom. 
8 BH3·DMS (1.5) 0.3 rt 1 117 +decom. 
9 Superhydride (3.0) 0.3 rt 15 decom. 
10 NaBH4/TFA (3.0) 0.3 rt 15 ket 
11 LiAlH4 (1.0) 0.3 rt 15 117 +decom. 
12 NaBH4/Tf2O (3.0) 0.3 0 15 s.m. + decom. 
13 
Zn(OAc)2 (10 mol%), (EtO)3SiH 
(3.0) 
0.3 rt 22 s.m. 
14b 
Zn(OAc)2 (10 mol%), (EtO)3SiH 
(3.0) 
0.3 60 22 86%  
a Determined by 1H and 13C NMR analysis of crude product. b Isolated yield 
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2.3.3 Conclusions and outlook 
 
In summary, a synthesis of the antimalarial drug candidate OZ439, using a machine-assisted 
protocol, has been developed. Three key transformations, such as selective partial 
hydrogenation, acetylation reaction of the phenol group and Griesbaum co-ozonolysis, were 
performed using flow technologies, exhibiting significant improvement for the limitations 
previously observed for batch process. Moreover, this process has shown the practicality of 
continuous processing for gram scale production and should provide some significant values 
when developing for further scale up. The procedure clearly improves the safety issues 
associated in batch mode, for example, the use of pentane as solvent in co-ozonolysis and 
genotoxic 4-(2-chloroethyl)morpholine as coupling reagent for the installation of the side 
chain were replaced with EtOAc the corresponding amide respectively, in the new process 
and the development for telescoped multstep synthesis is currently under investigation in our 
laboratories.  
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2.3.4 Experimental details 
 
2.3.4.1 General experimental 
 
Unless stated otherwise, reagents were obtained from commercial sources and used without 
purification. New compounds have been fully characterized. NMR characterization was 
performed on reported ones.  1H-NMR spectra were recorded on Bruker Avance DPX-400 or 
DPX-600 (600 MHz), with the residual solvent peak as the internal reference (CDCl3 = 7.26 
ppm). 1H resonances are reported to the nearest 0.01 ppm. 13C-NMR spectra were recorded 
on the same spectrometer with proton decoupling, with the solvent peak as the internal 
reference (CDCl3=77.00 ppm). All 13C resonances are reported to the nearest 0.01 ppm. 
DEPT 135, COSY, HMQC, and HMBC experiments were used to aid structural 
determination and spectral assignment. The multiplicity of 1H signals are indicated as: s 
=singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublets of doublets, t = 
triplet, q = quadruplet, sext = sextet, m = multiplet, br = broad, or combinations of thereof. 
Coupling constants (J) are quoted in Hz and reported to the nearest 0.1 Hz. Where 
appropriate, measures of the same coupling constant are averaged. The removal of solvent 
under reduced pressure was carried out on a standard rotary evaporator. High resolution mass 
spectrometry (HRMS) was performed using a Waters Micromass LCT Premier™ 
spectrometer using time of flight with positive ESI, or a Bruker BioApex 47e FTICR 
spectrometer using (positive or negative) ESI or EI at 70 eV to within a tolerance of 5 ppm of 
the theoretically calculated value. Infrared spectra were recorded on a Perkin-Elmer 
Spectrum RX One FT-IR ATR (Attenuated Total Reflectance) spectrometer. The samples 
were prepared as thin films deposited on the ATR, unless otherwise specified. Only 
structurally important absorptions are quoted. Absorption maxima (νmax) are reported in 
wavenumbers (cm-1). Optical rotations were measured on a Perkin-Elmer Polarimeter 343 at 
589 nm (Na D-line) with a path length of 10 cm path length. Melting points were using an 
OptiMelt automated melting point system available from Standord Research Systems. The 
flow experiments were performed on a Vapourtec R2+/R4 module,1 Uniqsis Flowsyn 
module2 and HEL FlowCAT module.3 All gas-flow reactions were performed either with a 
gas-liquid T-piece reactor or HEL FlowCAT3 as described to introduce gases into a 
continuous flow stream. Omnifit® columns4 were used for the containment of polymer-
supported reagent or other solid reagents.   
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2.3.4.2 Experimental procedure 
 
Preparation of OZ439 
 
Preparation of 4-(4-hydroxyphenyl)cyclohexan-1-one 110 (Flow hydrogenation): 
 
A solution of 4,4’-dihydroxybiphenyl 109 (2.8 g, 15 mmol) in EtOH and H2O (0.05 M, 1:1) 
was pumped at 1.0 mL/min of flow rate and combined with a stream of hydrogen (20 bar, gas 
flow rate 0.2 L/min) in the HEL FlowCAT, entering a column of 20 wt % Pd/C (2.0 g, 
packed with glass beads) at 110 oC. The output was directed into a pre-weighed flask and 
flushed with argon. The solvent was removed in vacuo to afford the crude product. 
Recrystallisation in acetone yielded the titled product (1.71 g, 60 %) as a white amorphous 
solid. Data are consistent with a reported example.iv 
 
1H NMR (400 MHz, DMSO-d6): δ 7.05 (d, J = 8.4 Hz, 2 H, H6), 6.70 (d, J = 8.4 Hz, 2 H, 
H7), 2.90 (m, 1 H, H4), 2.22-2.30 (m, 4 H, H2), 2.08-1.90 (m, 4 H, H3). 
13C NMR (120 MHz, DMSO-d6): δ 210.8 (C1), 156.1 (C8), 135.9 (C5), 127.9 (C6), 115.5 
(C7), 41.3 (C2), 41.3 (C4), 34.2 (C3). 
 
Preparation of 4-(cyclohexanone-4-yl)-phenyl acetate 105 (Flow acetylation): 
 
A solution of 4-(4-hydroxyphenyl)cyclohexan-1-one 110 (3.80 g, 20.0 mmol) and DMAP 
(124 mg, 1.0 mmol) and Et3N (6.48 mL, 89.7 mmol) were dissolved in CH2Cl2 (80 mL) and 
was injected using pump A. A solution of acetic anhydride (2.44 g, 24.0 mmol, 0.3 M in 
CH2Cl2) and was injected using pump B. Both reagents were pumped using a Vapourtec E-
series (each stream ran at 0.4 mL min-1) and were combined at a T-piece. The combined 
stream was directed to a 10 mL PFA reactor coil which was held at room temperature. The 
output was passed through a Omnifit® column containing silica gel and a 100 psi BPR, 
directed into a round-bottom flask. The solvent was removed in vacuo to afford the analytical 
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pure product (4.60 g, 99%) as a brown solid. The product was used in the next stage without 
need for further purification. Data are consistent with a reported example.v  
 
1H NMR (600 MHz, CDCl3) δ 7.26 (d, J = 8.4 Hz, 2 H, H6), 7.05 (d, J = 8.4 Hz, 2 H, H7), 
3.05 (m, 1 H, H2), 2.53-2.51 (m, 4 H, H2), 2.30 (s, 3 H, H10), 2.241.90 (m, 4 H, H3). 
13C NMR (120 MHz, CDCl3) δ 210.9 (C1), 169.6 (C9), 149.2 (C8), 142.3 (C5), 127.6 (C6), 
121.6 (C7), 42.2 (C2), 41.3 (C4), 34.0 (C3), 21.1 (C10) 
 
Preparation of adamantane-2-spiro-3′-1′,2′,4′-trioxaspiro[4.5]decane 115 (Flow co-
ozonlysis): 
 
A 100 mL solution of O-methyl 2-adamantanone oxime 104 (0.2 M in EtOAc) and 
cyclohexane 118 (0.3 M in EtOAc) was pumped at a flow rate of 0.5 mL min1 and combined 
with the ozone stream (1.25 bar, flow rate 1.0 L min-1) at a T piece connector, entering the 2 
mL reactor coil. The reactor output was collected directly in a flask under a constant flow of 
argon to remove excess ozone and the process was performed for 15 min. The solvent was 
removed to provide the crude product. Isolated as a colorless oil (372.8 mg, 47%) after silica 
gel column chromatography (eluent: diethyl ether:petroleum ether = 3:97). Data are 
consistent with a reported example.vi 
 
1H NMR (400 MHz, CDCl3) δ 2.19-1.18 (m, 24 H, H1, H2, H3, H4, H7, H8, H9) 
 13C NMR (120 MHz, CDCl3) δ 111.2 (C5), 108.9 (C6), 36.8 (C4), 36.4 (C1), 34.8 (C3), 
34.7 (C2), 26.9 (C7), 25.0 (C8), 23.8 (C9). 
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Preparation of cis-adamantane-2-spiro-3'-8'-phenyl-1',2',4'-trioxaspiro[4.5]decane 120 
(Flow co-ozonlysis): 
 
A 100 mL solution of O-methyl 2-adamantanone oxime 104 (0.2 M in EtOAc) and 4-
phenylcyclohexanone 119 (0.1 M in EtOAc) was pumped at a flow rate of 1.0 mL min1 and 
combined with the ozone stream (1.25 bar, flow rate 1.0 L min-1) at a T piece connector, 
entering the 2 mL reactor coil. The reactor output was collected directly in a flask under a 
constant flow of argon to remove excess ozone and the process was performed for 3 h. The 
solvent was removed to provide the crude product. Isolated as a colorless oil (4.78 g, 78%, 
mixture of two isomers, >20:1; ratio determined by HPLC) after silica gel column 
chromatography (eluent: diethyl ether:petroleum ether = 3:97). Data are consistent with a 
reported example.vii 
 
1H NMR (400 MHz, CDCl3) δ 7.36-7.19 (m, 5H), 2.64-2.53 (m, 1 H, H9), 2.16-1.70 (m, 22 
H, H1, H2, H3, H4, H7, H8) 
 13C NMR (120 MHz, CDCl3) δ 146.1 (C10), 128.3 (C12), 126.7 (C11), 126.1 (C5), 111.3 
(C13), 108.3 (C6), 42.9 (C9), 36.8 (C4), 36.4 (C1), 34.8 (C8), 34.7 (C3), 26.8 (C7), 26.4 
(C2). 
 
4-((1R,3S,4''S,5R,5's,7R)-dispiro[adamantane-2,3'-[1,2,4]trioxolane-5',1''-cyclohexan]-
4''-yl)phenyl acetate 106 (Flow co-ozonlysis): 
 
A 100 mL solution of O-methyl 2-adamantanone oxime 104 (0.2 M in EtOAc) and 4-
(cyclohexanone-4-yl)-phenyl acetate 105 (0.1 M in EtOAc) was pumped at a flow rate of 1.0 
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mL min1 and combined with the ozone stream (1.25 bar, flow rate 1.0 L min-1) at a T piece 
connector, entering the 2 mL reactor coil. The reactor output was collected directly in a flask 
under a constant flow of argon to remove excess ozone and the process was performed for 3.5 
h. The solvent was removed to provide the crude product. Recrystallisation in Et2O afforded 
the pure compound (mixture of two isomers, 9:1; ratio determined by HPLC) as a white solid 
(5.86 g, 70%). Data are consistent with a reported example.vii 
 
1H NMR (400 MHz, CDCl3) δ 7.20 (d, J= 8.4 Hz, 2 H, H11), 6.99 (d, J= 8.4 Hz, 2 H, H12), 
2.60 – 2.49 (m, 1 H, H9), 2.27 (s, 3 H, H15), 2.11 – 1.63 (m, 22 H, H1, H2, H3, H4, H7, H8) 
 13C NMR (120 MHz, CDCl3) δ 169.5 (C14), 148.9 (C13), 143.7 (C10), 127.6 (C11), 121.3 
(C5), 115.5 (C12), 111.3 (C6), 108.3 (C6), 42.3 (C9), 36.7 (C4), 36.3 (C1), 34.7 (C8), 34.6 
(C7), 31.4 (C3), 26.8 (C2), 26.4 (C15). 
 
Preparation of 2-(4-((1R,3S,4''S,5R,5's,7R)-dispiro[adamantane-2,3'-[1,2,4]trioxolane-
5',1''-cyclohexan]-4''-yl)phenoxy)-1-morpholinoethan-1-one 107: 
 
To a solution of acetate 106 (200 mg, 0.5 mmol) in dry acetonitrile (5 mL) were added 
powdered NaOH (120 mg, 3.0 mmol) and tetrabutylammonium hydrogen sulphate (34 mg, 
0.1 mmol). The mixture was stirred at 25 oC for 30 min before 2-chloro-1-morpholinoethan-
1-one (164 g, 1 mmol) was added. After addition, it was stirred at 60 oC overnight. The 
inorganic solid was filtered off and washed with CH2Cl2. After removal of the solvents, the 
residue was diluted in EtOAc (15 mL). The combined organic layer was washed with water 
and brine, dried over anhydrous MgSO4 and filtered. The solvent was removed in vacuo to 
afford the pure titled compound as a pale brown solid. 
1H NMR (600 MHz, CDCl3) δ 7.14 (d, J = 8.7 Hz, 2 H, H11), 6.88 (d, J = 8.7 Hz, 2 H, 
H12), 4.67 (s, 2 H, H14), 3.68-3.62 (m, 8 H, H16, H17), 2.51 (m, 1 H, H9), 2.06 – 1.71 (m, 
22 H, H1, H2, H3, H4, H7, H8). 
13C NMR (120 MHz, CDCl3) δ 166.7 (C15), 156.0 (C13), 150.0 (C10), 127.8 (C11), 114.5 
(C5), 111.4 (C6), 108.4 (C12), 67.8 (C17), 66.8 (C14), 46.0 (C16), 42.1 (C9), 34.8 (C1, C4), 
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31.6 (C3, C8), 26.9 (C7), 26.5 (C2).  
FTIR (νmax, cm-1):  2915 (m), 2858 (m), 1651 (s, CO), 1512 (m), 1443 (m), 1360 (w), 1274 
(w). 1221 (m). 1181 (w), 1113(s), 1074 (m), 1018 (m), 966 (w), 912 (w), 830 (m), 731 (m). 
HRMS (ESI): calculated for C28H38NO6 [M+H]+ 484.2620, found 484.2626 
 
Preparation of 4-(2-(4-((1R,3S,4''S,5R,5's,7R)-dispiro[adamantane-2,3'-
[1,2,4]trioxolane-5',1''-cyclohexan]-4''-yl)phenoxy)ethyl)morpholine 103 free base, 
OZ439 free base: 
 
A 10 mL schlenk tube containing a stirrer bar was charged with zinc acetate (4 mg, 0.02 
mmol). Dry THF (1 mL) and triethoxysilane (0.12 mL, 0.06 mmol) were added respectively 
after purging the schlenk tube with argon. The resulting mixture was stirred for 0.5 h at room 
temperature. A solution of amide 107 (100 mg, 0.2 mmol) in CH2Cl2 (1 mL) was added to the 
mixture under argon. The reaction mixture was stirred at 60 oC for 22 h and monitored by 
TLC. After complete disappearance of the substrate, 1M NaOH solution (5 mL) was added to 
the reaction mixture. The reaction mixture was vigorously stirred for 3 h and then extracted 
with EtOAc (3 x 5 mL). The combined organic later dried over anhydrous Na2SO4, filtered 
and concentrated in vacuo to yield the product 103 (81 mg, 86 %) as a white solid. Data are 
consistent with a reported example.viii 
1H NMR (400 MHz, CDCl3) δ 7.05 (d, J = 8.4 Hz, 2 H, H11), 6.79 (d, J = 8.4 Hz, 2 H, 
H12), 4.02 (t, J = 5.5 Hz, 2 H, H14), 3.70 – 3.63 (m, 4 H, H17), 2.72 (t, J = 5.5 Hz, 2 H, 
H15), 2.56 – 2.39 (m, 5 H, H9, H16), 2.07 – 1.58 (m, 22 H, H1, H2, H3, H4, H7, H8). 
13C NMR (120 MHz, CDCl3) δ 156.8 (C13), 138.1 (C10), 127.3 (C11), 114.1 (C5), 110.9 
(C6), 108.0 (C12), 66.6 (C14), 65.5 (C17), 57.4 (C15), 53.8 (C16), 41.7 (C9), 36.5 (C4), 36.1 
(C1), 34.5 (C8), 34.4 (C3), 31.4 (C7), 26.6 (C2). 
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3.1 Literature examples of reactions using boronic compounds 
and diazo compounds 
 
3.1.1 Carbon-carbon bond forming reactions of organoboranes with diazo compounds 
 
Organoboron compounds are an important class of reagents in organic synthesis, as these 
have been utilised widely as building blocks for the construction of complex molecular 
structures.71 These compounds often promote carbon-carbon bond forming reactions with 
high chemo- and stereoselectivity without the need of expensive, and sometimes unstable or 
toxic metal catalysts.72 Thus, extensive research has focused on the synthesis of various 
organoboron compounds and their applications. Recently, metal-free coupling reactions of 
organoboron derivatives and diazo compounds have also gained attention in organic 
synthesis.73  
 
In the resonance structure II, the diazo carbon is electron-rich in nature and can therefore 
react as nucleophilic at carbon (Scheme 40).74 Since a trigonal planar boron reagent contains 
a vacant p orbital and can act as an electrophile, it can react with a diazo compound to 
generate a tetracoordinated boronate intermediate III. Subsequent 1,2-migration occurs when 
one of the substituents on boron shifts to the carbon centre with the release of nitrogen gas. 
Depending on the nature of the migratory group R on the boron reagent, various 
transformations can result. In this section, representative examples of C-C bond formations 
using organoboron compounds and diazo compounds are highlighted. 
 
 
Scheme 40 General mechanism of organoboron compounds and diazo compounds via 1,2-migration. 
 
In 1968, Hooz et al. discovered a metal-free C(sp3)-C(sp3) bond forming reaction of 
trialkylboranes 126 and diazoacetone 125, resulting in the migration of one of the R groups 
from boron to the diazo carbon (Scheme 41).75 Since the preparation of trialkylboranes can be 
conducted via hydroboration of the corresponding olefins, this reaction is a useful protocol to 
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install an alkyl group at the α-carbon of a ketone. However, steric hindrance in the 
organoborane reagent (e.g. sec-butyl group) reduces the product yield, and increasing the 
temperature or utilising an excess amount of diazoacetone does not improve the yield.  
 
 
Scheme 41 Metal-free coupling of diazoacetone 125 with trialkylboranes. 
 
Similar coupling processes using trialkylboranes with stabilised α-diazocarbonyl compounds, 
such as diazoacetonitrile,76 ethyl diazoacetate (EDA),76 diazoacetaldehyde,77 and 
bisdiazoketones78 were later developed. Mechanistically, it is proposed that the nucleophilic 
attack of a diazo compound on the organoborane generates tetracoordinated boron 
intermediate V, followed by one of the three R groups on boron undergoing a 1,2-migration 
with the release of nitrogen gas to provide a β-oxoborane intermediate VI (Scheme 42).79 
This intermediate VI is in equilibrium with enol borinate VII and subsequent hydrolysis or 
trapping with an electrophile E+ yields the product.80  
 
 
Scheme 42 The proposed reaction mechanism of trialkylboranes with α-diazocarbonyl compounds. 
Numerous examples of tandem reactions of enol borinates with various electrophiles were 
subsequently developed. In 1971, Pasto et al. described a tandem reaction of enol borinate 
with alkyl halides (Scheme 43).81 In this report, the enol borinate was first generated in situ, 
followed by transformation to a lithium enolate using n-BuLi. Trapping with methyl iodide 
afforded an α,α-dialkylated ketone 132. An analogous process was developed by Hooz et al., 
instead using lithium 2-(dimethylamino)ethoxide to generate the lithium enolate 133 then 
trapping with various alkylating reagents, including dimethyl sulfate, methyl iodide, benzyl 
bromide and allyl bromide afforded a variety of α,α-dialkylated ketones (Scheme 43).82  
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Scheme 43 Transformation of enol borinates to lithium enolates and subsequent trapping with alkyl halides. 
 
Dimethyl(methylene)ammonium iodide, also known as Eschenmoser’s salt, has also been 
employed as an electrophile to trap the enol borinate, providing Mannich bases 138 in 
excellent yields and high regioselectivity (Scheme 44).83 In comparison to typical Mannich 
reactions with unsymmetrical ketones, this protocol did not provide the amine products in 
isomeric mixtures.  
 
 
Scheme 44 Reaction with a Mannich reagent with stabilised α-diazocarbonyl compounds. 
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Despite the reaction of diazo compounds with boron compounds being a very useful 
transformation, they have the following limitations, high sensitivity to steric hindrance in the 
boron reagents, instability of trialkylboron reagents compared to organoboronic acids and 
only migration of one of the R groups from the boron reagent to the product.84 Reports using 
B-R-BBN were conducted in an attempt to overcome these limitations. However, these 
processes had limited synthetic value due to competing migration of the cyclooctyl group 
over the anticipated R group. For example, treatment of B-alkenyl-BBN 140 with ethyl 
diazoacetate 139 provided a mixture of boranes 141 and 142 that could be oxidised to yield a 
mixture of 143 and 144 (Scheme 45). From the observed product ratio, migration of the 
cyclooctyl group is more favourable compared to the alkenyl migration, leading to 
predominant formation of the side product 141.84a Another example further illustrated that 
only migration of the cyclooctyl group occurred when B-n-butyl-BBN 145 was utilised, 
providing the borane 146 exclusively, which yielded product 143 after subsequent oxidation. 
This is because the primary alkyl group has a poorer migratory aptitude compared to 
secondary alkyl group.84b  
 
Scheme 45 Reaction of ethyl diazoacetate with B-alkenyl-BBN 140 and B-alkyl-BBN 145. 
Considering the lower steric demands and the increased electron-deficiency of 
dialkylchloroborane compared with the corresponding trialkylboranes, a higher reactivity 
would be anticipated. Indeed, this was observed by Brown et al. when they performed the 
reaction with dialkylchloroboranes 148 at low temperature to give the desired products 149 in 
excellent yield (Scheme 46).  
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Scheme 46 Reaction of ethyl diazoacetate with dialkylchloroborane. 
 
This concept can be further extended to alkyl- and aryldichloroboranes in this type of 
reaction (Scheme 47). However, the yields were only moderate when alkyldichloroboranes 
were employed, resulting from significant amounts of ethyl chloroacetate being isolated as a 
major side product from chloro migration. In contrast, when aryldichloroboranes were 
utilised in this reaction, the corresponding products were obtained in excellent yields and 
good chemoselectivity.86  
 
 
Scheme 47 Reaction of ethyl diazoacetate with alkyl- and aryldichloroboranes. 
 
In 1991, Brown et al. described the reaction of dichloro(vinyl)boranes 152 with ethyl 
diazoacetate 139, affording β,γ-unsaturated carboxylic esters 153 in satisfactory yields 
(Scheme 48).87 Notably, the E/Z configuration of the boron reagents was retained in the 
corresponding products.  
 
 
Scheme 48 Reaction of ethyl diazoacetate with dichloro(vinyl)boranes 
 
Kabalka et al. later expanded the scope to less stabilised diazo compounds by reacting 
trialkylboranes with aryl aldehyde derived sulfonylhydrazones in the presence of base 
(Scheme 49). The reaction yields were generally moderate to excellent.88 However, the 
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preparation of boranes other than alkylboranes was not straightforward, restricting the 
practicality of the method.   
 
 
Scheme 49 Reaction of trialkylboranes with aryl-derived sulfonylhydrazones. 
 
These reactions are attractive protocols for C-C bond formation in a metal-free process. 
However, several drawbacks with regards to these borane reagents limit further development 
of these reactions. For example, these reagents are usually sensitive to moisture, unstable 
under ambient conditions and are inconvenient to prepare. Therefore, more research efforts 
have been made to explore the reaction of diazo compounds with other more stable 
organoboron compounds.   
 
3.1.2 Carbon-carbon bond forming reactions of other organoboron compounds with diazo 
compounds 
 
Alternative organoboron compounds, including organotrifluoroborates, boronate esters, 
boronic acids and their derivatives, and have been widely investigated in transition-metal-
catalysed cross coupling reactions, for instance, the Suzuki-Miyaura reaction. Moreover, 
these compounds are usually readily available, less toxic and stable. However, the reactions 
of these organoboron compounds and diazo compounds have only been developed very 
recently.   
 
Molander et al. employed potassium organotrifluoroborates (RBF3K) for reaction with 2,2,2-
trifluorodiazoethane in the presence of a fluorophile, either Me3SiCl or p-tolylSiCl3, 
affording α-trifluoromethylated organotrifluoroborates (Scheme 50).89 This reaction operated 
under mild conditions and has a broad functional group tolerance, including heteroaryl 
potassium organotrifluoroborates. Since the organotrifluoroborates are inert to nucleophilic 
attack when tetrasubstituted, these compounds can be activated in situ and then react with 
diazo compounds, illustrating great potential for development of new C-C bond forming 
reactions. In the proposed mechanism, the reaction begins after the removal of a fluoride ion 
from boron by Me3SiCl or p-tolylSiCl3 to reveal the highly electrophilic dihaloboranes 161 
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(Scheme 50). Subsequent nucleophilic attack of CF3CHN2 provides the tetracoordinated 
boron intermediate 162, which then undergoes a 1,2-migration to produce the α-
trifluoromethylated difluoroboron intermediate 163. Further reaction with KHF2 yields the 
desired product 159. 
 
Scheme 50 Coupling of in situ generated CF3CHN2 and RBF3K and the proposed mechanism. 
 
Following their previous work, Molander et al. extended the reaction of CF3CHN2 to 
boroxines, providing vicinally ditrifluoromethylated alkylboron compounds in a 
diastereoselective fashion (Scheme 51).90 Mechanistically, the boron intermediate generated 
from the first insertion is electrophilic enough to undergo another insertion. Subsequent 
trapping with pinacol affords the syn-organoboron compounds 165 as the major products. 
The authors also performed DFT calculations to investigate the diastereoselectivity, in which 
the result suggested that the reaction is kinetically controlled and that α-transfer is the rate-
limiting step.  
 
 
Scheme 51 Coupling of CF3CHN2 and boroxines. 
 
Wang et al. reported the reaction of boroxines with α-diazocarbonyl compounds 166 to afford 
α-arylated and α-vinylated carbonyl compounds 168 in moderate to excellent yields (Scheme 
52).91  
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Scheme 52 Reaction of boroxines with α-diazocarbonyl compounds.  
 
Later, the same group also developed a transition metal-free method to access 1,1-
diboronates and 1-silyl-1-boron compounds using non-stabilised diazo compounds which 
were prepared in situ by thermal decomposition of N-tosylhydrazones (Scheme 53).92 An 
insertion reaction of these diazoalkanes into boronate esters, including H-Bpin, Me2PhSi-
Bpin and B2pin2 provided the desired products. The reaction yields were moderate to 
excellent, however, drawbacks included a limited functional group tolerance and high 
reaction temperature. 
 
 
Scheme 53 gem-Diborylation and gem-silylborylation of tosylhydrazones. 
 
Barluenga et al. made a breakthrough using readily available alkyl-, alkenyl- and arylboronic 
acids with in situ generated diazo compounds from tosylhydrazones in the presence of base 
(Scheme 54).93 Notably, the scope of this reaction was extended to less stabilised diazo 
compounds. This transition metal-free coupling reaction was applied to various substrates 
and demonstrates excellent functional group tolerance. However, the in situ generation of 
potential explosive diazo compounds at high temperature raises safety concerns.  
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Scheme 54 Transition-metal-free coupling of boronic acids with tosylhydrazones 
 
Since the tosylhydrazone can be generated in situ from the corresponding ketones and 
aldehydes, the authors also developed a one-pot, two-step transformation which could be 
considered as reductive coupling between carbonyl compounds and boronic acids (Scheme 
55). Similar results were obtained from this one-pot reductive coupling compared to the 
coupling between isolated tosylhydrazones and boronic acids.  
 
 
Scheme 55 One-pot reductive coupling of carbonyl compounds and boronic acids. 
 
Mechanistically, the authors proposed that the tosylhydrazone undergoes the thermal 
decomposition in the presence of base, generating the diazo compound 176 in situ (Scheme 
56). This could then proceed by one of the two possible pathways. The first being 
nucleophilic attack of the diazo compound with the boronic acid providing the 
tetracoordinated boronate intermediate 177, which then undergoes the 1,2-migration to 
produce the tertiary boronic acid 178. Alternatively, the decomposition of the diazo 
compound could generate a carbene 179 which can then react with the boronic acid to give a 
zwitterionic intermediate 180. The R group on the boron could subsequently shift to the α-
carbon to provide 178, followed by protodeboronation of the tertiary boronic acid to afford 
the desired product 174.  
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Scheme 56 Proposed mechanism of coupling between boronic acids and tosylhydrazones.  
 
Further development of coupling reactions between tosylhydrazones and boronic acids have 
subsequently been reported by a number of research groups for the applications in flow 
chemistry 94 and drug discovery library synthesis.95  
 
In 2012, Valdés et al. reported the coupling of alkenylboronic acids and tosylhydrazones 
using a combination of K2CO3 and CsF, providing isomeric products (Scheme 57).96 The 
regioselectivity of the reaction arises from [1,3]-borotropic rearrangement and subsequent γ-
protodeboronation. However, γ-protodeboronated products were only obtained when 
styrylboronic acid and hydrazones derived from cyclic ketones were employed. 
 
 
Scheme 57 Coupling of styrylboronic acids and tosylhydrazones. 
 
Ley et al. demonstrated the metal-free C(sp2)-C(sp3) coupling of 4-, 5- and 6- membered 
saturated heterocyclic p-methoxyphenyl (PMP) sulfonylhydrazones with aryl and 
heteroaromatic boronic acids in a two-step procedure (Scheme 58).97 This reaction has a wide 
range of functional group tolerance, including, oxetanes, piperidines, and azetidines, from 
corresponding ketones. However, most of the examples have only moderate yields. 
 
172
R1
N
R2
NH
Ts
base
R1
N
R2
N
Ts
175
- Ts
R1
N
R2
N
176
-N2
R3 B(OH)2
R1
N2
R2
B
R3
OH
OH
R1 R2
177
179
R3 B(OH)2
R1
R2 B
R3
OH
OH
180
R1
R2 B
OH
OHR3
178
-N2
H+
R1
R2 H
R3
174
NNHTs
Ar
B(OH)2+
Ar
K2CO3 (2 equiv.)
CsF (2 equiv.)
dioxane, Microwave
150 °C
181 182 183
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 			 97	
 
Scheme 58 Coupling of saturated heterocyclic sulfonylhydrazones with boronic acids. 
 
Developing alternative mild protocols to generate diazo compounds in situ and subsequent 
coupling with boronic acids has attracted significant attention. Wang et al. described one-pot 
deaminative coupling of arylboronic acids with α-aminoesters and α-aminoacetonitriles in the 
presence of sodium nitrite (Scheme 59).98 With electron-withdrawing groups adjacent to the 
α-carbon of the amino group, the α-aminoesters and α-aminoacetonitriles can be converted 
into the corresponding diazo compounds 191 through diazotisation and subsequent 
deprotonation. The resulting diazo compound 191 then reacts with boronic acid to form the 
tetracoordinated boronate 192, then subsequent 1,2-migration and protodeboronation gave the 
α-arylester or nitrile. However, some substrates still require high temperature and only 
stabilised diazo compounds can be generated in situ using this protocol.  
 
 
Scheme 59 Transition metal-free coupling for synthesis of α-arylesters and nitrile. 
 
In 2015, Ley et al. developed a flow process for the mild generation of semi-stabilised aryl- 
and vinyl diazo compounds from the corresponding hydrazones via activated MnO2 oxidation 
and their subsequent C(sp2)-C(sp3) cross-coupling with arylboronic acids under ambient 
conditions (Scheme 60).99 A range of diazo compounds could be generated rapidly at room 
temperature using this flow process, illustrating significant improvements over the original 
Barluenga methodology, for instance, milder conditions, better atom economy and greater 
functional group tolerance. According to the reaction mechanism proposed by Barluenga et 
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al., a tertiary boronic intermediate 197 is generated prior to protodeboronation. However, this 
intermediate 197 could not be further derivatised under these harsh conditions (Scheme 60). 
Ley et al. were also able to intercept this transient boron intermediate 197 with H2O2/NaOH, 
producing the corresponding alcohol.    
 
 
Scheme 60 Flow assisted transition metal-free coupling of hydrazones and boronic acids.  
 
With this mild flow protocol in hand, Ley et al. further developed an iterative cross coupling 
process by the sequential interception of the transient boronic intermediate 197 with a series 
of flow-generated diazo compounds (Scheme 61).100 This protocol demonstrated an efficient 
and controlled way to construct multiple C-C bonds. In each iteration step, a number of 
interceptions of the transient boronic intermediate 197 could be conducted: 1) trapping with 
pinacol to form the corresponding boronic ester, 2) further reaction with another diazo 
compounds, 3) protodeboronation, 4) oxidation of boron intermediate and 5) allylation of the 
aldehyde (if an allylic boronic acid was employed).  
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Scheme 61 Iterative reactions of transient boronic acids for sequential C-C bond formation. 
 
3.1.3 Carbon-carbon bond forming reactions of (trimethylsilyl)diazomethane with 
organoboron compounds 
 
(Trimethylsilyl)diazomethane TMSCHN2 is a diazo compound widely employed as a less 
explosive alternative to diazomethane.101 TMSCHN2 is usually used as a methylating agent in 
organic synthesis as a reagent in the Doyle-Kirmse reaction.102 Since coupling of diazo 
compounds and organoboron compounds has become popular, the use of readily available 
TMSCHN2 has also been investigated in the recent developments in this field.  
 
Mioskowski, Gall and their co-workers described the preparation of alcohols from alkenes 
via homologation of alkylcatecholboranes with TMSCHN2 (Scheme 62).103 Hydroboration of 
alkenes with these catecholborane provides alkylcatecholboranes, and their reaction with 
TMSCHN2 under reflux forms the tetracoordinated boron intermediate 208 which undergoes 
1,2-migration to produce gem-trimethylsilyl boron intermediate 209. Subsequent H2O2 
oxidation of this intermediate followed by desilylation with TBAF to provide corresponding 
alcohols in moderate yield and the reaction, thus far, has a limited scope.  
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Scheme 62 Preparation of alcohols from alkenes via the homologation of boronates with Me3SiCHN2. 
 
A similar approach has been utilised by Morken et al. in the regioselective homologation of 
alkyl-1,2-bis(catecholboronates) with Me3SiCHN2 (Scheme 63).104 To begin, Rh-catalysed 
diboration of alkene 210 provides a diborane intermediate, subsequent reaction with 
Me3SiCHN2 generates a tetracoordinated boron intermediate which then proceed with 1,2-
migration followed by oxidation to provide the corresponding homologated diol product 211.  
 
 
Scheme 63 One-pot diboration-homologation-oxidation of alkenes. 
In 2016, Fernández et al. reported a direct, gram-scale synthesis of trisubstituted compounds, 
H-C(SR)(Bpin)(SiMe3), via the insertion of trimethylsilyldiazomethane into pinB-SR bonds 
(Scheme 64).105 These trisubstituted compounds can be utilised in various base-assisted 
transformations such as deprotoalkylation, deborylative alkylation, deborylative cyclisation 
and desilylative cyclisation.  
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Scheme 64 Metal-free insertion of Me3SiCHN2 into PhS-Bpin, TolS-Bpin, and BnS-Bpin 
 
These coupling reactions illustrated the potential of employing Me3SiCHN2 for the 
development of new homologation with organoboron compounds. In this thesis, two new 
methods using Me3SiCHN2 with boronic acids and their derivatives have been developed and 
will be described in further detail in the following sections. 
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3.2 A multicomponent approach for diastereoselective synthesis of 
anti-homoallylic alcohols  
 
3.2.1 Introduction 
 
The allylboration of carbonyl compounds is widely applied to prepare homoallylic 
alcohols, which serve as valuable synthetic building blocks, in particular, for the 
construction of a variety of natural products and pharmaceutically relevant 
compounds.106 This reaction introduces not only the alcohol but also the carbon-
carbon double bond which serves as a versatile motif for further derivatisation. This 
carbon-carbon double bond can be readily transformed into a range of other functional 
groups such as carbonyls, alkanes and diols, or employed in a carbon chain 
elongation.107 Therefore, this field has received extensive research and some 
impressive progress has been made in stereoselective allylation of carbonyl 
compounds. Introduction of stoichiometric chiral reagents or catalytic asymmetric 
allylation using either chiral ligand-metal complexes or chiral Lewis acids are 
common approaches to control stereoselectivity.106 
 
The first example of allylboration was reported in 1964 by Mikhailov and Bubnov, in 
which homoallylic alcohols were prepared by the reaction of triallylborane with 
aldehydes or ketones.108 In 1966, Gaudemar et al. developed an allylation of aldehydes 
using allylic boronates.109 After these pioneering reports, numerous allylboration 
methods have been developed (Scheme 65). 
  
 
Scheme 65 Allylboration of carbonyl compounds. 
 
In the late 1970s, Hoffmann et al. proposed a model to rationalise the regio- and 
diastereospecific addition of crotylboronates with aldehydes (Scheme 66).110 In their 
model, diastereoisomeric control of the allylation outcome can be explained using a 
six-membered transition state depending the E/Z geometry of the starting allylboron 
reagent.  
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Scheme 66 Hoffmann's model for rationalisation of allylboration diastereoselectivity. 
 
Following Hoffmann’s work, Denmark et al. categorised two modes of addition for 
different allylation reagents (Scheme 67).111 In the Type I class, the carbonyl 
compound reacts with allylic boron reagents to generate a closed six-membered chair-
like transition state, leading to the formation of γ-allylation products.112 Alternatively, 
as shown in the Type II class, allyl trialkysilanes and allyl trialkylstannanes generally 
react with Lewis acid-activated aldehydes through an open transition state. In these 
two modes, reactions via the Type I mechanism generally have greater regioselectivity 
and diastereoselectivity than those proceeding via Type II. Since this report, numerous 
preparative methods using chiral boron reagents reacting via the Type I class have 
been reported.  
 
 
Scheme 67 Denmark’s mechanistic model for allylation of aldehydes using different organometallic reagents. 
Pioneered by Hoffmann et al., the first chiral allylborane derived from camphor was 
employed in allylboration with aldehydes. Since then, several chiral allylborane 
reagents have been introduced and have attracted significant interest in this field, 
including camphorquinone-derived borane (Reetz),113 bis(sulphonamide) derivatives 
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(Corey),114 diisopinocampheyboranes (Brown),115 borolane derivatives 
(Masamune),116 tartrate-derived boronates (Roush)117 and 9-BBN-derived reagents 
(Soderquist)117 (Scheme 68). Reaction of alkyl and aryl carbonyl compounds with 
these chiral allylborane reagents generally provide moderate to excellent yields with 
excellent enantioselectivity. However, the major drawbacks are instability of some 
boron reagents towards hydrolysis and the stoichiometric use of C2-symmetric ligands. 
Moreover, both the installation of a wide range of side chain groups in the allyl boron 
coupling partner and the preparation of the chiral ligands are inconvenient using 
existing methods.  
 
 
Scheme 68 Representative examples of chiral modified allyl boron reagents for enantioselective allylboration. 
 
In order to improve the resource efficiency (time, cost, etc.) and simplify experimental 
implementation, γ-substituted allylboron reagents have often been prepared in situ 
with subsequent addition to carbonyl compounds. For example, Aggarwal et al. 
reported the synthesis of homoallylic alcohols with high diastereoselectivity and 
enantioselectivity through a one-pot reaction of lithiated carbamates, vinyl boronic 
esters and aldehydes (Scheme 69).119 The tetrasubstituted homoallylic alcohols were 
isolated in excellent yields with exceptional levels of anti-Z-selectivity (>20:1). 
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However, the required use of chiral benzylic carbamates as starting materials limited 
the scope of the reaction. 
 
 
Scheme 69 One-pot lithiation-borylation-allylboration of secondary benzylic carbamates. 
 
Carboni el al. prepared the α-substituted γ-alkoxyallylboronates in situ by 1,4-addition 
of an organometallic reagent to an alkenyl boronate with a γ-acetal group, followed by 
allylboration with aldehydes to afford anti configured derivatives (Scheme 70).120 
Hydroboration of propargyl bromide as the first step in a three-component reaction 
was also described to yield anti-homoallylic alcohols.  
 
 
Scheme 70 One-pot preparation of anti-diol derivatives via allylboration of α-substituted γ-alkoxyallylboronates 
 
These reactions have demonstrated synthetic value in the preparation of homoallylic alcohols 
with high stereoselectivity. However, these methods often suffer a number of drawbacks 
including the generation of stoichiometric waste, extreme reaction conditions, oxygen-
sensitive/water sensitive starting materials and the use of additives.  
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3.2.2 Aim of this work 
 
As described in the previous section, Ley et al. developed a mild preparation of 
transient allyl boron intermediates 197 from aryl or alkyl boronic acids 247 with vinyl 
diazo compounds 195, which could be followed by allylboration of aldehydes as 
electrophiles to provide homoallylic alcohols 249 in high yields with a broad substrate 
scope.100 It was proposed that switching the vinyl substituent on the diazo compound 
to the boronic acid could also furnish the same allyl boron intermediate. Using a range 
of readily available vinylboronic acids, the scope of the reaction could then be further 
expanded.  
 
In this investigation, the principal aim was to develop a metal-free allylboration 
reaction of aldehydes in a one-pot procedure, involving reactions of vinyl boronic 
acids with trimethylsilyl diazomethane (TMSCHN2) to generate the transient allylic 
boronic species 251 in situ, followed by subsequent addition to aldehydes to produce 
homoallylic alcohols (Scheme 71). 
 
 
Scheme 71 Allylboration using transient allylboron intermediates from reaction of vinylboronic acids and TMSCHN2.  
 
Taking advantage of the enabling technologies for safer handling of hazardous 
materials, for instance TMSCHN2, the investigation would to be initially performed in 
a flow system. Once the reactivity profile of this chemical transformation was 
understood, an analogous batch protocol could then be developed.  
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3.2.3 Results and Discussion 
 
3.2.3.1 Optimisation under flow conditions 
 
Investigation into a one-pot allylboration from vinyl boronic acids initially focused on 
treatment of trans-2-(4-methylphenyl)vinylboronic acid 254 with TMSCHN2 212 and 
4-bromobenzaldehyde 253 using the flow apparatus setup shown in Table 8. A first 
attempt of this flow reaction was performed where a solution containing the vinyl 
boronic acid 254 (0.033 M, in THF) and a solution of TMSCHN2 212 and aldehyde 
253 (0.033 M and 0.033 M, respectively, in THF) were combined at a T-piece and 
reacted in a 20 mL perfluoroalkoxy alkanes (PFA) reactor coil (tR = 25 min) at room 
temperature. The exiting stream (gas evolution of N2 gas was observed) was collected 
and quenched using MeOH and unreacted aldehyde scavenged polymer-supported 
tosylhydrazine resin PS-TsNHNH2, to afford homoallylic alcohol 252a in 32% yield 
with high diastereoselectivity (dr >95:5).  
 
The reaction was then optimised and the results summarised in Table 8. Solvent choice 
was crucial not only because the reaction rate was much faster in CH2Cl2 than in THF 
(according to the discolouring of the TMSCHN2 containing reaction mixture, Table 8, 
entries 2 and 3), but also due to the limited solubility of vinyl boronic acid in various 
non-polar organic solvents. Furthermore, formation of by-products was more 
significant when the reaction was performed in THF, which can strongly coordinate 
with the boronic acid partner and therefore limit attack of this diazo species on the 
boron atom. Therefore, a mixture of CH2Cl2 and THF (4:1 v/v) was identified as the 
optimal solvent system to carry out the reaction (Table 8, entry 4). Vinyl boronic acids 
were found to be insoluble at high concentrations, so the solution was kept at 0.04 M. 
In order to ensure full consumption of starting material, 2 equivalents of TMSCHN2 
212 and 1.2 equivalents of vinyl boronic acid 254 with respect to the aldehyde 253 
were used. Further increases in the equivalents of TMSCHN2 did not lead to an 
improvement in yield. Raising the temperature to 60 °C increased the rate of reaction 
and led to the complete consumption of starting material (Table 8, entry 8). It was 
found that under the optimised conditions the homoallylic alcohol 252a was obtained 
in 91% yield with high diastereoselectivity (dr >95:5) (Table 8, entry 8).  
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Table 8 Optimisation of flow synthesis of homoallylic alcohol 255 using TMSCHN2 212, aldehyde 253 and vinyl boronic 
acid 254. 
 
Entry 
Solvent of 
solution 
A 
Solvent of 
solution  
B 
TMSCHN2 
212 
[M] 
Aldehyde 
253 
[M] 
Vinyl 
boronic 
acid 254  
[M] 
T 
(°C) 
tR 
(min) 
Yield 
(%)a 
1 THF THF 0.033 0.033 0.033 25 25 32 
2 THF THF 0.033 0.033 0.033 25 100 38 
3 CH2Cl2 THF 0.033 0.033 0.033 25 25 42 
4 CH2Cl2 
CH2Cl2:THF 
(4:1) 
0.033 0.033 0.033 25 25 51 
5 CH2Cl2 
CH2Cl2:THF 
(4:1) 
0.066 0.033 0.033 25 25 63 
6 CH2Cl2 
CH2Cl2:THF 
(4:1) 
0.066 0.033 0.040 25 25 75 
7 CH2Cl2 
CH2Cl2:THF 
(4:1) 
0.099 0.033 0.040 25 25 78 
8 CH2Cl2 
CH2Cl2:THF 
(4:1) 
0.066 0.033 0.040 60 25 91b 
a Yield was measured using a 1H NMR standard (1,3,5-trimethoxybenzene).  b Isolated yield 
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3.2.3.2 Substrate scope using flow protocol 
 
Once the reaction conditions were optimised, various vinyl boronic acids and aldehydes were 
employed to synthesise a range of homoallylic alcohols (Table 9). The reaction generally 
proceeded with good to excellent yields with excellent anti diastereoselectivity. Both 
electron-donating and electron-withdrawing substituents, including aryl and alkyl groups on 
the E-vinyl boronic acids were well tolerated. In addition, both aromatic and aliphatic 
aldehydes also afforded the products with good to excellent yields. Heteroaromatic aldehydes 
also showed good tolerance in this reaction (Table 9, 252e, 252f, 252j). However, treatment 
of Z-vinyl boronic acids with the optimised conditions provided a complex mixture of 
undesired products, suggesting that the geometry of the double bond of the boronic partner 
restricts the formation of corresponding boroxine intermediate due to steric hindrance (see 
Section 3.3.2.2). Moreover, reaction did not proceed with substrates bearing unprotected OH 
group (Table 9, 252p). A gram-scale preparation (10 mmol) was performed to assess the 
robustness of the flow protocol and afforded homoallylic alcohol 252b in a consistent yield 
of 73% compared to the smaller scale reaction.  
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Table 9 Multicomponent synthesis of homoallylic alcohol in flow. 
 
 
a Reaction performed on 4.49 mmol scale (analytic sample was collected at steady state for 340 min). b 
Conversion was measured using a 1H NMR standard (1,3,5- trimethoxybenzene). c E/Z ratio 2 : 1. d Solvent 
mixture used for the vinyl boronic acid was CH2Cl2 : THF (2 : 1 v/v, 0.04 M). 
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3.2.3.3 Substrate scope into batch protocol 
 
In order to develop a method that can be employed by a wider community that may 
not have direct access to enabling technologies, this method was then transferred 
directly into a batch process. The batch protocol could be conducted under milder 
conditions, for example, under open flask conditions at room temperature but required 
longer reaction time (2 h to 16 h). An extended scope was evaluated under batch 
conditions, demonstrating the generality and practical flexibility of the method (Table 
10). Both electron-donating and electron-withdrawing substituents, including aryl and 
alkyl groups on the E-vinyl boronic acids were well tolerated. In addition, both 
aromatic and aliphatic aldehydes also afforded the products with good to excellent 
yields. 
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Table 10 Multicomponent synthesis of homoallylic alcohol under batch conditions.^ 
 
 
a Standard reaction conditions: 0.6 mmol of TMSCHN2 212, 0.36 mmol of vinyl boronic acid 250, 0.3 mmol of 
aldehyde 248, in CH2Cl2 : THF (4 : 1 v/v, 4 mL) at rt, 2 h to 16 h; 
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^This work was conducted in collaboration with Iain G. Dykes 
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3.2.3.4 Iterative process   
 
 
Scheme 72 Iterative process of multicomponent coupling reaction to polylol 258 and tetrahydropyran derivative 259.^ 
To further illustrate the utility of this method, an iterative process was conducted using a 
sequence of allylboration reactions to demonstrate its potential application in synthesis of 
polyols (Scheme 72). Between each allylboration step, the hydroxyl group of homoallylic 
alcohol intermediate was first protected, followed by ozonolysis of the olefin to generate an 
aldehyde for further iteration. In this study, the sequence was repeated four times to produce 
a complex polyol derivative 258.  Also, treatment of TES-protected intermediate 257 with 
TBAF at room temperature gave the corresponding tetrahydropyran derivative 259 in 99% 
yield.   
 
The relative stereochemistry of 4,6-disubstituted 1,3-diol acetonides for the 2nd iteration 
product 256 can be determined by analysis of the 13C shifts.121 In 13C NMR analysis, the 
conformation differences between the syn (chair) and anti (twist boat) 1,3-diol acetonides 
provide different chemical shifts of the ketal carbon and associated methyl substituents. Syn 
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isomers generally have acetonide methyl groups at chemical shift of 30 and 19 ppm, whereas 
anti isomers generally have the methyl resonances in the range of 24-25 ppm. The 2nd 
iteration product 256 had 13C resonances of the acetonide methyl groups at 25.0 and 24.6 
ppm, consistent with an as anti isomer, thus indicating Felkin-Anh selectivity for allylation of 
the aldehyde (Figure 11).122 
 
 
Figure 11 13C NMR resonances of the 1,3-diol acetonide of the 2nd iteration product 256. 
 
3.2.3.5 Mechanistic studies 
 
During the reaction optimisation, a decreased reaction rate was observed when THF was 
used, potentially due to coordination with the boronic acid. This suggests that the 
electrophilicity of the boron atom may affect the nucleophilic addition of TMSCHN2. When 
catechol borane 260 was utilised as the vinyl boronic species partner, the reaction did not 
proceed at room temperature under the standard conditions. However, silyl vinyl derivative 
261 was obtained in 19% yield along with recovered starting materials when the reaction was 
conducted at 60 °C for 16 h (Scheme 73). Since the boronic ester is less electrophilic than 
corresponding boronic acids, it reflects that addition of TMSCHN2 to E-vinyl boronic species 
is a high activation energy step, suggesting TMSCHN2 was not the active reagent in the 
mechanism.  
 
 
Scheme 73 Multicomponent reaction of catechol borane 260, aldedyhe 253 and TMSCHN2. 
1H-NMR and COSY studies indicated that after addition of TMSCHN2 to the vinyl boronic 
acid 253 in ether-d10, a major intermediate in the reaction mixture appeared to correspond to 
allylic boronic acid 262, in which no silylated intermediate was observed (Scheme 74). The 
decomposition of TMSCHN2 to diazomethane is known in the presence of acid and water.124 
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Since diazomethane is more nucleophilic than TMSCHN2 due to less steric hindrance and 
deactivation of the trimethyl group (p-orbital of C(sp2) overlaps with Si-C(Me) σ* molecular 
orbital), it was suggested that diazomethane is the reactive species that reacts with vinyl 
boronic acid to generate the allyl boronic acid in situ. 
 
 
 
Scheme 74 2D NMR study of reaction of vinyl boronic acid 253 and TMSCHN2 in Et2O-d10. 
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When the vinyl boroxine derivative 263 was prepared using Dean-Stark apparatus and treated 
with TMSCHN2 in anhydrous PhMe at 60 °C followed by trapping with pinacol, a mixture of 
allylic boronic acid 267 and silylated allylic boronic acid 266 in 1:4 ratio was observed by 
1H-NMR analysis (Scheme 75). However, the ratio decreased to 1:1 when vinyl boronic acid 
254 was employed, suggesting the water content in the reaction mixture could have an effect 
on the reaction pathway.124 When the reaction was performed using aldehyde 253 for 
trapping, both homoallylic alcohol 252a and silylated homoallylic alcohol 268 were produced 
from boroxine derivative 263 in similar ratios. The water content in the solvent, for instance 
in Et2O-d10, THF and PhMe, led to different reaction outcomes, illustrating water may take 
part in the boroxine formation and decomposition of TMSCHN2 to diazomethane. 
 
Scheme 75 Reaction of vinylboroxine with TMSCHN2 in toluene. 
With these observations, it is proposed that the boronic acid is in equilibrium with 
corresponding boroxine derivative 269 and provides water as side product (Scheme 
76). The equilibrium between water and vinyl boronic acid gives the tetracoordinated 
boronate species 270 and H3O+. TMSCHN2 212 can then be decomposed in situ to 
highly reactive diazomethane 272 in the presence of H3O+. Diazomethane then attacks 
the boroxine derivative 269 to give the transient allylic boroxine species 275. This 
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intermediate 275 subsequently undergoes allylboration with the aldehyde electrophile 
to produce the final anti product 277 after deborylation.  
 
  
Scheme 76 Proposed mechanism for homoallylic alcohol synthesis via transient allylic boroxine species intermediate. 
 
3.2.4 Conclusion and outlook 
 
To summarise, a robust and scalable metal-free multi-component synthesis of 
homoallylic alcohols has been developed using TMSCHN2, E-vinyl boronic acids and 
aldehydes. This method has exhibited broad scope for both the diazo compound 
component and the vinyl boronic acid component, in addition to moderate to high 
yields and fast reaction times. Moreover, it has shown that handling hazardous 
chemicals using flow chemistry can be an attractive approach for the discovery of new 
chemical transformations. The flow protocol was transferred to a batch procedure in 
order to demonstrate the generality of the chemistry. The power of this method was 
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further exemplified in an iterative fashion to construct new and highly complex 
oligomeric materials. The concept of this chemistry using TMSCHN2 and 
organoboron compounds can be extended to a new approach to access the gem-
trimethylsilyl boronic esters, which will be discused in more details in Section 3.3. 
Other investigations are also directed towards the development of an asymmetric 
version of this method.  
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3.2.5 Experimental details 
 
3.2.5.1 General experimental 
 
All batch reactions were performed using oven-dried glassware (200 °C) under an 
atmosphere of argon unless otherwise stated. All flow reactions were performed using a 
Uniqsis FlowSyn platform1 or a Vapourtec R2+R4 system.2 Solvents were freshly distilled 
over sodium benzophenone ketyl (THF) or calcium hydride (CH2Cl2, hexane and EtOAc). 
All reagents were obtained from commercial sources and used without further purification.  
 
Flash column chromatography was performed using high-purity grade silica gel (Merck grade 
9385) with a pore size 60 Å and 230–400 mesh particle size under air pressure. Analytical 
thin layer chromatography (TLC) was performed using silica gel 60 F254 pre-coated glass 
backed plates and visualized by ultraviolet radiation (254 nm) and/or potassium 
permanganate solution as appropriate.  
 
1H NMR spectra were recorded on a 600 MHz Avance 600 BBI Spectrometer as indicated. 
Chemical shifts are reported in ppm with the resonance resulting from incomplete deuteration 
of the solvent as the internal standard (CDCl3: 7.26 ppm). 13C NMR spectra were recorded 
the same spectrometer with complete proton decoupling. Chemical shifts are reported in ppm 
with the solvent resonance as the internal standard (13CDCl3: 77.16 ppm, t). 19F NMR spectra 
were recorded on a 376 MHz Avance III HD Spectrometer. Chemical shifts are reported in 
ppm with CFCl3 as the external standard (CFCl3: 0.00 ppm). Data are reported as follows: 
chemical shift δ/ppm, integration (1H only), multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, qn = quintet, br = broad, m = multiplet or combinations thereof; 13C signals are 
singlets unless otherwise stated), coupling constants J in Hz, assignment. Spectra are 
assigned as fully as possible, using 1H-COSY, DEPT-135, HMQC and HMBC where 
appropriate to facilitate structural determination. Signals that cannot be unambiguously 
assigned are reported with all possible assignments separated by a slash (e.g. H1/H2) or 
descriptions of their environments (e.g. ArH, OH). Multiple signals arising from 
diastereotopic or (pseudo)axial/equatorial positions are suffixed alphabetically (e.g. H1a, H1b). 
Overlapping signals that cannot be resolved are reported with their assignments denoted in 
list format (e.g. H1, H2 and H3). 1H NMR signals are reported to 2 decimal places and 13C 
signals to 1 decimal place unless rounding would produce a value identical to another signal. 
In this case, an additional decimal place is reported for both signals concerned.  
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Infrared spectra were recorded neat as thin films on a Perkin-Elmer Spectrum One FTIR 
spectrometer and selected peaks are reported (s = strong, m = medium, w = weak, br = broad). 
 
High-resolution mass spectrometry (HRMS) was performed using positive electrospray 
ionisation (ESI+), on either a Waters Micromass LCT Premier spectrometer or performed by 
the Mass Spectrometry Service for the Chemistry Department at the University of Cambridge. 
All m/z values are reported to 4 decimal places and are within ± 5 ppm of theoretical values. 
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3.2.5.2 Experimental procedure 
 
Homoallylic alcohol synthesis in flow 
 
General flow procedure for homoallylic alcohol synthesis:  
 
A solution of aldehyde (0.033 M, 1.0 equiv.) and (trimethylsilyl)diazomethane (0.066 M, 2.0 
equiv., diluted from an initial commercial stock solution of 2 M in hexanes) in CH2Cl2 was 
primed on pump A. A separate solution of vinylboronic acid (0.040 M, 1.2 equiv.) in 
CH2Cl2/THF (4:1) was primed on pump B. The two stock solutions were pumped at 0.4 
mL/min for each pump through a T-piece, followed by a 20 mL reactor coil at 60 °C, then 
finally through a 100 psi BPR. The system was run at a pre-steady state for 40 min and then 
the output solution collected for 20 min (0.285 mmol with respect to aldehyde) into a flask 
containing MeOH (15 mL), which was stirred at r.t. for 16 h. The solvent was removed under 
reduced and the residue purified by silica gel column chromatography to provide the desired 
homoallylic alcohol. 
 
1-(4-bromophenyl)-2-(p-tolyl)but-3-en-1-ol 252a: 
 
Isolated as a colourless oil (82.6 mg, 0.260 mmol, 91%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general flow procedure 
for homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.33 (d, J = 8.4 Hz, 2 H, H2), 7.04 (d, J = 7.9 Hz, 2 H, H11), 
7.02 (d, J = 8.4 Hz, 2 H, H3), 6.93 (d, J = 7.9 Hz, 2 H, H10), 6.20 (ddd, J = 17.3, 10.2, 8.4 Hz, 
1 H, H7), 5.26 (d, J = 10.2 Hz, 1 H, H8cis), 5.22 (d, J = 17.3 Hz, 1 H, H8trans), 4.78 (dd, J = 
7.8, 2.0 Hz, 1 H, H5), 3.45 (t, J = 8.4 Hz, 1 H, H6), 2.37 (d, J = 2.0 Hz, 1 H, OH), 2.29 (s, 3 
H, H13). 
13C NMR (150 MHz, CDCl3): δ 141.0 (C1), 137.8 (C7), 137.2 (C9), 136.5 (C12), 131.1 
(C2), 129.3 (C11), 128.6 (C3), 128.2 (C10), 121.3 (C4), 118.7 (C8), 76.7 (C5), 59.0 (C6), 
21.1 (C13). 
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FTIR (νmax, cm-1): 3440 (br w, OH), 3023 (w), 2919 (w), 1637 (w, C=C), 1593 (w), 1513 
(m), 1487 (m), 1407 (w), 1307 (w), 1188 (w), 1104 (w), 1070 (m), 1041 (m), 1010 (s), 920 
(m), 819 (s), 777 (w). 
HRMS (ESI): calculated for C17H18BrO [M+H]+ 317.0536, found 317.0538.  
Rf = 0.30 (15% EtOAc/hexane). 
 
1-(4-bromophenyl)-2-(4-fluorophenyl)but-3-en-1-ol 252b:  
 
Isolated as a colourless oil (67.1 mg, 0.209 mmol, 73%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general flow procedure 
for homoallylic alcohol synthesis. Collection at steady state over 340 min for scale up 
provided 1.14 g of material (79%). 
 
1H NMR (600 MHz, CDCl3): δ 7.33 (d, J = 8.4 Hz, 2 H, H2), 6.98 (m, 4 H, H3 and H10), 
6.91 (t, J = 8.7 Hz, 2 H, H11), 6.18 (ddd, J = 17.1, 10.2, 8.1, 1 H, H7), 5.29 (dd, J = 10.2, 0.5 
Hz, 1 H, H8cis), 5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.74 (dd, J = 8.1, 2.0 Hz, 1 H, H5), 3.47 (t, 
J = 8.1 Hz, 1 H, H6), 2.38 (d, J = 2.0 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 245.3 Hz, C12), 140.8 (C1), 137.5 (C7), 136.0 
(d, J = 3.2 Hz, C9), 131.2 (C2), 129.9 (d, J = 7.9 Hz, C10), 128.5 (C3), 121.5 (C4), 119.0 
(C8), 115.4 (d, J = 21.2 Hz, C11), 76.8 (d, J = 1.1 Hz, C5), 58.5 (C6). 
19F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F). 
FTIR (νmax, cm-1): 3420 (w, OH), 3076 (w), 2890 (w), 1637 (w, C=C), 1603 (w), 1508 (s), 
1488 (m), 1407 (w), 1306 (w), 1222 (s), 1160 (m), 1095 (w), 1070 (m), 1042 (w), 1010 (s), 
923 (w), 860 (w), 824 (s). 
HRMS (ESI): calculated for C16H13BrF [M+H-H2O]+ 303.0179, found 303.0193.  
Rf = 0.17 (10% EtOAc/hexane). 
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1-(4-bromophenyl)-2-(4-(trifluoromethyl)phenyl)but-3-en-1-ol 252c: 
 
Isolated as a colourless oil (75.6 mg, 0.204 mmol, 71%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.48 (d, J = 8.1 Hz, 2 H, H11), 7.35 (d, J = 8.4 Hz, 2 H, H2), 
7.17 (d, J = 8.1 Hz, 2 H, H10), 7.01 (d, J = 8.4 Hz, 2 H, H3), 6.20 (ddd, J = 17.1, 10.2, 9.0 Hz, 
1 H, H7), 5.31 (d, J = 10.2 Hz, 1 H, H8cis), 5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.82 (d, J = 7.5 
Hz, 1 H, H5), 3.59 – 3.54 (m, 1 H, H6), 2.32 (br d, J = 1.6 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 144.5 (q, J = 0.9 Hz, C9), 140.6 (C1), 136.7 (C7), 131.4 
(C2), 129.2 (q, J = 32.4 Hz, C12), 128.8 (C10), 128.4 (C3), 125.5 (q, J = 3.8 Hz, C11), 124.2 
(q, J = 272.0 Hz, C13), 121.7 (C4), 119.7 (C8), 76.6 (C5), 59.0 (C6). 
19F NMR (376 MHz, CDCl3): δ -62.5 (s, 3 F). 
FTIR (νmax, cm-1): 3420 (br w, OH), 2922 (w), 1618 (w, C=C), 1592 (w), 1487 (w), 1413 
(w), 1384 (w), 1324 (s), 1163 (m), 1122 (s), 1068 (s), 1010 (m), 925 (w), 821 (w), 767 (w). 
HRMS (ESI): calculated for C17H13BrF3 [M+H-H2O]+ 353.0147, found 353.0150.  
Rf = 0.22 (15% EtOAc/hexane). 
 
1-(4-bromophenyl)-2-(chloromethyl)but-3-en-1-ol 252d: 
 
Isolated as a colourless oil (65.2 mg, 0.237 mmol, 79%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.47 (d, J = 8.3 Hz, 2 H, H2), 7.23 (d, J = 8.3 Hz, 2 H, H3), 
5.83 (ddd, J = 17.3, 10.4, 8.7 Hz, 1 H, H7), 5.28 (dd, J = 10.4, 0.5 Hz, 1 H, H8cis), 5.16 (dd, J 
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= 17.3, 0.5 Hz, 1 H, H8trans), 4.87 (d, J = 5.9 Hz, 1 H, H5), 3.62 (dd, J = 11.0, 6.2 Hz, 1 H, 
H9a), 3.38 (dd, J = 11.0, 5.5 Hz, 1 H, H9b), 2.63 – 2.57 (m, 1 H, H6), 2.19 (br s, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 140.9 (C1), 134.4 (C7), 131.6 (C2), 128.2 (C3), 121.8 (C4), 
120.6 (C8), 72.6 (C5), 53.5 (C6), 45.6 (C9). 
FTIR (νmax, cm-1): 3438 (w, OH), 2961 (w), 1676 (w), 1639 (w, C=C), 1591 (w), 1488 (m), 
1406 (w), 1293 (w), 1191 (w), 1071 (s), 1010 (s), 925 (m), 866 (w), 825 (s), 776 (w). 
HRMS (ESI): calculated for C11H11BrClO [M+H-H2]+ 272.9676, found 272.9680.  
Rf = 0.27 (10% EtOAc/hexane). 
 
1-(pyridin-3-yl)-2-(4-(trifluoromethyl)phenyl)but-3-en-1-ol 252e: 
 
Isolated as a brown oil (74.5 mg, 0.254 mmol, 89%) after silica gel column chromatography 
(eluent: 80% EtOAc/hexane), following the general flow procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 8.31 (dd, J = 4.8, 1.3 Hz, 1 H, H1), 8.25 (d, J = 1.7 Hz, 1 H, 
H5), 7.50 – 7.45 (m, 3 H, H3 and H12), 7.18 (d, J = 8.1 Hz, 2 H, H11), 7.13 (dd, J = 7.8, 4.8 
Hz, 1 H, H2), 6.21 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H, H8), 5.29 (d, J = 10.3 Hz, 1 H, H9cis), 
5.18 (d, J = 17.1 Hz, 1 H, H9trans), 4.88 (d, J = 7.3 Hz, 1 H, H6), 3.65 (br s, 1 H, OH), 3.61 – 
3.56 (m, 1 H, H7). 
13C NMR (150 MHz, CDCl3): δ 148.7 (C1), 148.1 (C5), 144.4 (q, J = 1.0 Hz, C10), 137.5 
(C4), 136.3 (C8), 134.4 (C3), 131.0, 129.1 (q, J = 32.4 Hz, C13), 128.7 (C11), 125.4 (q, J = 
3.7 Hz, C12), 124.0 (d, J = 272.0 Hz, C14), 123.1 (C2), 119.5 (C9), 74.7 (C6), 58.6 (C7). 
19F NMR (376 MHz, CDCl3): δ -62.5 (s, 3 F, F14). 
FTIR (νmax, cm-1): 3164 (br w, OH), 1617 (w, C=C), 1581 (w), 1509 (w), 1426 (w), 1325 (s), 
1164 (w), 1122 (m), 1068 (m), 1018 (w), 924 (w), 831 (w). 
HRMS (ESI): calculated for C16H15F3NO [M+H]+ 294.1100, found 294.1104.  
Rf = 0.30 (80% EtOAc/hexane). 
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2-(4-fluorophenyl)-1-(pyridin-3-yl)but-3-en-1-ol 252f: 
 
Isolated as a brown solid (39.0 mg, 0.160 mmol, 56%) after silica gel column 
chromatography (eluent: 80% EtOAc/hexane → EtOAc), following the general flow 
procedure for homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 8.34 (dd, J = 4.8, 1.8 Hz, 1 H, H1), 8.24 (d, J = 1.8 Hz, 1 H, 
H5), 7.47 (dt, J = 7.8, 1.8 Hz, 1 H, H3), 7.13 (dd, J = 7.8, 4.8 Hz, 1 H, H2), 6.99 (dd, J = 8.6, 
5.4 Hz, 2 H, H11), 6.90 (t, J = 8.6 Hz, 2 H, H12), 6.20 (ddd, J = 17.1, 10.2, 8.3 Hz, 1 H, H8), 
5.29 (dd, J = 10.2, 0.7 Hz, 1 H, H9cis), 5.21 (d, J = 17.1 Hz, 1 H, H9trans), 4.81 (d, J = 8.3 Hz, 
1 H, H6), 3.50 (t, J = 8.3 Hz, 1 H, H7), 3.31 (br s, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 161.8 (d, J = 245.6 Hz, C13), 148.7 (C1), 148.4 (C5), 137.6 
(C4), 137.2 (C8), 135.9 (d, J = 3.3 Hz, C10), 134.5 (C3), 129.9 (d, J = 7.9 Hz, C11), 123.1 
(C2), 119.1 (C9), 115.5 (d, J = 21.2 Hz, C12), 75.2 (C6), 58.4 (C7). 
19F NMR (376 MHz, CDCl3): δ -115.6 (s, 1 F, F13). 
FTIR (νmax, cm-1): 3176 (br w, OH), 1638 (w, C=C), 1601 (w), 1507 (s), 1427 (w), 1222 (m), 
1160 (w), 1043 (w), 1029 (w), 922 (w), 829 (w). 
HRMS (ESI): calculated for C15H15FNO [M+H]+ 244.1132, found 244.1129.  
Rf = 0.17 (80% EtOAc/hexane). 
 
(E)-3-(4-(trifluoromethyl)phenyl)hepta-1,5-dien-4-ol 252g: 
 
Isolated as a yellow oil (52.8 mg, 0.206 mmol, 72%) after silica gel column chromatography 
(eluent: 15% EtOAc/hexane), following the general flow procedure for homoallylic alcohol 
synthesis. 
 
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 129	
1H NMR (600 MHz, CDCl3): δ 7.56 (d, J = 8.2 Hz, 2 H, H10), 7.33 (d, J = 8.2 Hz, 2 H, H9), 
6.13 (ddd, J = 17.1, 10.2, 8.7 Hz, 1 H, H6), 5.60 (dqd, J = 15.3, 6.5, 0.9 Hz, 1 H, H2), 5.37 
(ddq, J = 15.3, 7.1, 1.5 Hz, 1 H, H3), 5.26 (d, J = 10.3 Hz, 1 H, H7cis), 5.19 (d, J = 17.1 Hz, 1 
H, H7trans), 4.31 – 4.27 (m, 1 H, H4), 3.44 – 3.40 (m, 1 H, H5), 1.86 (br s, 1 H, OH), 1.61 
(ddd, J = 6.5, 1.5, 0.5 Hz, 3 H, H1). 
13C NMR (150 MHz, CDCl3): δ 145.4 (q, J = 1.1 Hz, C8), 137.3 (C6), 131.1 (C3), 129.0 (q, 
J = 32.4 Hz, C11), 129.0 (C9), 128.9 (C2), 125.4 (q, J = 3.8 Hz, C10), 124.4 (q, J = 271.8 Hz, 
C12), 118.6 (C7), 75.3 (C4), 57.0 (C5), 17.8 (C1). 
19F NMR (376 MHz, CDCl3): δ -62.4 (s, 3 F, F12). 
FTIR (νmax, cm-1): 3420 (br w, OH), 2919 (w), 1618 (w, C=C), 1326 (s), 1164 (m), 1124 (m), 
1069 (m), 1019 (w), 966 (w), 923 (w), 834 (w). 
HRMS (ESI): calculated for C14H14F3O [M+H-H2]+ 255.0991, found 255.1004.  
Rf = 0.22 (15% EtOAc/hexane). 
 
1-(4-bromophenyl)-2-vinylhexan-1-ol (252h): 
 
Isolated as a colourless oil (63.5 mg, 0.224 mmol, 75%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 8.3 Hz, 2 H, H2), 7.19 (d, J = 8.3 Hz, 2 H, H3), 
5.62 (ddd, J = 17.2, 10.2, 9.3 Hz, 1 H, H7), 5.25 (dd, J = 10.2, 1.8 Hz, 1 H, H8cis), 5.17 (ddd, 
J = 17.2, 1.8, 0.6 Hz, 1 H, H8trans), 4.35 (dd, J = 7.7, 1.2 Hz, 1 H, H5), 2.27 – 2.16 (m, 2 H, 
H6 and H9a), 1.30 – 1.04 (m, 6 H, H9b, H10, H11 and OH), 0.80 (t, J = 7.1 Hz, 3 H, H12). 
13C NMR (150 MHz, CDCl3): δ 141.7 (C1), 139.1 (C7), 131.4 (C2), 128.8 (C3), 121.5 (C4), 
119.3 (C8), 76.1 (C5), 52.9 (C6), 30.2 (C9), 29.5 (C10), 22.6 (C11), 14.1 (C12). 
FTIR (νmax, cm-1): 3430 (w, OH), 2956 (m), 2930 (m), 2858 (m), 1639 (w, C=C), 1593 (w), 
1487 (m), 1466 (w), 1405 (w), 1379 (w), 1307 (w), 1190 (w), 1121 (w), 1070 (m), 1041 (m), 
1010 (s), 915 (m), 821 (s). 
HRMS (ESI): calculated for C14H18BrO [M+H-H2]+ 281.0536, found 281.0541.  
Rf = 0.23 (10% EtOAc/hexane). 
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(E)-3-(4-methoxyphenyl)hepta-1,5-dien-4-ol 252i: 
 
Isolated as a yellow oil (52.5 mg, 0.240 mmol, 84%) after silica gel column chromatography 
(eluent: 15% EtOAc/hexane), following the general flow procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.12 (d, J = 8.7 Hz, 2 H, H9), 6.85 (d, J = 8.7 Hz, 2 H, H10), 
6.11 (ddd, J = 17.1, 10.2, 8.8 Hz, 1 H, H6), 5.59 (dqd, J = 15.3, 6.5, 0.9 Hz, 1 H, H2), 5.39 
(ddq, J = 15.3, 6.8, 1.6 Hz, 1 H, H3), 5.21 (dd, J = 10.2, 1.1 Hz, 1 H, H7cis), 5.17 (d, J = 17.1 
Hz, 1 H, H7trans), 4.25 – 4.21 (m, 1 H, H4), 3.79 (s, 3 H, H12), 3.32 – 3.28 (m, 1 H, H5), 1.86 
(br s, 1 H, OH), 1.61 (ddd, J = 6.5, 1.6, 0.9 Hz, 3 H, H1). 
13C NMR (150 MHz, CDCl3): δ 158.4 (C11), 138.5 (C6), 133.1 (C8), 131.5 (C3), 129.5 
(C9), 128.1 (C2), 117.6 (C7), 114.0 (C10), 75.4 (C4), 56.5 (C5), 55.3 (C12), 17.9 (C1). 
FTIR (νmax, cm-1): 3425 (br w, OH), 2937 (w), 1611 (w, C=C), 1512 (s), 1465 (w), 1303 (w), 
1247 (s), 1179 (m), 1036 (m), 966 (w), 919 (w), 828 (w). 
HRMS (ESI): calculated for C14H17O [M+H-H2O]+ 201.1274, found 201.1280.  
Rf = 0.32 (15% EtOAc/hexane). 
 
2-(4-fluorophenyl)-1-(furan-2-yl)but-3-en-1-ol 252j: 
 
Isolated as a yellow oil (55.9 mg, 0.241 mmol, 84%) after silica gel column chromatography 
(eluent: 15% EtOAc/hexane), following the general flow procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.31 (dd, J = 1.8, 0.7 Hz, 1 H, H1), 7.09 (dd, J = 8.7, 5.4 Hz, 
2 H, H10), 6.92 (t, J = 8.7 Hz, 2 H, H11), 6.21 (dd, J = 3.2, 1.8 Hz, 1 H, H2), 6.18 (ddd, J = 
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17.1, 10.3, 8.2 Hz, 1 H, H7), 6.05 (d, J = 3.2 Hz, 1 H, H3), 5.28 (d, J = 10.3 Hz, 1 H, H8cis), 
5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.84 (d, J = 8.2 Hz, 1 H, H5), 3.83 (t, J = 8.2 Hz, 1 H, H6), 
2.27 (br s, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 161.8 (d, J = 245.0 Hz, C12), 154.1 (C4), 142.0 (C1), 137.6 
(C7), 136.2 (d, J = 3.3 Hz, C9), 129.7 (d, J = 7.9 Hz, C10), 118.7 (C8), 115.4 (d, J = 21.2 Hz, 
C11), 110.2 (C2), 107.8 (C3), 71.1 (C5), 55.1 (C6). 
19F NMR (376 MHz, CDCl3): δ -116.1 (s, 1 F, F12). 
FTIR (νmax, cm-1): 3435 (br w, OH), 1603 (w, C=C), 1509 (s), 1412 (w), 1223 (m), 1160 (w), 
1149 (w), 1011 (w), 920 (w), 884 (w), 859 (w), 832 (w). 
HRMS (ESI): calculated for C14H12FO2 [M+H-H2]+ 231.0816, found 231.0822.  
Rf = 0.24 (15% EtOAc/hexane). 
 
2-([1,1'-biphenyl]-4-yl)-1-(2-methoxyphenyl)but-3-en-1-ol 252k: 
 
Isolated as a colourless oil (73.4 mg, 0.222 mmol, 78%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following a modified general flow procedure 
for homoallylic alcohol synthesis; the boronic acid was dissolved in CH2Cl2/THF (2:1) 
instead. 
 
1H NMR (600 MHz, CDCl3): δ 7.55 (dd, J = 8.2, 1.0 Hz, 2 H, H17), 7.46 (d, J = 8.2 Hz, 2 H, 
H13), 7.42 (t, J = 7.7 Hz, 2 H, H18), 7.33 (t, J = 7.4 Hz, 1 H, H19), 7.25 – 7.21 (m, 3 H, H1 
and H14), 7.19 (td, J = 8.1, 1.7 Hz, 1 H, H3), 6.88 (td, J = 8.1, 0.7 Hz, 1 H, H2), 6.79 (d, J = 
8.1 Hz, 1 H, H4), 6.34 (ddd, J = 17.2, 10.2, 8.6 Hz, 1 H, H10), 5.23 (dd, J = 10.2, 1.1 Hz, 1 H, 
H11cis), 5.20 (t, J = 6.0 Hz, 1 H, H8), 5.13 (d, J = 17.2 Hz, 1 H, H11trans), 3.83 – 3.78 (m, 1 H, 
H9), 3.74 (s, 3 H, H6), 2.68 (d, J = 6.0 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 156.5 (C5), 141.1 (C12/C16), 141.0 (C12/C16), 139.3 
(C15), 137.9 (C10), 130.3 (C7), 128.9 (C14/C18), 128.8 (C14/C18), 128.4 (C3), 128.1 (C1), 
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127.2 (C19), 127.1 (C17), 126.9 (C13), 120.6 (C2), 117.8 (C11), 110.4 (C4), 73.8 (C8), 56.5 
(C9), 55.3 (C6). 
FTIR (νmax, cm-1): 3526 (br w, OH), 2960 (w), 2837 (w), 1602 (m, C=C), 1488 (w), 1460 
(w), 1438 (w), 1239 (w), 1205 (m), 1151 (s), 1067 (m), 1008 (w), 918 (w), 821 (w), 755 (w). 
HRMS (ESI): calculated for C23H21O2 [M+H-H2]+ 329.1536, found 329.1542.  
Rf = 0.24 (15% EtOAc/hexane). 
 
(E)-3-(4-fluorophenyl)-6,10-dimethylundeca-1,5,9-trien-4-ol (252l-E, geranial-derived) 
and (Z)-3-(4-fluorophenyl)-6,10-dimethylundeca-1,5,9-trien-4-ol (252l-Z, neral-derived): 
    
(N.B. Using citral as the aldehyde component, 2:1 mixture of geranial and neral). Isolated as 
separable E/Z isomers as colourless oils (E-isomer: 53.7 mg, 0.186 mmol; Z-isomer: 26.2 mg, 
0.091 mmol; combined yield 97%, E/Z ratio 2:1) after silica gel column chromatography 
(eluent: 10% EtOAc/hexane), following the general flow procedure for homoallylic alcohol 
synthesis. 
 
E-isomer: 
1H NMR (600 MHz, CDCl3): δ 7.16 (dd, J = 8.7, 5.5 Hz, 2 H, H15), 6.97 (t, J = 8.7 Hz, 2 H, 
H16), 6.14 (ddd, J = 17.1, 10.2, 8.8 Hz, 1 H, H12), 5.24 (dd, J = 10.2, 1.0 Hz, 1 H, H13cis), 
5.21 (d, J = 17.1 Hz, 1 H, H13trans), 5.09 (dd, J = 8.9, 1.0 Hz, 1 H, H9), 4.99 – 4.94 (m, 1 H, 
H4), 4.53 – 4.48 (m, 1 H, H10), 3.35 – 3.30 (m, 1 H, H11), 2.05 – 1.88 (m, 4 H, H5 and H6), 
1.74 (br s, 1 H, OH), 1.66 (s, 3 H, H1/H3), 1.57 (s, 3 H, H1/H3), 1.47 (d, J = 1.0 Hz, 3 H, 
H8). 
13C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 244.6 Hz, C17), 140.1 (C7), 138.2 (C12), 
136.8 (d, J = 3.2 Hz, C14)), 131.7 (C2), 130.0 (d, J = 7.8 Hz, C15), 125.1 (C9), 124.0 (C4), 
118.0 (C13), 115.2 (d, J = 21.1 Hz, C16), 71.1 (C10), 56.8 (C11), 39.7 (C6), 26.4 (C5), 25.8 
(C1/C3), 17.8 (C1/C3), 16.8 (C8). 
19F NMR (376 MHz, CDCl3): δ -116.5 (s, 1 F, F17). 
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FTIR (νmax, cm-1): 3447 (br w, OH), 2918 (m), 1638 (w), 1603 (w, C=C), 1509 (s), 1448 (w), 
1378 (w), 1223 (m), 1159 (w), 1096 (w), 1001 (w), 918 (w), 861 (w), 829 (m). 
HRMS (ESI): calculated for C19H24FO [M+H-H2]+ 287.1806, found 287.1808.  
Rf = 0.20 (10% EtOAc/hexane). 
 
Z-isomer: 
1H NMR (600 MHz, CDCl3): δ 7.17 (dd, J = 8.7, 5.5 Hz, 2 H, H15), 6.97 (t, J = 8.7 Hz, 2 H, 
H16), 6.15 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H, H12), 5.23 (dd, J = 10.3, 1.2 Hz, 1 H, H13cis), 
5.18 (d, J = 17.1 Hz, 1 H, H13trans), 5.14 (d, J = 9.1 Hz, 1 H, H9), 5.05 (t, J = 6.8 Hz, 1 H, 
H4), 4.53 – 4.47 (m, 1 H, H10), 3.35 – 3.29 (m, 1 H, H11), 2.05 – 1.96 (m, 2 H, H5a and H6a), 
1.96 – 1.90 (m, 1 H, H6b), 1.90 – 1.80 (m, 1 H, H5b), 1.69 (s, 3 H, H1/H3), 1.66 (br d, J = 1.7 
Hz, 1 H, OH), 1.64 (d, J = 1.3 Hz, 3 H, H8), 1.58 (s, 3 H, H1/H3). 
13C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 244.6 Hz, C17), 140.4 (C7), 138.1 (C12), 
137.1 (d, J = 3.2 Hz, C14), 132.4 (C2), 129.9 (d, J = 7.8 Hz, C15), 126.1 (C9), 124.0 (C4), 
117.9 (C13), 115.3 (d, J = 21.1 Hz, C16), 70.6 (C10), 56.4 (C11), 32.4 (C6), 26.5 (C5), 25.8 
(C1/C3), 23.4 (C8), 17.8 (C1/C3). 
19F NMR (376 MHz, CDCl3): δ -116.6 (s, 1 F, F17). 
FTIR (νmax, cm-1): 3447 (br w, OH), 2967 (w), 2914 (w), 1637 (w), 1603 (w, C=C), 1508 (s), 
1448 (w), 1377 (w), 1222 (m), 1159 (w), 1094 (w), 996 (w), 919 (w), 859 (w), 829 (m). 
HRMS (ESI): calculated for C19H24FO [M+H-H2]+ 287.1806, found 287.1809.  
Rf = 0.27 (10% EtOAc/hexane). 
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4-(3-fluorophenyl)hex-5-en-3-ol 252m: 
 
Isolated as a colourless oil (39.0 mg, 0.201 mmol, 70%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.30 – 7.26 (m, 1 H, H11), 7.00 (d, J = 7.7 Hz, 1 H, H8), 
6.96 – 6.89 (m, 2 H, H10 and H12), 6.09 (ddd, J = 17.1, 10.2, 9.1 Hz, 1 H, H5), 5.25 (dd, J = 
10.2, 1.2 Hz, 1 H, H6cis), 5.21 (d, J = 17.1 Hz, 1 H, H6trans), 3.74 – 3.69 (m, 1 H, H3), 3.29 – 
3.25 (m, 1 H, H4), 1.75 (br d, J = 3.2 Hz, 1 H, OH), 1.48 – 1.41 (m, 1 H, H2a), 1.37 – 1.29 (m, 
1 H, H2b), 0.94 (t, J = 7.4 Hz, 3 H, H1). 
13C NMR (150 MHz, CDCl3): δ 163.1 (d, J = 246.0 Hz, C9), 144.5 (d, J = 6.9 Hz, C7), 
137.8 (C5), 130.2 (d, J = 8.3 Hz, C11), 123.8 (d, J = 2.8 Hz, C12), 118.5 (C6), 115.1 (d, J = 
21.4 Hz, C8), 113.7 (d, J = 21.0 Hz, C10), 75.3 (C3), 56.7 (d, J = 1.5 Hz, C4), 27.5 (C2), 
10.1 (C1). 
19F NMR (376 MHz, CDCl3): δ -112.9 (s, 1 F, F9). 
FTIR (νmax, cm-1): 3447 (br w, OH), 2937 (m), 1614 (m, C=C), 1588 (s), 1489 (s), 1448 (m), 
1261 (m), 1151 (w), 965 (w), 921 (w), 782 (m). 
HRMS (ESI): calculated for C12H16FO [M+H]+ 195.1180, found 195.1182.  
Rf = 0.27 (15% EtOAc/hexane). 
 
6-methyl-3-phenylhept-1-en-4-ol 252n: 
 
Isolated as a colourless oil (37.8 mg, 0.185 mmol, 65%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
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1H NMR (600 MHz, CDCl3): δ 7.32 (t, J = 7.5 Hz, 2 H, H11), 7.23 (t, J = 7.5 Hz, 1 H, H12), 
7.20 (d, J = 7.5 Hz, 2 H, H10), 6.12 (ddd, J = 17.1, 10.1, 9.0 Hz, 1 H, H7), 5.25 – 5.17 (m, 2 
H, H8cis and H8trans), 3.90 – 3.85 (m, 1 H, H5), 3.21 (dd, J = 9.0, 7.3 Hz, 1 H, H6), 1.86 – 
1.76 (m, 1 H, H3), 1.74 (dd, J = 3.4, 0.8 Hz, 1 H, OH), 1.33 (ddd, J = 14.1, 9.8, 4.5 Hz, 1 H, 
H4a), 1.12 – 1.06 (m, 1 H, H4b), 0.87 (d, J = 6.7 Hz, 3 H, H1/H2), 0.84 (d, J = 6.6 Hz, 3 H, 
H1/H2). 
13C NMR (150 MHz, CDCl3): δ 141.9 (C9), 138.5 (C7), 128.8 (C11), 128.2 (C10), 126.8 
(C12), 118.0 (C8), 72.1 (C5), 58.1 (C6), 43.8 (C4), 24.7 (C3), 23.8 (C1/C2), 21.7 (C1/C2). 
FTIR (νmax, cm-1): 3436 (br w, OH), 2956 (m), 2929 (w), 2869 (w), 1602 (w, C=C), 1493 
(w), 1468 (w), 1453 (w), 1367 (w), 1151 (w), 1063 (w), 918 (w), 843 (w), 759 (w). 
HRMS (ESI): calculated for C14H19 [M+H-H2O]+ 187.1481, found 187.1490.  
Rf = 0.39 (15% EtOAc/hexane). 
 
(4-fluorophenyl)-6-methylhept-1-en-4-ol 252o:  
 
Isolated as a colourless oil (28.1 mg, 0.126 mmol, 44%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general flow procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.17 (dd, J = 8.7, 5.4 Hz, 2 H, H10), 7.01 (t, J = 8.7 Hz, 2 H, 
H11), 6.08 (ddd, J = 17.1, 10.2, 9.1 Hz, 1 H, H7), 5.23 (dd, J = 10.2, 1.4 Hz, 1 H, H8cis), 5.18 
(d, J = 17.1 Hz, 1 H, H8trans), 3.86 – 3.80 (td, J = 7.0, 3.5 Hz, 1 H, H5), 3.20 (dd, J = 8.5, 7.4 
Hz, 1 H, H6), 1.85 – 1.75 (m, 1 H, H3), 1.72 (br d, J = 2.5 Hz, 1 H, OH), 1.31 (ddd, J = 14.0, 
9.8, 4.5 Hz, 1 H, H4a), 1.07 (ddd, J = 14.0, 9.6, 2.9 Hz, 1 H, H4b), 0.87 (d, J = 6.7 Hz, 3 H, 
H1/H2), 0.84 (d, J = 6.6 Hz, 3 H, H1/H2). 
13C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 244.8 Hz, C12), 138.3 (C7), 137.6 (d, J = 3.2 
Hz, C9), 129.6 (d, J = 7.8 Hz, C10), 118.2 (C8), 115.6 (d, J = 21.1 Hz, C11), 72.1 (C5), 57.1 
(C6), 43.9 (C4), 24.7 (C3), 23.8 (C1/C2), 21.7 (C1/C2). 
19F NMR (376 MHz, CDCl3): δ -116.4 (s, 1 F, F12). 
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FTIR (νmax, cm-1): 3426 (br w, OH), 2957 (m), 1603 (w, C=C), 1509 (s), 1468 (w), 1368 (w), 
1224 (m), 1160 (w), 1063 (w), 920 (w), 831 (w). 
HRMS (ESI): calculated for C14H20FO [M+H]+ 223.1493, found 223.1499.  
Rf = 0.26 (10% EtOAc/hexane). 
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Homoallylic alcohol synthesis in batch 
 
General batch procedure for homoallylic alcohol synthesis: 
 
To a solution of aldehyde (0.3 mmol, 1.0 equiv.) and vinylboronic acid (0.36 mmol, 1.2 
equiv.) in CH2Cl2/THF (4:1, 4 mL) was added (trimethylsilyl)diazomethane (0.3 mL, 2 M in 
hexanes, 0.6 mmol, 2.0 equiv.) and the mixture subsequently stirred at room temperature for 
2-20 h. The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography to provide the desired homoallylic alcohol.  
 
1-(4-bromophenyl)-2-(p-tolyl)but-3-en-1-ol 252a: 
 
Isolated as a colourless oil (67.8 mg, 0.214 mmol, 71%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general batch procedure 
for homoallylic alcohol synthesis. Spectral data consistent with results from flow procedure. 
 
1-(4-bromophenyl)-2-(4-fluorophenyl)but-3-en-1-ol 252b:  
 
Isolated as a colourless oil (70.3 mg, 0.219 mmol, 73%) after silica gel column 
chromatography (eluent: 10% → 15% EtOAc/hexane), following the general batch procedure 
for homoallylic alcohol synthesis. Spectral data consistent with results from flow procedure. 
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1-(4-bromophenyl)-2-(chloromethyl)but-3-en-1-ol 252d: 
 
Isolated as a colourless oil (65.2 mg, 0.237 mmol, 79%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. Spectral data consistent with results from flow procedure. 
 
1-(4-bromophenyl)-2-vinylhexan-1-ol 252h: 
 
Isolated as a colourless oil (63.5 mg, 0.224 mmol, 75%) after silica gel column 
chromatography (eluent: 10% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. Spectral data consistent with results from flow procedure. 
 
2-benzyl-1-(4-bromophenyl)but-3-en-1-ol 252q: 
 
Isolated as a colourless oil (69.7 mg, 0.220 mmol, 73%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.48 (d, J = 8.4 Hz, 2 H, H2), 7.27 (t, J = 7.3 Hz, 2 H, H12), 
7.22 – 7.17 (m, 3 H, H3 and H13), 7.10 (d, J = 7.3 Hz, 2 H, H11), 5.69 (ddd, J = 17.2, 10.3, 
8.4 Hz, 1 H, H7), 5.15 (dd, J = 10.3, 1.4 Hz, 1 H, H8cis), 4.98 (d, J = 17.2 Hz, 1 H, H8trans), 
4.50 (d, J = 5.8 Hz, 1 H, H5), 2.72 (dd, J = 12.7, 4.9 Hz, 1 H, H9a), 2.64 – 2.53 (m, 2 H, H6 
and H9b), 2.27 (br s, 1 H, OH). 
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 139	
13C NMR (150 MHz, CDCl3): δ 141.7 (C1), 139.8 (C10), 137.3 (C7), 131.4 (C2), 129.2 
(C11), 128.5 (C3), 128.3 (C12), 126.2 (C13), 121.5 (C4), 119.5 (C8), 74.8 (C5), 53.9 (C6), 
37.2 (C9). 
FTIR (νmax, cm-1): 3423 (w, OH), 3062 (w), 3027 (w), 2920 (w), 1638 (w, C=C), 1593 (w), 
1488 (m), 1455 (w), 1405 (w), 1308 (w), 1229 (w), 1192 (w), 1103 (w), 1071 (m), 1031 (w), 
1009 (s), 918 (m), 836 (m), 820 (m), 784 (w). 
HRMS (ESI): calculated for C17H16Br [M+H-H2O]+ 299.0430, found 299.0437.  
Rf = 0.43 (15% EtOAc/hexane). 
 
tert-butyl (2-(2-(4-fluorophenyl)-1-hydroxybut-3-en-1-yl)phenyl)carbamate 252r: 
 
Isolated as a colourless oil (77.2 mg, 0.216 mmol, 72%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.87 (br s, 1 H, NH), 7.78 (d, J = 7.5 Hz, 1 H, H8), 7.15 (t, J 
= 7.5 Hz, 1 H, H7), 6.91 (dd, J = 8.4, 5.5 Hz, 2 H, H15), 6.83 (t, J = 8.6 Hz, 2 H, H16), 6.76 
(t, J = 7.5 Hz, 1 H, H6), 6.64 (d, J = 7.5 Hz, 1 H, H5), 6.23 (dt, J = 17.1, 9.6 Hz, 1 H, H12), 
5.35 (d, J = 9.6 Hz, 1 H, H13cis), 5.31 (d, J = 17.1 Hz, 1 H, H13trans), 4.74 (d, J = 9.6 Hz, 1 H, 
H10), 3.76 (t, J = 9.6 Hz, 1 H, H11), 3.00 (br s, 1 H, OH), 1.54 (s, 9 H, H1). 
13C NMR (150 MHz, CDCl3): δ 161.6 (d, J = 245.2 Hz, C17), 153.5 (C3), 137.7 (C12), 
137.0 (C4), 135.9 (d, J = 3.2 Hz, C14), 129.6 (d, J = 7.9 Hz, C15), 129.1 (two overlapping 
signals, C5 and C9), 128.4 (C7), 122.9 (C6), 122.3 (C8), 119.0 (C13), 115.3 (d, J = 21.2 Hz, 
C16), 80.3 (C2), 78.3 (C10), 55.6 (C11), 28.5 (C1). 
19F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F17). 
FTIR (νmax, cm-1): 3358 (w, OH), 2980 (w), 1698 (m, C=O), 1637 (w, C=C), 1590 (m), 1508 
(s), 1479 (w), 1446 (m), 1393 (w), 1368 (m), 1302 (m), 1226 (s), 1156 (s), 1050 (m), 1024 
(m), 908 (m), 860 (w), 830 (m), 755 (m). 
HRMS (ESI): calculated for C21H25FNO3 [M+H]+ 358.1813, found 358.1808.  
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Rf = 0.29 (15% EtOAc/hexane). 
 
1-(5-bromo-2-chlorophenyl)-2-(4-fluorophenyl)but-3-en-1-ol 252s: 
 
Isolated as a colourless oil (88.0 mg, 0.247 mmol, 82%) after silica gel column 
chromatography (eluent: 5% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.68 (d, J = 2.3 Hz, 1 H, H5), 7.30 (dd, J = 8.5, 2.3 Hz, 1 H, 
H3), 7.24 (dd, J = 8.6, 5.5 Hz, 2 H, H12), 7.13 (d, J = 8.5 Hz, 1 H, H2), 6.98 (t, J = 8.6 Hz, 2 
H, H13), 6.21 (ddd, J = 17.1, 10.3, 9.0 Hz, 1 H, H9), 5.27 – 5.24 (m, 1 H, H7), 5.22 (d, J = 
10.3 Hz, 1 H, H10cis), 5.00 (d, J = 17.1 Hz, 1 H, H10trans), 3.69 (dd, J = 9.0, 5.0 Hz, 1 H, H8), 
2.25 (d, J = 3.4 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 161.9 (d, J = 245.3 Hz, C14), 141.7 (C6), 136.6 (d, J = 3.2 
Hz, C11), 135.3 (C9), 131.7 (C5), 131.5 (C3), 131.0 (C1), 130.7 (C2), 129.8 (d, J = 7.9 Hz, 
C12), 120.7 (C4), 119.5 (C10), 115.4 (d, J = 21.2 Hz, C13), 73.4 (C7), 55.1 (C8). 
19F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F14). 
FTIR (νmax, cm-1): 3455 (w, OH), 1637 (w, C=C), 1603 (w), 1508 (s), 1456 (m), 1390 (w), 
1222 (s), 1182 (w), 1159 (m), 1136 (w), 1085 (m), 1042 (s), 1016 (m), 995 (m), 908 (m), 858 
(m), 829 (s), 810 (s). 
HRMS (ESI): calculated for C16H14BrClFO [M+H]+ 354.9895, found 354.9899.  
Rf = 0.16 (5% EtOAc/hexane). 
 
1-(4-(thiophen-2-yl)phenyl)-2-(4-(trifluoromethyl)phenyl)but-3-en-1-ol 252t: 
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Isolated as a yellow oil (69.6 mg, 0.166 mmol, 62%) after silica gel column chromatography 
(eluent: 30% Et2O/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.48 (two superimposed d, J = 8.0 Hz, 4 H, H6 and H15), 
7.29 (d, J = 3.7 Hz, 1 H, H3), 7.26 (d, J = 5.0 Hz, 1 H, H1), 7.21 (d, J = 8.0 Hz, 2 H, H14), 
7.14 (d, J = 8.0 Hz, 2 H, H7), 7.07 (dd, J = 5.0, 3.7 Hz, 1 H, H2), 6.24 (ddd, J = 17.1, 10.2, 
8.1 Hz, 1 H, H11), 5.32 (d, J = 10.2 Hz, 1 H, H12cis), 5.24 (d, J = 17.1 Hz, 1 H, H12trans), 4.87 
(d, J = 8.1 Hz, 1 H, H9), 3.64 (t, J = 8.1 Hz, 1 H, H10), 2.35 (br s, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 144.8 (C13), 144.0 (C4), 140.8 (C8), 137.0 (C11), 133.9 
(C5), 129.0 (q, J = 32.4 Hz, C16), 128.9 (C14), 128.1 (C2), 127.3 (C7), 125.7 (C6), 125.4 (q, 
J = 3.7 Hz, C15), 125.0 (C1), 124.3 (q, J = 272.0 Hz, C17), 123.2 (C3), 119.3 (C12), 76.9 
(C9), 58.9 (C10). 
19F NMR (376 MHz, CDCl3): δ -62.4 (s, 3 F, F17). 
FTIR (νmax, cm-1): 3432 (w, OH), 1617 (w, C=C), 1537 (w), 1501 (w), 1414 (w), 1323 (s), 
1260 (w), 1162 (m), 1118 (s), 1067 (s), 1017 (m), 959 (w), 924 (w), 818 (s), 767 (w). 
HRMS (ESI): calculated for C21H18F3OS [M+H]+ 375.1025, found 375.1021.  
Rf = 0.31 (30% Et2O/hexane). 
 
1-(furan-2-yl)-2-(4-methoxyphenyl)but-3-en-1-ol 252u: 
 
Isolated as a yellow oil (49.7 mg, 0.203 mmol, 68%) after silica gel column chromatography 
(eluent: 20% EtOAc/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.32 (d, J = 1.8 Hz, 1 H, H1), 7.06 (d, J = 8.7 Hz, 2 H, H10), 
6.78 (d, J = 8.7 Hz, 2 H, H11), 6.23 – 6.16 (m, 2 H, H2 and H7), 6.06 (d, J = 3.2 Hz, 1 H, 
H3), 5.25 (d, J = 10.3 Hz, 1 H, H8cis), 5.23 (d, J = 17.1 Hz, 1 H, H8trans), 4.85 (d, J = 8.0 Hz, 
1 H, H5), 3.79 (t, J = 8.0 Hz, 1 H, H6), 3.75 (s, 3 H, H13), 2.34 (br s, 1 H, OH). 
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13C NMR (150 MHz, CDCl3): δ 158.4 (C12), 154.4 (C4), 141.9 (C1), 138.0 (C7), 132.5 
(C9), 129.1 (C10), 118.2 (C8), 113.9 (C11), 110.2 (C2), 107.6 (C3), 71.1 (C5), 55.2 (C13), 
55.0 (C6). 
FTIR (νmax, cm-1): 3437 (w, OH), 2916 (w), 2837 (w), 1637 (w, C=C), 1611 (m), 1584 (w), 
1511 (s), 1465 (w), 1442 (w), 1414 (w), 1303 (w), 1245 (s), 1178 (m), 1149 (m), 1033 (m), 
1009 (m), 912 (m), 884 (w), 856 (w), 826 (m). 
HRMS (ESI): calculated for C15H15O3 [M+H-H2]+ 243.1016, found 243.1026.  
Rf = 0.22 (20% EtOAc/hexane). 
 
4-(1-hydroxy-3-phenylbut-3-en-1-yl)benzonitrile 252v: 
 
Isolated as a colourless oil (56.9 mg, 0.228 mmol, 76%) after silica gel column 
chromatography (eluent: 30% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.62 (d, J = 8.1 Hz, 2 H, H3), 7.45 (d, J = 8.1 Hz, 2 H, H4), 
7.42 (d, J = 7.4 Hz, 2 H, H11), 7.38 (t, J = 7.4 Hz, 2 H, H12), 7.33 (t, J = 7.4 Hz, 1 H, H13), 
5.44 (s, 1 H, H9a), 5.16 (s, 1 H, H9b), 4.76 (dd, J = 9.0, 4.2 Hz, 1 H, H6), 3.00 (dd, J = 14.2, 
4.2 Hz, 1 H, H7a), 2.80 (dd, J = 14.2, 9.0 Hz, 1 H, H7b), 2.20 (br s, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 149.2 (C5), 144.3 (C10), 139.8 (C8), 132.4 (C3), 128.8 
(C12), 128.2 (C13), 126.6 (C4), 126.4 (C11), 119.0 (C1), 116.7 (C9), 111.3 (C2), 71.4 (C6), 
46.2 (C7). 
FTIR (νmax, cm-1): 3422 (w, OH), 3055 (w), 2947 (w), 2228 (m, C≡N), 1627 (w, C=C), 1609 
(m), 1574 (w), 1495 (m), 1445 (m), 1408 (m), 1303 (w), 1201 (w), 1056 (m), 1017 (m), 951 
(w), 905 (m), 879 (w), 838 (s), 780 (s). 
HRMS (ESI): calculated for C17H16NO [M+H]+ 250.1226, found 250.1236.  
Rf = 0.22 (30% EtOAc/hexane). 
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1,5-diphenylhex-5-en-1-yn-3-ol 252w: 
 
Isolated as a yellow oil (53.2 mg, 0.214 mmol, 71%) after silica gel column chromatography 
(eluent: 15% EtOAc/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.48 – 7.45 (m, 2 H, ArH), 7.38 – 7.34 (m, 4 H, ArH), 7.30 
(m, 4 H, ArH), 5.48 (d, J = 1.1 Hz, 1 H, H10a), 5.30 (d, J = 1.1 Hz, 1 H, H10b), 4.68 (ddd, J = 
7.5, 5.9, 5.3 Hz, 1 H, H7), 3.08 (ddd, J = 14.2, 5.9, 0.9 Hz, 1 H, H8a), 3.03 (ddd, J = 14.2, 7.5, 
0.7 Hz, 1 H, H8b), 2.02 (d, J = 5.3 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 144.0 (C11), 140.4 (C9), 131.8 (C2/C3/C12/C13), 128.6 
(C2/C3/C12/C13), 128.5 (C1/C14), 128.4 (C2/C3/C12/C13), 127.9 (C1/C14), 126.5 
(C2/C3/C12/C13), 122.7 (C4), 116.5 (C10), 89.6 (C6), 85.5 (C5), 61.6 (C7), 44.1 (C8). 
FTIR (νmax, cm-1): 3374 (w, OH), 3057 (w), 1629 (w, C=C), 1599 (w), 1574 (w), 1490 (m), 
1443 (m), 1341 (w), 1029 (s), 982 (w), 904 (m), 779 (m), 756 (s).  
HRMS (ESI): calculated for C18H15O [M+H-H2]+ 247.1117, found 247.1129.  
Rf = 0.28 (15% EtOAc/hexane). 
 
2-(4-methoxyphenyl)-1-(perfluorophenyl)but-3-en-1-ol 252x: 
 
Isolated as a colourless oil (77.5 mg, 0.225 mmol, 75%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.00 (d, J = 8.6 Hz, 2 H, H10), 6.75 (d, J = 8.6 Hz, 2 H, 
H11), 6.18 (dt, J = 17.2, 10.1 Hz, 1 H, H7), 5.33 (d, J = 17.2 Hz, 1 H, H8trans), 5.31 (d, J = 
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10.1 Hz, 1 H, H8cis), 5.18 (dd, J = 10.1, 4.7 Hz, 1 H, H5), 3.85 – 3.80 (m, 1 H, H6), 3.74 (s, 3 
H, H13), 2.56 (d, J = 4.7 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 158.8 (C12), 144.9 (approx. d, J = 248.4 Hz, C2), 140.6 (dtt, 
J = 253.8, 13.0, 5.2 Hz, C1), 138.3 (C7), 137.4 (approx. d, J = 249.9 Hz, C3), 131.3 (C9), 
128.6 (C10), 118.8 (C8), 115.3 (approx. t, J = 15.2 Hz, C4), 114.3 (C11), 69.1 (C5), 55.6 
(C6), 55.3 (C13). 
19F NMR (376 MHz, CDCl3): δ -142.2 (dd, J = 21.8, 7.6 Hz, 2 F, F3), -154.8 (t, J = 20.9 Hz, 
1 F, F1), -162.1 – -162.4 (m, 2 F, F2). 
FTIR (νmax, cm-1): 3449 (w, OH), 2939 (w), 2841 (w), 1654 (w, C=C), 1611 (w), 1585 (w), 
1521 (m), 1500 (s), 1467 (w), 1444 (w), 1418 (w), 1303 (w), 1245 (m), 1179 (m), 1143 (w), 
1120 (m), 1033 (m), 991 (s), 927 (m), 856 (w), 828 (m), 776 (w). 
HRMS (ESI): calculated for C17H12F5O2 [M+H-H2]+ 343.0752, found 343.0752.  
Rf = 0.33 (15% EtOAc/hexane). 
 
1-(3-(-1-hydroxy-2-(p-tolyl)but-3-en-1-yl)-1H-indol-1-yl)ethan-1-one 252y: 
 
Isolated as an orange oil (57.3 mg, 0.179 mmol, 60%) after silica gel column chromatography 
(eluent: 40% EtOAc/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 8.39 (d, J = 7.7 Hz, 1 H, H5), 7.61 (d, J = 7.7 Hz, 1 H, H2), 
7.33 (t, J = 7.7 Hz, 1 H, H4), 7.25 (t, J = 7.7 Hz, 1 H, H3), 7.06 (appears as s, 4 H, H16 and 
H17), 7.04 (br s, 1 H, H8), 6.26 (ddd, J = 17.1, 10.3, 9.0 Hz, 1 H, H13), 5.26 (d, J = 10.3 Hz, 
1 H, H14cis), 5.19 (d, J = 17.1 Hz, 1 H, H14trans), 5.11 (d, J = 6.9 Hz, 1 H, H11), 3.86 – 3.80 
(m, 1 H, H12), 2.58 (br s, 1 H, OH), 2.42 (s, 3 H, H10), 2.29 (s, 3 H, H19). 
13C NMR (150 MHz, CDCl3): δ 168.7 (C9), 138.0 (C15), 137.4 (C13), 136.5 (C18), 136.0 
(C1), 129.3 (C17), 128.7 (C6), 128.1 (C16), 125.3 (C4), 123.56 (C3), 123.55 (C7), 123.0 
(C8), 119.9 (C2), 118.5 (C14), 116.7 (C5), 71.4 (C11), 56.3 (C12), 23.9 (C10), 21.1 (C19). 
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FTIR (νmax, cm-1): 3434 (w, OH), 2923 (w), 1705 (s, C=O), 1606 (w, C=C), 1570 (w), 1513 
(w), 1450 (s), 1382 (s), 1348 (s), 1329 (s), 1249 (s), 1219 (s), 1147 (w), 1123 (m), 1087 (w), 
1034 (m), 1020 (m), 935 (m), 845 (s), 813 (m). 
HRMS (ESI): calculated for C21H22NO2 [M+H]+ 320.1645, found 320.1631.  
Rf = 0.43 (40% EtOAc/hexane). 
 
6,10-dimethyl-3-(p-tolyl)undeca-1,9-dien-4-ol 252z: 
 
Isolated as an inseparable mixture of regioisomers (1:1) as a colourless oil (56.9 mg, 0.203 
mmol, 67%) after silica gel column chromatography (eluent: 5% EtOAc/hexane), following 
the general batch procedure for homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.13 (two superimposed d, J = 7.9 Hz, 2 H, H16), 7.11 – 
7.07 (m, 2 H, H15), 6.14 – 6.06 (m, 1 H, H12), 5.23 – 5.16 (m, 2 H, H13cis and H13trans), 5.09 
– 5.05 (m, 1 H, H4), 3.89 – 3.84 (m, 1 H, H10), 3.20 – 3.14 (m, 1 H, H11), 2.33 (two 
superimposed s, 3 H, H18), 1.97 – 1.83 (m, 2 H, H5), 1.77 (s, 1 H, OH), 1.71 – 1.63 (m, 1 H, 
H7), 1.68 and 1.66 (two s, 3 H, H1/H3), 1.58 (two superimposed s, 3 H, H1/H3), 1.42 – 1.35 
(m, 1 H, H6/H9), 1.31 – 1.08 (m, 2 H, H6/H9), 1.07 – 0.96 (m, 1 H, H6/H9), 0.88 and 0.83 
(two d, J = 6.6 Hz, 3 H, H8). 
13C NMR (150 MHz, CDCl3): δ 138.9 and 138.5 (C12), 138.8 and 138.7 (C14), 136.3 (C17), 
131.26 and 131.24 (C2), 129.5 (C16), 127.9 (C15), 124.99 and 124.93 (C4), 117.9 and 117.8 
(C13), 72.1 and 71.6 (C10), 58.0 and 57.4 (C11), 42.0 and 41.9 (C6/C9), 38.2 and 36.0 
(C6/C9), 29.3 and 29.0 (C7), 25.88 and 25.87 (C1/C3), 25.7 and 25.3 (C5), 21.2 (C18), 20.6 
and 18.9 (C8), 17.8 (C1/C3). 
FTIR (νmax, cm-1): 3483 (br w, OH), 2923 (s), 1726 (w), 1637 (w, C=C), 1514 (m), 1457 (m), 
1377 (m), 1251 (w), 1112 (m), 1063 (m), 1022 (m), 993 (m), 916 (s), 840 (s), 812 (s), 781 
(w). 
HRMS (ESI): calculated for C20H31O [M+H]+ 287.2369, found 287.2370.  
Rf = 0.19 (5% EtOAc/hexane). 
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3-benzyl-7-(5,5-dimethyl-1,3-dioxan-2-yl)hept-1-en-4-ol 252aa: 
 
Isolated as a colourless oil (58.4 mg, 0.183 mmol, 61%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.26 (t, J = 7.5 Hz, 2 H, H16), 7.20 – 7.14 (m, 3 H, H15 and 
H17), 5.75 (ddd, J = 17.3, 10.3, 9.0 Hz, 2 H, H11), 5.11 (dd, J = 10.3, 1.8 Hz, 1 H, H12cis), 
4.98 (dd, J = 17.3, 1.1 Hz, 1 H, H12trans), 4.40 (t, J = 5.0 Hz, 1 H, H, H5), 3.59 (d, J = 11.0 
Hz, 2 H, H4a), 3.51 (m, 1 H, H9), 3.40 (d, J = 11.0 Hz, 2 H, H4b), 2.87 (dd, J = 13.6, 6.7 Hz, 
1 H, H13a), 2.67 (dd, J = 13.6, 8.3 Hz, 1 H, H13b), 2.40 – 2.32 (m, 1 H, H10), 1.69 – 1.58 (m, 
2 H, H6), 1.58 – 1.52 (m, 2 H, H7a and OH), 1.51 – 1.46 (m, 2 H, H8), 1.46 – 1.39 (m, 1 H, 
H7b), 1.18 (s, 3 H, H1/H2), 0.71 (s, 3 H, H1/H2). 
13C NMR (150 MHz, CDCl3): δ 140.4 (C14), 137.6 (C11), 129.4 (C15), 128.3 (C16), 126.0 
(C17), 118.2 (C12), 102.2 (C5), 77.33 (C4, almost overlaps with CDCl3 peak), 72.5 (C9), 
51.3 (C10), 37.7 (C13), 35.1 (C8), 34.7 (C6), 30.3 (C3), 23.1 (C1/C2), 22.0 (C1/C2), 20.5 
(C7). 
FTIR (νmax, cm-1): 3465 (w, OH), 3027 (w), 2952 (m), 2850 (m), 1734 (w), 1638 (w, C=C), 
1603 (w), 1496 (w), 1455 (m), 1394 (m), 1363 (w), 1311 (w), 1237 (w), 1176 (w), 1135 (s), 
1080 (m), 1015 (s), 972 (m), 913 (s), 837 (w), 791 (w). 
HRMS (ESI): calculated for C20H30O3Na [M+Na]+ 341.2087, found 341.2081.  
Rf = 0.20 (15% EtOAc/hexane). 
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(E)-1-phenyl-4-(p-tolyl)hexa-1,5-dien-3-ol 252ab: 
 
Isolated as a yellow oil (49.3 mg, 0.186 mmol, 62%) after silica gel column chromatography 
(eluent: 15% EtOAc/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 7.32 – 7.27 (m, 4 H, H2 and H3), 7.25 – 7.21 (m, 1 H, H1), 
7.18 – 7.13 (m, 4 H, H12 and H13), 6.57 (dd, J = 15.9, 1.2 Hz, 1 H, H5), 6.21 (ddd, J = 17.1, 
10.3, 8.8 Hz, 1 H, H9), 6.13 (dd, J = 15.9, 6.1 Hz, 1 H, H6), 5.30 – 5.22 (m, 2 H, H10cis and 
H10trans), 4.51 (m, 1 H, H7), 3.49 – 3.43 (m, 1 H, H8), 2.34 (s, 3 H, H15), 2.05 (d, J = 3.6 Hz, 
1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 138.1 (C9), 137.6 (C11), 137.0 (C4), 136.5 (C14), 131.1 
(C5), 130.0 (C6), 129.4 (C13), 128.6 (C3), 128.4 (C12), 127.6 (C1), 126.6 (C2), 118.1 (C10), 
75.1 (C7), 57.3 (C8), 21.2 (C15). 
FTIR (νmax, cm-1): 3420 (br w, OH), 3025 (w), 2923 (w), 1670 (w, C=C), 1637 (w, C=C), 
1600 (w), 1514 (m), 1495 (m), 1449 (m), 1381 (w), 1297 (w), 1112 (m), 1070 (m), 966 (s), 
919 (m), 812 (s), 781 (w). 
HRMS (ESI): calculated for C19H19O [M+H-H2]+ 263.1430, found 263.1438.  
Rf = 0.36 (15% EtOAc/hexane). 
 
Methyl 4-(2-(chloromethyl)-1-hydroxybut-3-en-1-yl)benzoate 252ac: 
 
Isolated as a colourless oil (49.7 mg, 0.195 mmol, 66%) after silica gel column 
chromatography (eluent: 15% EtOAc/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
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1H NMR (600 MHz, CDCl3): δ 8.01 (d, J = 8.3 Hz, 2 H, H4), 7.43 (d, J = 8.3 Hz, 2 H, H5), 
5.82 (ddd, J = 17.3, 10.4, 8.7 Hz, 1 H, H9), 5.25 (dd, J = 10.4, 1.0 Hz, 1 H, H10cis), 5.12 (d, J 
= 17.3 Hz, 1 H, H10trans), 5.01 (dd, J = 5.1, 3.7 Hz, 1 H, H7), 3.91 (s, 3 H, H1), 3.66 (dd, J = 
11.0, 6.6 Hz, 1 H, H11a), 3.41 (dd, J = 11.0, 5.5 Hz, 1 H, H11b), 2.69 – 2.62 (m, 1 H, H8), 
2.25 (d, J = 3.7 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 167.0 (C2), 147.2 (C6), 134.1 (C9), 129.8 (C4), 129.7 (C3), 
126.4 (C5), 120.6 (C10), 72.8 (C7), 53.6 (C8), 52.3 (C1), 45.5 (C11). 
FTIR (νmax, cm-1): 3468 (w, OH), 2955 (w), 1703 (m, C=O), 1611 (w, C=C), 1577 (w), 1437 
(m), 1418 (w), 1311 (m), 1277 (s), 1193 (w), 1178 (w), 1111 (m), 1076 (w), 1018 (w), 996 
(w), 966 (w), 924 (w), 860 (w), 824 (w), 775 (w), 755 (w). 
HRMS (ESI): calculated for C13H16ClO3 [M+H]+ 255.0782, found 255.0790.  
Rf = 0.24 (15% EtOAc/hexane). 
 
2-(chloromethyl)-1-(3-nitrophenyl)but-3-en-1-ol 252ad: 
 
Isolated as a colourless oil (66.7 mg, 0.276 mmol, 92%) after silica gel column 
chromatography (eluent: 40% Et2O/hexane), following the general batch procedure for 
homoallylic alcohol synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 8.22 (t, J = 1.5 Hz, 1 H, H2), 8.12 (dd, J = 7.9, 1.5 Hz, 1 H, 
H6), 7.68 (d, J = 7.9 Hz, 1 H, H4), 7.52 (t, J = 7.9 Hz, 1 H, H5), 5.81 (ddd, J = 17.3, 10.3, 8.9 
Hz, 1 H, H9), 5.25 (d, J = 10.4 Hz, 1 H, H10cis), 5.14 – 5.06 (m, 2 H, H7 and H10trans), 3.71 
(dd, J = 11.0, 7.1 Hz, 1 H, H11a), 3.45 (dd, J = 11.0, 5.3 Hz, 1 H, H11b), 2.71 – 2.61 (m, 1 H, 
H8), 2.40 (br s, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 148.4 (C1), 144.4 (C3), 133.4 (C9), 132.6 (C4), 129.4 (C5), 
122.8 (C6), 121.4 (C2), 121.1 (C10), 72.0 (C7), 53.5 (C8), 45.3 (C11). 
FTIR (νmax, cm-1): 3518 (w, OH), 3080 (w), 1638 (w, C=C), 1583 (w), 1526 (s, N=O), 1480 
(w), 1440 (w), 1422 (w), 1348 (s, N=O), 1313 (m), 1255 (w), 1204 (w), 1092 (w), 1067 (w), 
995 (w), 926 (m), 908 (m), 838 (w), 810 (m), 788 (w). 
HRMS (ESI): calculated for C11H13ClNO3 [M+H]+ 242.0578, found 242.0580.  
Rf = 0.39 (40% Et2O/hexane). 
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2-benzyl-1-(2-chloro-6-methoxyquinolin-3-yl)but-3-en-1-ol 252ae: 
 
Isolated as a white solid (88.0 mg, 0.249 mmol, 83%) after silica gel column chromatography 
(eluent: 15% EtOAc/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
 
1H NMR (600 MHz, CDCl3): δ 8.06 (s, 1 H, H5), 7.82 (d, J = 9.2 Hz, 1 H, H9), 7.33 – 7.26 
(m, 3 H, H10 and H18), 7.24 (d, J = 7.0 Hz, 2 H, H17), 7.20 (t, J = 7.2 Hz, 1 H, H19), 6.98 (d, 
J = 2.7 Hz, 1 H, H3), 5.79 (ddd, J = 17.3, 10.4, 8.3 Hz, 1 H, H13), 5.08 (t, J = 3.7 Hz, 1 H, 
H11), 5.01 (dd, J = 10.4, 1.1 Hz, 1 H, H14cis), 4.74 (d, J = 17.3 Hz, 1 H, H14trans), 3.89 (s, 3 
H, H1), 3.00 – 2.91 (m, 2 H, H15), 2.85 (qd, J = 8.3, 3.7 Hz, 1 H, H12), 2.70 (d, J = 3.7 Hz, 1 
H, OH). 
13C NMR (150 MHz, CDCl3): δ 158.2 (C2), 146.0 (C7), 142.8 (C8), 139.6 (C16), 135.92 
(C5/C13), 135.91 (C5/C13), 135.3 (C6), 129.4 (two overlapping signals, C9 and C17), 128.4 
(C18), 128.2 (C4), 126.3 (C19), 123.0 (C10), 119.0 (C14), 105.2 (C3), 70.9 (C11), 55.6 (C1), 
50.5 (C12), 38.2 (C15). 
FTIR (νmax, cm-1): 3364 (w, OH), 3065 (w), 3027 (w), 2915 (w), 1623 (m, C=C), 1591 (m), 
1496 (s), 1465 (w), 1455 (m), 1418 (w), 1380 (w), 1339 (m), 1295 (w), 1227 (s), 1165 (m), 
1125 (w), 1085 (w), 1049 (s), 1030 (s), 998 (w), 959 (w), 911 (s), 829 (s), 793 (w). 
HRMS (ESI): calculated for C21H21ClNO2 [M+H]+ 354.1255, found 354.1267.  
Rf = 0.20 (15% EtOAc/hexane). 
 
1-(2-chloro-6-methoxyquinolin-3-yl)-2-vinylhexan-1-ol 252af: 
 
Isolated as a white solid (62.6 mg, 0.194 mmol, 65%) after silica gel column chromatography 
(eluent: 40% EtOAc/hexane), following the general batch procedure for homoallylic alcohol 
synthesis. 
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1H NMR (600 MHz, CDCl3): δ 8.11 (s, 1 H, H5), 7.88 (d, J = 9.2 Hz, 1 H, H9), 7.34 (dd, J = 
9.2, 2.8 Hz, 1 H, H10), 7.06 (d, J = 2.8 Hz, 1 H, H3), 5.71 (ddd, J = 17.3, 10.2, 9.0 Hz, 1 H, 
H13), 5.18 – 5.10 (m, 2 H, H11 and H14cis), 4.92 (dd, J = 17.3, 1.0 Hz, 1 H, H14trans), 3.91 (s, 
3 H, H1), 2.52 – 2.45 (m, 1 H, H12), 2.38 (d, J = 3.8 Hz, 1 H, OH), 1.62 – 1.52 (m, 1 H, 
H15a), 1.52 – 1.43 (m, 1 H, H15b), 1.40 – 1.33 (m, 1 H, H16a), 1.33 – 1.23 (m, 3 H, H16b and 
H17), 0.86 (t, J = 7.1 Hz, 3 H, H18). 
13C NMR (150 MHz, CDCl3): δ 158.3 (C2), 146.6 (C7), 143.0 (C8), 137.3 (C13), 135.8 
(C5), 135.2 (C6), 129.6 (C9), 128.4 (C4), 123.1 (C10), 119.1 (C14), 105.3 (C3), 72.4 (C11), 
55.7 (C1), 50.6 (C12), 31.1 (C15), 29.7 (C16), 22.7 (C17), 14.1 (C18). 
FTIR (νmax, cm-1): 3359 (w, OH), 2957 (m), 2931 (m), 2858 (m), 1623 (m, C=C), 1591 (m), 
1497 (s), 1465 (w), 1420 (w), 1379 (w), 1338 (m), 1228 (s), 1166 (m), 1118 (w), 1046 (m), 
1001 (w), 959 (w), 917 (m), 830 (m). 
HRMS (ESI): calculated for C18H23NO2Cl [M+H]+ 320.1412, found 320.1411.  
Rf = 0.35 (40% EtOAc/hexane). 
 
 Summary of Data CCDC 1483699  
Compound Name: Formula: C18 H22 Cl1 N1 O2  
Unit Cell Parameters: a 9.46790(10) b 11.3192(2) c 16.4547(3) P-1 
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Iterative sequence 
 
1-(4-bromophenyl)-2-(chloromethyl)but-3-en-1-yl)oxy)triethylsilane 255: 
 
To a solution of 252d (43.5 mg, 0.156 mmol, 1 equiv.) in anhydrous CH2Cl2 (1 mL) at 0 °C 
was added DIPEA (0.06 mL, 0.312 mmol, 2 equiv.) then triethylsilyl 
trifluoromethanesulfonate (0.06 mL, 0.234 mmol, 1.5 equiv.). The mixture was warmed to r.t. 
and stirred for 15 min, then partitioned between EtOAc (15 mL) and sat. aq. NaHCO3 
solution (15 mL). The organic layer was separated and the aqueous layer extracted further 
with EtOAc (3 × 10 mL). The combined organic extracts were dried (MgSO4) and evaporated 
under reduced pressure. The residue was purified by silica gel column chromatography 
(eluent: hexane) to provide the title product 5 (58.2 mg, 0.149 mmol, 95%) as a colourless oil. 
 
1H NMR (600 MHz, CDCl3): δ 7.42 (d, J = 8.3 Hz, 2 H, H2), 7.16 (d, J = 8.3 Hz, 2 H, H3), 
5.74 (ddd, J = 17.4, 10.2, 9.0 Hz, 1 H, H10), 5.11 (dd, J = 10.4, 0.7 Hz, 1 H, H11cis), 4.98 (d, 
J = 3.7 Hz, 1 H, H5), 4.93 (dd, J = 17.3, 0.7 Hz, 1 H, H11trans), 3.70 (dd, J = 10.7, 7.7 Hz, 1 H, 
H9a), 3.37 (dd, J = 10.7, 5.8 Hz, 1 H, H9b), 2.52 – 2.45 (m, 1 H, H8), 0.89 (t, J = 8.0 Hz, 9 H, 
H7), 0.54 (q, J = 8.0 Hz, 6 H, H6). 
13C NMR (150 MHz, CDCl3): δ 142.3 (C1), 134.3 (C10), 131.1 (C2), 128.3 (C3), 121.1 
(C4), 119.4 (C11), 73.5 (C5), 55.0 (C8), 45.8 (C9), 6.9 (C7), 4.9 (C6). 
FTIR (νmax, cm-1): 2956 (w), 2912 (w), 2877 (w), 1640 (w, C=C), 1592 (w), 1486 (m), 1458 
(w), 1406 (w), 1363 (w), 1294 (w), 1239 (w), 1201 (w), 1107 (m), 1085 (s), 1003 (s), 922 (m), 
872 (w), 826 (m), 788 (w). 
HRMS (ESI): calculated for C17H27BrClOSi [M+H]+ 389.0698, found 389.0703.  
Rf = 0.49 (hexane). 
 
 
 
 
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 152	
1-(4-bromophenyl)-2-(chloromethyl)-4-(4-fluorophenyl)-1-((triethylsilyl)oxy)hex-5-en-3-
ol 255a: 
 
To a solution of 255 (55.8 mg, 0.143 mmol) in CH2Cl2/MeOH (9:1, 15 mL) was bubbled 
O3/O2 at -78 °C until the reaction mixture turned blue (ca. 5-10 min). Argon was then 
bubbled through the solution until residual O3 had disappeared. Polymer-supported PPh3 (3 
mmol/g loading, 144 mg, ca. 0.42 mmol) was then added and the mixture stirred at r.t. for 1 h. 
The polymer-supported reagent was then filtered off and the filtrate evaporated under 
reduced pressure to provide the crude aldehyde, which was used immediately without further 
purification.  
 
To a solution of the crude aldehyde and trans-2-(4-fluorophenyl)vinylboronic acid (35.7 mg, 
0.21 mmol, 1.5 equiv.) in CH2Cl2/THF (4:1, 1.5 mL) was added (trimethylsilyl)diazomethane 
(0.14 mL, 2 M in hexanes, 0.28 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 
h. The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (eluent: 5% EtOAc/hexane) to provide the title product 5a (57.6 mg, 0.140 
mmol, 98% over 2 steps) as a colourless viscous oil.  
 
1H NMR (600 MHz, CDCl3): δ 7.45 (d, J = 8.3 Hz, 2 H, H2), 7.02 (d, J = 8.3 Hz, 2 H, H3), 
6.82 (t, J = 8.6 Hz, 2 H, H14), 6.62 (dd, J = 8.6, 5.4 Hz, 2 H, H13), 5.94 (ddd, J = 17.1, 10.3, 
7.8 Hz, 1 H, H16), 5.28 (s, 1 H, H5), 5.06 (d, J = 10.3 Hz, 1 H, H17cis), 4.96 (d, J = 17.1 Hz, 
1 H, H17trans), 3.99 (d, J = 10.3 Hz, 1 H, H10), 3.85 (dd, J = 11.5, 3.4 Hz, 1 H, H9a), 3.79 (t, J 
= 11.5 Hz, 1 H, H9b), 3.52 (s, 1 H), 3.31 (dd, J = 10.3, 7.8 Hz, 1 H, H11), 1.51 – 1.46 (m, 1 H, 
H8), 0.92 (t, J = 8.0 Hz, 9 H, H7), 0.61 (q, J = 8.0 Hz, 6 H, H6). 
13C NMR (150 MHz, CDCl3): δ 161.6 (d, J = 245.4 Hz, C15), 141.5 (C1), 139.4 (C16), 
136.2 (d, J = 3.3 Hz, C12), 131.4 (C2), 129.1 (d, J = 7.8 Hz, C13), 127.5 (C3), 121.2 (C4), 
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116.4 (C17), 115.7 (d, J = 21.2 Hz, C14), 74.0 (C5), 71.6 (C10), 53.2 (C11), 49.7 (C8), 41.9 
(C9), 6.9 (C7), 4.7 (C6). 
19F NMR (376 MHz, CDCl3): δ -115.7 (s, 1 F, F15). 
FTIR (νmax, cm-1): 3509 (br w, OH), 2957 (w), 2878 (w), 1637 (w, C=C), 1604 (w), 1509 
(m), 1486 (w), 1458 (w), 1440 (w), 1224 (m), 1194 (w), 1159 (w), 1067 (s), 995 (s), 919 (m), 
828 (s), 799 (w). 
HRMS (ESI): calculated for C25H34BrClFO2Si [M+H]+ 527.1179, found 527.1184.  
Rf = 0.30 (5% EtOAc/hexane). 
 
4-(4-bromophenyl)-5-(chloromethyl)-6-(1-(4-fluorophenyl)allyl)-2,2-dimethyl-1,3-
dioxane 256: 
 
To a solution of 255a (102 mg, 0.193 mmol) in acetone/2,2-dimethoxypropane (4:1, 4 mL) 
was added (±)-camphorsulfonic acid (9.0 mg, 0.039 mmol). The mixture was stirred at r.t. for 
16 h. The reaction was then quenched with Et3N (4 drops) and the solvent removed under 
reduced pressure. The residue was purified by silica gel column chromatography (eluent: 5% 
EtOAc/hexane) to provide the title product (79.8 mg, 0.176 mmol, 91%) as a white foam. 
 
1H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 8.4 Hz, 2 H, H2), 7.26 (d, J = 8.4 Hz, 2 H, H3), 
7.21 (dd, J = 8.6, 5.3 Hz, 2 H, H13), 7.04 (t, J = 8.6 Hz, 2 H, H14), 6.12 (ddd, J = 17.2, 10.3, 
6.2 Hz, 1 H, H16), 5.09 (d, J = 10.3 Hz, 1 H, H17cis), 4.89 (d, J = 6.9 Hz, 1 H, H5), 4.85 (d, J 
= 17.2 Hz, 1 H, H17trans), 4.44 (dd, J = 10.9, 4.5 Hz, 1 H, H10), 3.67 (dd, J = 11.6, 7.5 Hz, 1 
H, H9a), 3.61 (dd, J = 10.9, 6.2 Hz, 1 H, H11), 3.46 (dd, J = 11.6, 3.5 Hz, 1 H, H9b), 2.11 – 
2.06 (m, 1 H, H8), 1.54 (s, 3 H, H7a/H7b), 1.44 (s, 3 H, H7a/H7b). 
13C NMR (150 MHz, CDCl3): δ 161.9 (d, J = 246.1 Hz, C15), 140.7 (C1), 139.7 (d, J = 0.9 
Hz, C16), 135.6 (d, J = 3.4 Hz, C12), 131.8 (C2), 129.7 (d, J = 7.9 Hz, C13), 129.0 (C3), 
121.9 (C4), 116.4 (C17), 116.1 (d, J = 21.3 Hz, C14), 101.9 (C6), 72.9 (C5), 71.0 (C10), 49.1 
(C11), 45.8 (C8), 42.7 (C9), 25.0 (C7a/C7b), 24.6 (C7a/C7b). 
19F NMR (376 MHz, CDCl3): δ -115.0 (s, 1 F, F15). 
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FTIR (νmax, cm-1): 2986 (w), 2936 (w), 1637 (w, C=C), 1604 (w), 1509 (s), 1489 (m), 1445 
(w), 1409 (w), 1380 (m), 1281 (w), 1220 (s), 1159 (s), 1092 (m), 1071 (m), 1053 (m), 1009 
(s), 910 (m), 889 (w), 832 (s), 804 (m), 774 (w). 
HRMS (ESI): calculated for C22H24BrClFO2 [M+H]+ 453.0627, found 453.0616.  
Rf = 0.24 (5% EtOAc/hexane). 
 
1-(6-(4-bromophenyl)-5-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-1-(4-fluoro-
phenyl)-3-(p-tolyl)pent-4-en-2-ol 256a: 
 
To a solution of 256 (79.8 mg, 0.176 mmol) in CH2Cl2/MeOH (9:1, 15 mL) was bubbled 
O3/O2 at -78 °C until the reaction mixture turned blue (ca. 5 min). Argon was then bubbled 
through the solution until residual O3 had disappeared. Polymer-supported PPh3 (3 mmol/g 
loading, 175 mg, ca. 0.53 mmol) was then added and the mixture stirred at r.t. for 1 h. The 
polymer-supported reagent was then filtered off and the filtrate evaporated under reduced 
pressure to provide the crude aldehyde, which was used immediately without further 
purification.  
 
To a solution of the crude aldehyde and trans-2-(4-methylphenyl)vinylboronic acid (43.7 mg, 
0.27 mmol, 1.5 equiv.) in CH2Cl2/THF (4:1, 2 mL) was added (trimethylsilyl)diazomethane 
(0.18 mL, 2 M in hexanes, 0.36 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 
h. The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and 
evaporated under reduced pressure. The residue was purified by silica gel column 
chromatography (eluent: 10% EtOAc/hexane) to provide the title products as separable 
diastereomers (major diastereomer: 63.7 mg, 0.108 mmol; minor diastereomer: 10.1 mg, 
0.017 mmol; combined yield 71% over 2 steps, d.r. 6:1) as white foams.  
 
Major diastereomer: 
1H NMR (600 MHz, CDCl3): δ 7.44 (d, J = 8.4 Hz, 2 H, H2), 7.23 – 7.17 (m, 4 H, H3 and 
H13), 7.10 (d, J = 8.0 Hz, 2 H, H20), 7.09 – 7.04 (m, 4 H, H14 and H19), 6.30 (dt, J = 17.3, 
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10.0 Hz, 1 H, H23), 5.24 (dd, J = 10.0, 1.4 Hz, 1 H, H24cis), 4.93 (d, J = 17.3 Hz, 1 H, 
H24trans), 4.90 (d, J = 6.1 Hz, 1 H, H5), 4.77 (dd, J = 11.0, 3.9 Hz, 1 H, H10), 4.11 (dd, J = 
7.2, 3.5 Hz, 1 H, H16), 4.07 (s, 1 H, OH), 3.74 (dd, J = 11.4, 8.5 Hz, 1 H, H9a), 3.52 (dd, J = 
11.4, 3.3 Hz, 1 H, H9b), 3.12 (dd, J = 10.0, 3.5 Hz, 1 H, H17), 3.07 (dd, J = 11.0, 7.2 Hz, 1 H, 
H11), 2.32 (s, 3 H, H22), 1.89 – 1.84 (m, 1 H, H8), 1.55 (s, 3 H, H7a/H7b), 1.50 (s, 3 H, 
H7a/H7b). 
13C NMR (150 MHz, CDCl3): δ 162.1 (d, J = 247.0 Hz, C15), 140.5 (C1), 140.0 (C18), 
137.0 (C23), 136.0 (C21), 134.4 (d, J = 3.3 Hz, C12), 131.8 (C2), 130.2 – 129.8 (br, C13), 
129.2 (C20), 128.8 (C3), 128.1 (C19), 122.0 (C4), 118.2 (C24), 116.2 (d, J = 21.2 Hz, C14), 
102.1 (C6), 80.1 (C16), 73.1 (C5/C10), 73.0 (C5/C10), 52.7 (C17), 47.6 (C11), 45.1 (C8), 
42.6 (C9), 25.6 (C7a/C7b), 25.0 (C7a/C7b), 21.2 (C22). 
19F NMR (376 MHz, CDCl3): δ -114.0 (s, 1 F, F15). 
FTIR (νmax, cm-1): 3487 (br w, OH), 2989 (w), 2939 (w), 1606 (w, C=C), 1509 (s), 1490 (w), 
1445 (w), 1409 (w), 1382 (m), 1223 (s), 1160 (m), 1113 (m), 1097 (m), 1054 (m), 1010 (m), 
973 (w), 910 (m), 835 (s), 812 (m). 
HRMS (ESI): calculated for C31H33BrClFO3Na [M+Na]+ 609.1178, found 609.1165.  
Rf = 0.37 (10% EtOAc/hexane). 
 
Minor diastereomer: 
1H NMR (600 MHz, CDCl3): δ 7.41 (d, J = 8.3 Hz, 2 H, H2), 7.21 (d, J = 8.3 Hz, 2 H, H3), 
7.16 (d, J = 7.8 Hz, 2 H, H19), 6.98 (br s, 2 H, H14), 6.95 (d, J = 7.8 Hz, 2 H, H20), 5.87 (dt, 
J = 17.0, 10.0 Hz, 1 H, H23), 5.04 (d, J = 10.0 Hz, 1 H, H24cis), 4.97 (d, J = 17.0 Hz, 1 H, 
H24trans), 4.80 – 4.76 (m, 2 H, H5 and H10), 4.52 – 4.48 (m, 1 H, H16), 3.47 (dd, J = 11.3, 
8.6 Hz, 1 H, H9a), 3.20 (dd, J = 11.3, 3.3 Hz, 1 H, H9b), 2.78 (d, J = 11.5 Hz, 1 H, H11), 2.67 
(t, J = 10.0 Hz, 1 H, H17), 2.37 (s, 3 H, H22), 1.86 – 1.81 (m, 1 H, H8), 1.77 (d, J = 3.6 Hz, 1 
H, OH), 1.525 (s, 3 H, H7a/H7b), 1.517 (s, 3 H, H7a/H7b). (N.B. 2 H corresponding to H13 
appear broadened over 7.50 – 6.50 region). 
13C NMR (150 MHz, CDCl3): δ 162.2 (d, J = 246.1 Hz, C15), 141.1 (C1), 140.7 (C23), 
137.3 (C18), 136.6 (C21), 131.7 (d, J = 3.4 Hz, C12), 131.7 (C2), 129.7 (C20), 129.1 (C3), 
128.2 (C19), 121.8 (C4), 117.3 (C24), 115.5 – 115.0 (br, C14), 101.9 (C6), 73.3 (C5), 70.0 
(C16), 68.1 (C10), 55.2 (C17), 45.9 (C11), 45.1 (C8), 43.0 (C9), 25.3 (C7a/C7b), 24.8 
(C7a/C7b), 21.3 (C22). (N.B. signal corresponding to C13 too broadened to distinguish 
accurately). 
19F NMR (376 MHz, CDCl3): δ -114.9 (s, 1 F, F15). 
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FTIR (νmax, cm-1): 3569 (br w, OH), 2990 (w), 2934 (w), 1606 (w, C=C), 1509 (s), 1490 (w), 
1445 (w), 1380 (m), 1286 (w), 1223 (s), 1161 (m), 1102 (w), 1070 (m), 1010 (m), 974 (w), 
910 (w), 845 (w), 812 (m), 784 (w). 
HRMS (ESI): calculated for C31H33BrClFO3Na [M+Na]+ 609.1178, found 609.1167.  
Rf = 0.27 (10% EtOAc/hexane). 
 
((1-(6-(4-bromophenyl)-5-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-1-(4-
fluorophenyl)-3-(p-tolyl)pent-4-en-2-yl)oxy)triethylsilane 257: 
 
To a solution of 256a (44.1 mg, 0.075 mmol, 1 equiv.) in anhydrous CH2Cl2 (1 mL) at 0 °C 
was added DIPEA (0.04 mL, 0.150 mmol, 2 equiv.) then triethylsilyl 
trifluoromethanesulfonate (0.04 mL, 0.225 mmol, 1.5 equiv.). The mixture was warmed to r.t. 
and stirred for 30 min, then partitioned between EtOAc (15 mL) and sat. aq. NaHCO3 
solution (15 mL). The organic layer was separated and the aqueous layer extracted further 
with EtOAc (3 × 10 mL). The combined organic extracts were dried (MgSO4) and evaporated 
under reduced pressure. The residue was purified by silica gel column chromatography 
(eluent: 5% EtOAc/hexane) to provide the title product (50.8 mg, 0.072 mmol, 96%) as a 
white foam. 
 
1H NMR (600 MHz, CDCl3): δ 7.46 (d, J = 8.4 Hz, 2 H, H2), 7.28 (d, J = 8.4 Hz, 2 H, H3), 
7.19 (d, J = 7.8 Hz, 2 H, H19), 7.11 (d, J = 7.8 Hz, 2 H, H20), 6.93 (t, J = 8.6 Hz, 2 H, H14), 
6.88 (br s, 2 H, H13), 5.97 (ddd, J = 16.8, 9.7, 9.4 Hz, 1 H, H23), 5.00 – 4.95 (m, 3 H, H10, 
H24cis and H24trans), 4.84 (d, J = 6.8 Hz, 1 H, H5), 4.07 (t, J = 9.4 Hz, 1 H, H17), 4.00 (d, J = 
9.4 Hz, 1 H, H16), 3.28 (dd, J = 11.5, 7.9 Hz, 1 H, H9a), 3.02 (dd, J = 11.5, 3.5 Hz, 1 H, H9b), 
2.93 (d, J = 11.4 Hz, 1 H, H11), 2.38 (s, 3 H, H22), 2.08 – 2.03 (m, 1 H, H8), 1.60 (s, 3 H, 
H7a/H7b), 1.59 (s, 3 H, H7a/H7b), 0.89 (t, J = 8.0 Hz, 9 H, H26), 0.50 (q, J = 8.0 Hz, 6 H, 
H25). 
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13C NMR (150 MHz, CDCl3): δ 161.7 (d, J = 245.8 Hz, C15), 141.3 (C1), 140.9 (C23), 
140.1 (C18), 137.0 – 136.8 (br, C12), 136.1 (C21), 131.7 (C2), 130.2 – 129.2 (br, C13), 129.5 
(C19), 129.0 (C3), 128.9 (C20), 121.8 (C4), 116.4 (C24), 115.6 (br d, J = 20.7 Hz, C14), 
101.7 (C6), 82.7 – 82.4 (br, C16), 73.1 (C5), 67.1 (C10), 56.1 (C17), 45.7 (C8), 45.8 – 45.5 
(br, C11), 43.0 (C9), 25.6 (C7a/C7b), 24.8 (C7a/C7b), 21.3 (C22), 7.2 (C26), 5.9 (C25). 
19F NMR (376 MHz, CDCl3): δ -115.5 (s, 1 F, F15). 
FTIR (νmax, cm-1): 2953 (m), 2877 (m), 1607 (w, C=C), 1510 (s), 1490 (w), 1458 (w), 1411 
(w), 1380 (m), 1222 (s), 1160 (m), 1113 (s), 1089 (s), 1056 (m), 1010 (s), 975 (w), 911 (w), 
832 (w), 777 (w). 
HRMS (ESI): calculated for C37H46BrClFO2Si [M+H]+ 701.2150, found 701.2229.  
Rf = 0.40 (5% EtOAc/hexane). 
 
7-(6-(4-bromophenyl)-5-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-7-(4-
fluorophenyl)-3-phenyl-5-(p-tolyl)-6-((triethylsilyl)oxy)hept-1-en-4-ol 258: 
 
To a solution of 257 (50.8 mg, 0.072 mmol) in CH2Cl2/MeOH (9:1, 15 mL) was bubbled 
O3/O2 at -78 °C until the reaction mixture turned blue (ca. 3 min). Argon was then bubbled 
through the solution until residual O3 had disappeared. Polymer-supported PPh3 (3 mmol/g 
loading, 72 mg, ca. 0.21 mmol) was then added and the mixture stirred at r.t. for 1 h. The 
polymer-supported reagent was then filtered off and the filtrate evaporated under reduced 
pressure to provide the crude aldehyde, which was used immediately without further 
purification.  
 
To a solution of the crude aldehyde and trans-2-phenylvinylboronic acid (16.0 mg, 0.108 
mmol, 2 equiv.) in CH2Cl2/THF (4:1, 1 mL) was added (trimethylsilyl)diazomethane (0.07 
mL, 2 M in hexanes, 0.144 mmol, 2.0 equiv.) and the mixture subsequently stirred for 2 h. 
The mixture was quenched with SiO2 and stirred for a further 10 min, filtered and evaporated 
under reduced pressure. The residue was purified by silica gel column chromatography 
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(eluent: 10% EtOAc/hexane) to provide the title product (50.8 mg, 0.062 mmol, 86% over 2 
steps) as a white foam.  
 
1H NMR (600 MHz, CDCl3): δ 7.42 (d, J = 8.4 Hz, 2 H, H2), 7.34 (t, J = 7.4 Hz, 2 H, H27), 
7.27 (t, J = 7.4 Hz, 1 H, H28), 7.20 (d, J = 8.4 Hz, 2 H, H3), 7.06 (d, J = 7.4 Hz, 2 H, H26), 
6.90 (t, J = 8.6 Hz, 2 H, H14), 6.78 (br s, 2 H, H13), 5.93 (dt, J = 17.0, 10.0 Hz, 1 H, H29), 
5.11 (dd, J = 10.1, 1.1 Hz, 1 H, H30cis), 5.05 (d, J = 17.0 Hz, 1 H, H30trans), 4.84 – 4.79 (m, 1 
H, H10), 4.63 (d, J = 6.9 Hz, 1 H, H5), 4.31 (d, J = 10.0 Hz, 1 H, H23), 4.18 (d, J = 10.7 Hz, 
1 H, H16), 3.30 (br d, J = 10.7 Hz, 1 H, H17), 3.08 (dd, J = 11.4, 8.2 Hz, 1 H, H9a), 2.85 (dd, 
J = 11.4, 3.5 Hz, 1 H, H9b), 2.80 (t, J = 10.0 Hz, 1 H, H24), 2.63 (d, J = 11.4 Hz, 1 H, H11), 
2.43 (s, 3 H, H22), 1.99 – 1.94 (m, 1 H, H8), 1.78 (s, 1 H, OH), 1.18 (s, 3 H, H7a/H7b), 1.05 
(s, 3 H, H7a/H7b), 0.95 (t, J = 8.0 Hz, 9 H, H32), 0.61 – 0.48 (m, 6 H, H31). (N.B. 4 H 
corresponding to H19/H20 appear broadened over 7.60 – 7.10 region). 
13C NMR (150 MHz, CDCl3): δ 161.6 (d, J = 245.4 Hz, C15), 141.4 (C1), 141.2 (C25), 
140.5 (C29), 137.5 (br, C12), 136.3 (C18/C21), 136.2 (C18/C21), 131.7 (C2), 130.2 – 128.5 
(br, C13, C19 and C20), 129.1 (C3), 128.8 (C27), 128.6 (C26), 126.9 (C28), 121.7 (C4), 
118.0 (C30), 115.5 (br, C14), 101.5 (C6), 80.7 (C16), 73.1 (C5), 71.5 (C23), 66.8 (C10), 56.3 
(C24), 50.9 (C17), 45.7 (C8), 44.8 (br, C11), 43.0 (C9), 24.8 (C7a/C7b), 24.0 (C7a/C7b), 21.4 
(C22), 7.4 (C32), 5.7 (C31). 
19F NMR (376 MHz, CDCl3): δ -115.8 (s, 1 F, F15). 
FTIR (νmax, cm-1): 3569 (w, OH), 2954 (w), 2876 (w), 1606 (w, C=C), 1510 (s), 1490 (m), 
1454 (w), 1417 (w), 1380 (m), 1222 (s), 1160 (m), 1102 (s), 1074 (s), 1056 (m), 1009 (s), 961 
(w), 908 (m), 833 (s), 803 (m), 778 (w). 
HRMS (ESI): calculated for C45H56BrClFO4Si [M+H]+ 821.2798, found 821.2804.  
Rf = 0.59 (10% EtOAc/hexane). 
 
Confirming relative stereochemistry of 2nd/3rd iteration products: 
 
Analysis of the 1H/13C shifts of the acetonide for the 2nd iteration product 256 confirms a 
twist-boat structure, indicating that the reaction proceeds through Felkin-Anh selectivity. 
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Deprotection of the TES protecting group with TBAF allowed a spontaneous 6-ring 
cyclisation to the corresponding pyran. Analysis of the coupling constants once again 
confirms Felkin-Anh selectivity. 
 
4-(4-bromophenyl)-8-(4-fluorophenyl)-2,2-dimethyl-7-((1-(p-tolyl)allyl)tetrahydro-
4H,5H-pyrano[4,3-d][1,3]dioxine 259: 
 
To a solution of 257 (0.250 g, 0.356 mmol, 1 equiv.) in anhydrous THF (8.5 mL) at 0 °C was 
added a solution of TBAF (1.42 mL, 1.0 M in THF, 1.42 mmol, 4 equiv.). The mixture was 
then stirred at r.t. for 16 h. The mixture was diluted with brine (5 mL) and EtOAc (5 mL) and 
the organic layer separated. The aqueous layer was extracted further with EtOAc (3 × 5 mL) 
and the combined organic extracts dried (MgSO4) and evaporated under reduced pressure. 
The residue was purified by silica gel column chromatography (50% CH2Cl2/hexane) to 
provide the title product 9 (0.194 g, 0.352 mmol, 99%) as a white foam. 
 
1H NMR (600 MHz, CDCl3): δ 7.51 (d, J = 8.4 Hz, 2 H, H2), 7.29 (br dd, J = 7.5, 5.8 Hz, 2 
H, H13), 7.24 (d, J = 8.4 Hz, 2 H, H3), 7.18 (d, J = 8.0 Hz, 2 H, H19), 7.13 (d, J = 8.0 Hz, 2 
H, H20), 7.06 (appears t, J = 8.7 Hz, 2 H, H14), 6.16 (dt, J = 17.2, 10.0 Hz, 1 H, H23), 5.16 
(dd, J = 10.0, 1.7 Hz, 1 H, H24cis), 4.84 (dd, J = 17.2, 1.7 Hz, 1 H, H24trans), 4.27 (d, J = 11.0 
Hz, 1 H, H16), 4.24 (d, J = 6.1 Hz, 1 H, H5), 4.17 (t, J = 3.1 Hz, 1 H, H10), 4.01 (dd, J = 
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11.2, 5.9 Hz, 1 H, H9a), 3.93 (t, J = 11.2 Hz, 1 H, H9b), 3.09 (d, J = 9.6 Hz, 1 H, H17), 2.97 
(dd, J = 11.0, 3.1 Hz, 1 H, H11), 2.36 (s, 3 H, H22), 2.27 – 2.20 (m, 1 H, H8), 1.44 (s, 3 H, 
H7a/H7b), 1.09 (s, 3 H, H7a/H7b). 
13C NMR (150 MHz, CDCl3): δ 161.9 (d, J = 244.6 Hz, C15), 141.5 (C1), 140.4 (C18), 
136.3 (C23), 135.9 (C21), 135.1 (d, J = 3.2 Hz, C12), 131.8 (C2), 131.3 (d, J = 7.6 Hz, C13), 
129.1 (C20), 128.0 (C19), 127.5 (C3), 121.5 (C4), 117.7 (C24), 114.9 (d, J = 20.9 Hz, C14), 
101.5 (C6), 78.6 (C16), 71.6 (C5), 66.9 (C9), 66.7 (C10), 50.6 (C17), 47.5 (C11), 44.2 (C8), 
25.0 (C7a/C7b), 24.1 (C7a/C7b), 21.1 (C22). 
19F NMR (376 MHz, CDCl3): δ -116.1 (s, 1 F, F15). 
FTIR (νmax, cm-1): 2985 (w), 2925 (w), 1636 (w, C=C), 1605 (w), 1510 (s), 1489 (m), 1456 
(w), 1379 (m), 1283 (w), 1219 (s), 1159 (m), 1135 (m), 1112 (m), 1096 (m), 1073 (m), 1058 
(m), 1004 (m), 982 (m), 957 (w), 941 (w), 908 (s), 857 (m), 830 (s), 790 (m). 
HRMS (ESI): calculated for C31H33BrFO3 [M+H]+ 551.1592, found 551.1583.  
Rf = 0.36 (50% CH2Cl2/hexane). 
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3.3 Development of an orthogonal functionalisation protocol using 
gem-trimethylsilyl boronic esters 
 
3.3.1 Introduction 
 
gem-Trimethylsilyl boronic esters, compounds containing a doubly functionalised carbon are 
of interest, as they may be employed to perform sequential or orthogonal functionalisation at 
the geminally functionalised carbon atom. Pioneered by Matteson et al., homologation using 
halo(trialkylsilyl)methyllithium and organoboranes or boronates were first reported to 
prepare these compounds.125 Since this report, numerous preparative methods have been 
developed.103, 105, 118b, 126 In particular, homologation using TMSCHN2 and organoboron 
compounds has become an attractive metal-free protocol to install both the trimethylsilane 
and boron functionalities in one step. To date, the reaction of TMSCHN2 and organboronic 
acids have only provided desilylated products.127 In this chapter, investigations focus on the 
preparation of gem-trimethylsilyl boronic esters using TMSCHN2 and organoboroxines and 
their subsequent derivatisation by orthogonal activation of the trimethylsilane and boron 
moieties.  
 
3.3.2 Aim of this work 
 
Inspired by the work previously described in Section 3.2, the reaction outcome of TMSCHN2 
and organoboronic acids can possibly be controlled by adjusting the water content in the 
reaction as well as employing boroxine derivatives instead, potentially providing 
corresponding gem-trimethylsilyl boronic species. Trapping with pinacol could then provide 
the desired compounds, α-trimethylsilyl boronic pinacol esters. 
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Scheme 77 Proposal for preparation of α-trimethylsilyl boronic pinacol esters and subsequent derivatisation.  
In the investigation that follows, the principal aim was to examine the versatility of α-
trimethylsilyl boronic pinacol esters, utilised as intermediates or reagents for further 
transformation (Scheme 77). In addition, due to its geminally functionalised nature, it could 
be activated at either the trimethylsilyl group, the pinacol boronic esters or both groups 
sequentially. 
 
Olefination of these α-trimethylsilyl boronic pinacol esters with aldehydes would be first 
investigated for the potential stereospecific reactions of these compounds. Further 
investigations focused on orthogonal transition metal free activation of the trimethylsilyl 
group and the pinacol boronic ester group using fluoride reagents and organolithium reagents 
respectively to form carbon-carbon bonds.  
  
3.3.3 Results and Discussion 
 
3.3.3.1 Preparation of α-trimethylsilyl boronic pinacol esters 
 
Investigation was initiated by reacting p-methoxyphenylboronic acid 290 with 
trimethylsilyldiazomethane 212 in THF/CH2Cl2 (1:4) at room temperature for 16 h, followed 
by trapping with pinacol. The starting material was fully consumed, however, a mixture of 
benzyl Bpin derivative 286 and phenyl Bpin derivative 287 were obtained in a 1:1 ratio with 
only traces of the desired TMS-benzyl Bpin product 285a being observed (Table 11). 
Considering the proposed mechanism of the preparation of homoallylic alcohol as explained 
in the previous section, the decomposition of TMSCHN2 to diazomethane under acidic 
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conditions could occur due to the formation of H3O+ through an equilibrium between boronic 
acids or boroxines and their anionic tetrahedral species in the presence of water. It suggested 
that these two types of boronic species have different effects on the decomposition rate of 
TMSCHN2 and, hence, result in different product ratio between the corresponding benzyl 
Bpin and TMS-benzyl Bpin derivatives. Using the boroxines prepared from the 
corresponding boronic acids by dehydration using Dean-Stark protocol, the reaction was then 
further optimised and the results are shown in Table 11. Next, treatment of p-
methoxyphenylboroxine 284 with TMSCHN2 212 in anhydrous THF/CH2Cl2 (1:4) at room 
temperature overnight, followed by trapping with pinacol to provide the desired product 285a 
in 75% yield (Table 11, entry 2). However, when the reaction was conducted with wet 
solvent (107.8±0.7 ppm), a significant amount of benzyl Bpin 286 was obtained instead, 
suggesting the solvent water content promotes the formation of side product. The reaction 
outcome was consistent and reproducible when the reaction was performed in anhydrous 
toluene. When the temperature was raised to 60 °C, the reaction time could be reduced and 
provided 78 % yield of the desired product in 3 h (Table 11, entries 3 and 4). Increasing the 
equivalents of TMSCHN2 with respect to the boroxines did not improve the yield, indicating 
only a slight excess of 1.03 equiv. of TMSCHN2 per boron atom was adequate to fully 
consume the starting material (Table 11, entry 5). The side product formation of the 
corresponding aldehyde observed may be due to the hydrolysis of the TMS-boroxine 
intermediate, which could be suppressed by addition of a hindered base such as DIPEA 
(Table 11, entry 6). It was found that when boroxine 284 was treated with TMSCHN2 (3.09 
equiv.) and DIPEA (3.6 equiv.) at 85 °C for 1 h afforded the desired product 285a in 93% 
yield (Table 11, entry 8). 
 
 
 
 
 
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 166	
Table 11 Optimisation of homologation of TMSCHN2 and 4-methoxyphenylboroxine 284. 
 
Entry Solvent Base (equiv.) T (°C) Time (h) Yield of 285a  (%) 
1a THF/CH2Cl2 (1:4) - 24 29 2 b.c 
2 THF/CH2Cl2 (1:4) - 24 29 75b.c 
3 Toluene - 24 29 70 
4 Toluene - 60 3 78 
5 d Toluene - 60 3 82 
6 Toluene DIPEA (3.0) 60 3 88 
7 Toluene DIPEA (3.0) 85 1 87 
8 Toluene DIPEA (3.6) 85 1 93 
a p-methoxyphenylboronic acid was used. b NMR yield. c Aldehyde formation observed. d Reaction performed 
with 9.27 equiv. of TMSCHN2.  
 
Using the optimised conditions, the insertion reaction was next applied to a variety of 
boroxines using TMSCHN2 (Table 12). A wide range of functional groups, including halides, 
nitro groups, olefins, thiophenes, esters and amides were tolerated. Similar reactivity was 
observed when the standard conditions were applied to vinyl boroxine derivatives (Table 12, 
285r, 285s, 285t, 285u). For substrates bearing strongly electron withdrawing groups such as 
-CO2Me and -CN groups in the para position, the protodeborated byproduct was observed 
probably due to facile deboration when using DIPEA (Table 12, 285f, 285q). The 
protodeboration could be suppressed by performing the reaction of these electron poor 
substrates in the absence of base, albeit with 10-15% their corresponding aldehydes.  
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Table 12 Synthesis of gem-trimethylsilyl boronic esters using boroxines and TMSCHN2.^ 
 
 
a Rection conditions: Boroxine 289 (0.15 mmol, 1.0 equiv.), TMSCHN2  (0.465 mmol, 3.1 equiv.), DIPEA (0.54 
mmol, 3.6 equiv.) in Toluene (0.75 mL) at 85 °C for 1 h. b Reaction performed without DIPEA. c Yields are 
reported as isolated yields. 
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^This work was conducted in collaboration with Arthur R. Lit and Dr Claudio Bomio 
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3.3.2.1 Mechanistic Studies 
 
 3.3.2.2.1 Computational calculation 
 
As discussed in the previous section, it was suspected that the different reaction outcome 
between the boronic acids and boroxine might be due to the in situ decomposition of 
TMSCHN2 to diazomethane.123 Moreover, the reactivity of boroxines relative to boronic 
acids appeared to be important in the reaction with TMSCHN2 212. Quantum mechanical 
calculations were therefore conducted to gain deeper insight with the reaction mechanism 
(Figure 12).  
 
 
Figure 12 Computation calculation of homologation reaction using TMSCHN2. 
 
These calculations suggested that a two-step mechanism occurs during the reaction of 
TMSCHN2 with the boronic acid or boroxine (Figure 12). In the first step, the reaction 
DFT calculation conducted using ωB97xD/cc-pVTZ/ωB97xD/cc-pVDZ functionality and basis sets using a SMD solvation 
model (solvent = CH2Cl2, ε = 8.93). This study was performed by Dr Mikhail A. Kabeshov		
Bond making Bond breaking 
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proceeds via transition state B to form a tetracoordinated boronic intermediate C. This 
intermediate C then undergoes a 1,2-migration of the R group with the evolution of nitrogen 
gas through the transition state D, leading to the formation of TMS-homologated product E. 
At all points in the process, the boronic acid has a higher energy pathway than that of the 
boroxine. The rate-determining step of both boronic species was found to be the 1,2-
migration step. However, the reaction with the boronic acid was 13.9 kcal mol-1 higher in 
energy than that of the boroxine. This strongly suggested that TMSCHN2 should react with 
only the boroxine but not the boronic acid under standard conditions. The reaction of 
diazomethane with boronic acids and boroxines was studied using the same computational 
model. These results showed that diazomethane should have a faster reaction rate than 
TMSCHN2 212 and also reacts preferentially with boroxines (ΔGact = +22.5 kcal mol-1). 
Since a higher activation barrier (ΔGact = +36.4 kcal mol-1) would need to be overcome in the 
direct reaction between boronic acids and diazomethane, it is unlikely to occur.  
 
Further computational studies for the reaction of TMSCHN2 212 and other organoboron 
derivatives were performed to check the reliability of the current computational model 
(Figure 13). Compared to data from known literature reactions, these data are in agreement. 
From this set of organoboron compounds, the reactivity of these species ordered from the 
most reactive to the least reactive is as follows: organoboranes, difluoroorganoboranes, 
boroxines and catecholboranes, boronic acids, pinacol boronates and then MIDA boronates. 
As previously reported in the literature, the reaction of TMSCHN2 212 and organoboranes 
occurs rapidly at -78 °C129 whereas catecholboranes only react when the reaction mixture is 
heated over a period of time.103 When experiments using MIDA and pinacol boronates were 
conducted with TMSCHN2 under reflux for three days, only starting materials were observed 
with no conversions towards homologated products, which is in agreement with the 
calculations. 
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Figure 13 Calculated results of the reactivities of a range of organoboron compounds towards TMSCHN2 212
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3.3.2.1.1 Practical approach 
 
As observed during optimisation, reactions of TMSCHN2 212 with 4-methoxyphenylboronic 
acid 290 and its corresponding boroxine derivative 284 provided different reaction outcomes 
(Scheme 78). When the reaction was conducted using boronic acid 290 at room temperature, 
the addition of yellow TMSCHN2 to the reaction mixture was decolourised rapidly with a 
rapid evolution of nitrogen gas, resulting in an approximate ratio of 286 and 287 after 
quenching with pinacol. When the corresponding boroxine 284 was employed under the same 
conditions, gas evolution and decolourisation of the reaction mixture became very slow, but 
provided 75% of 286 after quenching with pinacol.  
 
 
Scheme 78 Reaction of TMSCHN2 212 with boronic acid 290 and boroxine 284 (conversion determined by 1H NMR 
analysis). 
 
Control experiments were next performed to verify the results from the computational studies 
(Table 13). The use of boronic acid 290 proceeded with a fast decomposition of TMSCHN2 
212, providing the desilylated homologated product with trace amount of desired TMS-
homologated product 285a. However, treatment of TMSCHN2 with boroxine 284 provided a 
predominant formation of the TMS-homologated product 285a in 75 % 1H NMR yield. This 
implies that the decomposition of TMSCHN2 occurs in the presence of boronic acids and the 
reaction with diazomethane 272 have a significantly faster rate than that of TMSCHN2 212, 
which is in agreement with our computational studies.  
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Table 13 Effects of base and water in the homologation using TMSCHN2. 
 
Entrya R-BX2 
TMSCHN2 
(equiv.) 
Time 
(h)b 
DIPEA 
(equiv.) 
H2O 
(equiv.) 
Yield (%)c 
285a 286 287 
1 290 1.03 1 - - 1 43 48 
2 284 3.09 29 - - 75 0 10 
3 290 1.03 15 2.1 - 2 40 51 
4 290 1.03 65 6.0 - 2 42 47 
5 290 1.03 10 2.1 2.0 0 14 83 
6 290 1.03 23 6.0 2.0 0 16 80 
7 290 1.03 1 - 2.0 0 19 78 
8 284 3.09 67d 6.0 - 80 0 17 
a Reaction conditions: boronic acid 290 or boroxine 284 (0.15 mmol, 1.00 equiv.). b Time required for complete 
decolourisation of TMSCHN2 212. c Conversion determined by 1H NMR analysis. d Decolourisation of 
TMSCHN2 was not observed. 
 
The effects of base and water on product distribution of homologated products are 
summarised in Scheme 79. Addition of base such as DIPEA to reducing the amount of H3O+ 
ion present in the solution should inhibit the decomposition of TMSCHN2, leading to a much 
slower reaction rate (Table 13, entries 1, 3, and 8). This may be because DIPEA can also 
coordinate with boroxine 284 to generate a Lewis acid-base adduct boronic intermediate 293. 
Thus, the concentration of DIPEA in the reaction mixture should be set at optimal in order to 
balance both the decomposition of TMSCHN2 and to counteract Lewis acid-base complex 
formation. 
 
Addition of water shifts the equilibrium towards boronic acid 292, leading to very low 
conversions to the homologated product but no formation of the TMS-homologated product 
(Table 13, entries 1 and 7). When both DIPEA and water were added to the reaction mixture, 
the conversion to homologated product was below 20% with, again, no formation of the TMS 
homologated product (Table 13, entries 5 and 6). Hence, removal of water from the reaction 
mixture is essential for the stability of both boroxine and TMSCHN2.  
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Scheme 79 Effect of water and DIPEA in the homologation reaction. 
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3.3.3.2 Development of further transformation of α-trimethylsilyl boronic pinacol esters 
 
Having a protocol for the preparation of α-trimethylsilyl boronic pinacol esters, olefination of 
these compounds in reaction with aldehydes was next investigated as a potential method for 
further derivatisation.  
 
 3.3.3.2.1 Olefination 
 
Adopting the protocol reported by Matteson et al.,125b initial investigations focused on the 
reaction of p-methoxybenzylsilyl boronic pinacol ester 285a and p-bromobenzaldehyde 253 
in the presence of a fluoride reagent to produce the corresponding E- and Z-stilbenes (Table 
14).  
 
Table 14 Optimisation of olefination using p-methoxybenzylsilyl boronic pinacol ester 285a and p-bromobenzaldehyde 253.  
 
Entry 
Silane  
(equiv.) 
Aldehyde  
(equiv.) 
Fluoride  
 (mol%) 
T 
(oC) 
Time 
(h) 
Yield (%) E:Z 
1 1.2 1.0 TBAF (100 mol%) 65 28 30 52:48 
2 1.0 1.0 TBAT (10 mol%) 85 4 33 46:54 
3 1.0 2.0 TBAT (10 mol%) 85 4 34 45:55 
4 2.0 1.0 TBAT (10 mol%) 85 4 76 44:56 
5 1.0 1.0 TBAT (100 mol%) 85 4 55 31:69 
6 1.0 1.0 TBAT (100 mol%) 65 4 45 44:56 
7 1.0 1.0 TBAT (200 mol%) 65 4 42 41:59 
 
Treatment of trimethylsilyl boronate 285a and aldehyde 253 using tetrabutylammonium 
fluoride (TBAF) at 65 oC for 16 h provided the olefin product 298 in 30% yield with an E/Z 
ratio of 52:48. The corresponding benzyl Bpin derivative from desilylation was obtained as a 
major side product, which may have been due to the presence of water in the TBAF solution. 
This side reaction could be suppressed by using tetrabutylammonium 
triphenyldifluorosilicate (TBAT) as an alternative anhydrous source of fluoride. Reactions 
performed using catalytic amounts of TBAT provided similar result as using stoichiometric 
amounts of TBAT, however, this fluoride reagent did not improve the E/Z selectivity of the 
Bpin
SiMe3
MeO Br
H
O
Conditions, THF
Br
MeO
285a 253 298
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olefin product. Increasing the equivalents of the aldehyde did not have any positive effect on 
the reaction yield. Employing 2 equivalents of trimethylsilyl boronate 285a in respect to 
aldehyde improved the yield of olefin product to 76% but the stereoselectivity was still poor. 
Moreover, no improvement in yield nor stereoselectivity was observed with increasing 
amounts of TBAT.  
 
From these results, it suggested that the benzyl anion generated in situ by desilylation is not a 
very reactive nucleophile, requiring high reaction temperatures and long reaction times. This 
may be due to anion stabilisation and steric hindrance provided by the bulky Bpin group. Any 
unreacted anionic intermediate could then be quenched with water to afford the desilylated 
side product. Further investigation of this olefination method was discontinued due to the 
lack of any stereoselectivity.  
 
 3.3.2.3.3 Alkylation reaction using fluoride 
 
Initial experiments were performed using para-methoxybenzyl α-trimethylsilyl boronic 
pinacol esters 285a and butyl iodide 299 in the presence of TBAT130 as the fluoride source, 
which provided the alkylated product in 67% yield. Unfortunately, separation from the side 
product fluorotriphenylsilane generated from TBAT was not straightforward, so an 
alternative source of fluoride was investigated using CsF in DMF, purification of alkylated 
product 300b was relatively simple. Utilising anhydrous CsF suppressed the formation of the 
corresponding benzyl Bpin derivative as a side product (Table 15, entry 5), thereby providing 
300b in 55% yield. Increasing the equivalents of alkyl iodide 299 led to an improvement in 
product yield.  Employing KHF2 as an alternative fluoride reagent provided benzyl BF3K salt 
instead of corresponding alkylated product.  
 
 
 
 
 
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 176	
Table 15 Optimisation of the alkylation reaction using butyl iodide 299 and fluoride sources. 
 
Entrya 
Silane 
(equiv.) 
Iodide 
(equiv.) 
Fluoride 
(equiv.) 
Solvent 
T 
(oC) 
Yield 
(%) 
1 1.0 1.0 TBAT (2.0) THF 75 67 
2 1.0 1.0 CsF (2.0) DMF 75 28 
3 1.0 2.0 CsF (2.0) DMF 75 43 
4 1.0 2.0 CsF (2.0) DMF 60 46 
5b 1.0 2.0 CsF (2.0) DMF 60 55 
6 1.0 2.0 KHF2 (2.0) DMF 60 0 
a Reaction were performed for 48 h. b Anhydrous CsF was employed. 
 
Further investigation was performed using allyl bromide as a substrate. Treatment of silane 
285a and allyl bromide 301 in the presence of CsF131 in DMF provided the allylated product 
300d in 43% yield. However, a significant amount of monoallylated and diallylated 
aldehydes 307 and 310 were observed as major side products (Scheme 80).  
 
Table 16 Attempts of the alkylation reaction using allyl bromide 301 and fluoride sources. 
 
Entry Solvent Yield (%) 
1 DMF 43 
2 DMA 66 
 
It was proposed that formation of these side products ocuured via the reaction of silane 285a 
with DMF to generate enamine 305, followed by subsequent allylation to produce iminium 
306. This intermediate could then undergo either hydration or another set of enamine-
iminium tautomerisations and allylation to afford the monoallylated aldehyde 307 or 
diallylated aldehyde 310. To avoid these side products, DMA was employed as less 
electrophilic solvent which provided the allylated Bpin derivative 300d in 66% yield (Table 
16, entry 2).  
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Scheme 80 Proposed mechanism of side product formation from the allylation reaction in DMF. 
In attempts to extend the scope, the method was applied to various α-trimethylsilyl boronic 
pinacol esters and alkyl/allyl bromides. Overall, the yields were moderate and tolerated 
benzyl, allyl and alkyl halides. However, substrates bearing halo and cyano functionality for 
the α-trimethylsilyl boronic pinacol esters component at the para position showed decreased 
yields, probably due to a reduction in nucleophilicity of the anion intermediate by electron 
withdrawal (Table 17, 300e). Reaction with 1,3-bromopropane did not provide the 
corresponding bromide product but an alcohol product 300c instead, speculating the ring 
opening of Bpin group occurred with fluoride under long reaction time. Given that the yields 
and functional group tolerance of the alkylation reaction were poor, further investigation was 
then focused on the activation of Bpin group of these α-trimethylsilyl boronic pinacol esters 
instead. 
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Table 17 Synthesis of alkylated boronic esters.  
 
 
a Isolated yields. 
 
 3.3.2.3.3 Cross coupling reaction with heteroaryl lithium compounds 
 
Adopting the protocol by Aggarwal et al.,132 α-trimethylsilyl boronic pinacol esters 285 were 
reacted with a range of heteroaryllithium compounds to provide the corresponding 
heteroarylated silane derivatives in poor to good yields (Table 18). Heteroaryl functionalities 
including furan, benzofuran and thiophene were tolerated as well as boronates bearing with 
electron rich and electron poor substituents.  
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Table 18 Coupling reaction of pinacol boronic esters with heteroaryllithium reagents. 
 
 
a Isolated yields. b conversion was measured using 1H NMR standard (1,3,5-trimethoxybenzene). 
 
With the desired silane derivatives 313 in hand, subsequent functionalisation of the silyl 
group through an addition reaction to aldehydes using catalytic amount of TBAT was 
attempted. This afforded the corresponding alcohol products as 1:1 mixture of 
diastereoisomers and provided generally good yields, tolerating aldehydes bearing both 
electron-withdrawing and electron-donating substituents. 
 
Table 19 Addition reaction to aldehydes using silanes in the presence of TBAT. 
 
 
a Isolated yields. b dr ratio was determined by 1H NMR analysis. 
 
Cross-coupling reaction of secondary boronic esters with heteroaryllithium, with subsequent 
fluoride activated addition reaction to aldehydes demonstrated the potential as an orthogonal 
activation protocol of α-trimethylsilyl boronic pinacol esters for multiple carbon-carbon 
formation.  
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  3.3.3 Conclusion and outlook 
 
To summarise, a vestile batch method for the prepartion of gem-trimethylsilyl boronic esters 
via the homologation of TMSCHN2 and boroxines has been developed. The method has 
displayed a high functional group tolerance on both the diazo compound and boroxine 
compnent, in addition to moderate to high yields and fast reaction times. A mechanistic study 
of the homologation of TMSCHN2 and organoboron compounds was conducted via both 
experimental and computational approach. It is shown that boroxines of the corresponding 
boronic acids are likely to be the reactive intermediates in the homologation reaction. 
Investigation on the selective derivatisation of gem-trimethylsilyl boronic esters was also 
conducted. After some attempts at selective functionalisation of boron component and silicon 
component of these compounds, two orthogonal transition metal free carbon-carbon 
formations, cross coupling with heteroaryllithium compounds and alkylation using CsF, were 
found to be good fits. These reactions provide acceptable yields, also demonstrating the 
potential to employ gem-trimethylsilyl boronic esters as useful building blocks for the 
construction of highly complex, potentially new molecules. Future investigations are directed 
towards a number of areas, including the incorporation of flow technologies into the 
synthesis program, the development of the corresonding asymetric protocol and the 
optimisation of the selective functionalisation reactions.    
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3.3.4 Experimental details 
  
3.2.4.1 General experimental 
 
All batch reactions were performed using oven-dried glassware (200 ˚C) under an 
atmosphere of argon unless otherwise stated. Solvents were freshly distilled over sodium 
benzophenone ketyl (THF) or calcium hydride (CH2Cl2, hexane, EtOAc and PhMe). DIPEA 
was distilled over CaH2.  All boronic acids were purchased at the highest commercial quality 
from Sigma Aldrich, Alfa Aesar and Fluorochem. nBuLi was purchased from Sigma Aldrich. 
The molarity of organolithium solutions was determined by titration using salicylaldehyde 
phenylhydrazone as an indicator. (Trimethylsilyl)diazomethane was obtained from Sigma 
Aldrich. All reagents were used without further purification.  
 
Flash column chromatography was performed using high-purity grade silica gel (Merck grade 
9385) with a pore size 60 Å and 230–400 mesh particle size under air pressure. Analytical 
thin layer chromatography (TLC) was performed using silica gel 60 F254 pre-coated glass 
backed plates and visualized by ultraviolet radiation (254 nm) and/or Seebach reagent (12.5 g 
phosphomolybdic acid, 5.0 g cerium(IV)sulfate tetrahydrate, 16.0 mL water, 450.0 mL conc. 
sulfuric acid).  
 
1H NMR spectra were recorded on a 400 MHz DPX-400 Dual Spectrometer or a 600 MHz 
Avance 600 BBI Spectrometer as indicated. Chemical shifts are reported in ppm with the 
resonance resulting from incomplete deuteration of the solvent as the internal standard 
(CDCl3: 7.26 ppm; (CD3)2SO: 2.50 ppm). 13C NMR spectra were recorded on a 600 MHz 
Avance 600 BBI Spectrometer with complete proton decoupling. Chemical shifts are 
reported in ppm with the solvent resonance as the internal standard (13CDCl3: 77.16 ppm; 
(13CD3)2SO: 39.52 ppm). Data are reported as follows: chemical shift δ/ppm, integration (1H 
only), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, br = broad, m 
= multiplet or combinations thereof; 13C signals are singlets unless otherwise stated), 
coupling constants J in Hz, assignment. Spectra are assigned as fully as possible, using 1H-
COSY, DEPT-135, HMQC and HMBC where appropriate to facilitate structural 
determination. Signals that cannot be unambiguously assigned are reported with all possible 
assignments separated by a slash (e.g. H1/H2) or descriptions of their environments (e.g. 
ArH, OH). Multiple signals arising from diastereotopic or (pseudo)axial/equatorial positions 
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are suffixed alphabetically (e.g. H1a, H1b). Overlapping signals that cannot be resolved are 
reported with their assignments denoted in list format (e.g. H1, H2 and H3). 1H NMR signals 
are reported to 2 decimal places and 13C signals to 1 decimal place unless rounding would 
produce a value identical to another signal. In this case, an additional decimal place is 
reported for both signals concerned. 
 
Infrared spectra were recorded neat as thin films on a Perkin-Elmer Spectrum One FTIR 
spectrometer and selected peaks are reported (s = strong, m = medium, w = weak, br = broad). 
 
High-resolution mass spectrometry (HRMS) was performed using positive electrospray 
ionisation (ESI+), on either a Waters Micromass LCT Premier spectrometer or performed by 
the Mass Spectrometry Service for the Chemistry Department at the University of 
Cambridge. All m/z values are reported to 4 decimal places and are within ± 5 ppm of 
theoretical values. Melting points were measured on a Stuart Scientific SMP3 melting point 
apparatus using a gradient of 0.5 °C.min-1. 
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3.2.5.2 Experimental procedure 
 
Synthetic Procedures and Characterisation of α-trimethylsilyl boronic pinacol esters 
 
General batch procedure A for preparation of α-trimethylsilyl boronic pinacol esters:  
 
The reaction was carried out under dry conditions and an atmosphere of argon. To a mixture 
of boroxine (0.15 mmol, 1.0 equiv.) and N,N-diisopropylethylamine (0.094 mL, 0.54 mmol, 
3.6 equiv.) in toluene (0.75 mL) was added (trimethylsilyl)diazomethane (0.23 mL, 0.465 
mmol, 2 M in hexanes, 3.1 equiv.). The reaction mixture was stirred at 85 ˚C for 1 h and 
allowed to cool to room temperature. Pinacol (70.9 mg, 0.60 mmol, 4.0 equiv.) was added 
and the reaction mixture was stirred at room temperature for 1 h. The reaction was quenched 
with a saturated aqueous solution of NH4Cl and the aqueous phase was extracted with 
EtOAc. The combined organic extracts were washed with brine, dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by silica gel flash column 
chromatography to provide the desired α-trimethylsilyl boronic pinacol esters.  
 
General batch procedure B for preparation of α-trimethylsilyl boronic pinacol esters:  
 
The reaction was carried out under dry conditions and an atmosphere of argon. To a mixture 
of boroxine (0.15 mmol, 1.0 equiv.) in toluene (0.75 mL) was added 
(trimethylsilyl)diazomethane (0.23 mL, 0.465 mmol, 2 M in hexanes, 3.1 equiv.). The 
reaction mixture was stirred at 85 ˚C for 1 h and allowed to cool to room temperature. 
Pinacol (70.9 mg, 0.60 mmol, 4.0 equiv.) was added and the reaction mixture was stirred at 
room temperature for 1 h. The reaction was quenched with a saturated aqueous solution of 
NH4Cl and the aqueous phase was extracted with EtOAc. The combined organic extracts 
were washed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by silica gel flash column chromatography to afford the desired α-
trimethylsilyl boronic pinacol esters. 
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((4-methoxyphenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)trimethylsilane 
285a:  
 
Isolated as a white crystalline solid (134.1 mg, 0.419 mmol, 93%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:40), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. Data are consistent with a reported example.ix 
 
1H NMR (600 MHz, CDCl3): δ 7.09 (d, J = 8.7 Hz, 2 H, H4), 6.77 (d, J = 8.7 Hz, 2 H, H3), 
3.77 (s, 3 H, H1), 1.90 (s, 1 H, H6), 1.26 (s, 6 H, H9a/H9b), 1.24 (s, 6 H, H9a/H9b), -0.01 (s, 
9 H, H7).  
13C NMR (150 MHz, CDCl3): δ 156.2 (C2), 132.7 (C5), 129.4 (C4), 113.4 (C3), 83.1 (C8), 
55.3 (C1), 25.2 (C9a/C9b), 25.0 (C9a/C9b), -1.4 (C7). (C6 broadened by quadrupolar 
relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.5.  
FTIR (νmax, cm-1): 2978 (w), 1610 (w, C=C), 1579 (w), 1508 (m), 1465 (w), 1371 (m), 1342 
(m), 1306 (m), 1290 (m), 1244 (m), 1141 (m), 1112 (w), 1037 (w), 970 (w), 851 (s), 839 (s).  
HRMS (ESI): calculated for C17H29O311BNaSi [M+Na]+ 343.1871, found 343.1858.  
m.p.: 74-75 ˚C.  
Rf = 0.41 (EtOAc:hexane = 1:10).  
 
Undesired Product 287 
 
Isolated as colourless oil.  
1H NMR (600 MHz, CDCl3): δ 7.75 (d, J = 8.4 Hz, 2 H, H4), 6.89 (d, J = 8.4 Hz, 2 H, H3), 
3.82 (s, 3 H, H1), 1.33 (s, 12 H, H6, H7). 
13C NMR (150 MHz, CDCl3):  δ 162.1 (C2), 136.5 (C4), 113.3 (C3), 83.5 (C6), 55.1 (C1), 
24.8 (C7). (C5 broadened by quadrupolar relaxation with boron) 
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11B NMR (128 MHz, CDCl3): δ 30.5.  
HRMS (ESI): calculated for C13H19O311BNa [M+Na]+ 257.2427, found 257.2431. 
Rf = 0.40 (EtOAc:hexane = 1:10). 
Data are consistent with a reported example.x 
 
Undesired Product 288 
 
1H NMR (600 MHz, CDCl3): 9.89 (s, 1 H, H7), 7.84 (d, J = 8.0 Hz, 2 H, H3), 7.00 (d, J = 
8.0 Hz, 2 H, H4), 3.89 (s, 3 H, H1). 
13C NMR (150 MHz, CDCl3): 190.8 (C6), 164.6 (C2), 132.0 (C3), 130.0 (C5), 114.3 (C4), 
55.6 (C1) 
Data are consistent with a reported example.xi 
 
((4-bromophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)trimethylsilane 
285b: 
 
Isolated as a white crystalline solid (124.7 mg, 0.338 mmol, 75%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:40), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.30 (d, J = 8.5 Hz, 2 H, H2), 7.05 (d, J = 8.5 Hz, 2 H, H3), 
1.94 (s, 1 H, H5), 1.26 (s, 6 H, H8a/H8b), 1.23 (s, 6 H, H8a/H8b), 0.00 (s, 9 H, H6).  
13C NMR (150 MHz, CDCl3): δ 140.1 (C4), 130.9 (C2), 130.4 (C3), 117.1 (C1), 83.3 (C7), 
25.2 (C8a/C8b), 25.0 (C8a/C8b), -1.5 (C6). (C5 broadened by quadrupolar relaxation with 
boron). 
11B NMR (128 MHz, CDCl3): δ 32.5.  
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FTIR (νmax, cm-1): 2979 (w), 1483 (m, C=C), 1404 (w), 1391 (w), 1367 (m), 1338 (m), 1316 
(m), 1298 (m), 1263 (m), 1248 (m), 1209 (w), 1165 (m), 1140 (m), 1071 (m), 1050 (m), 1007 
(m), 968 (m), 853 (s), 838 (s).  
HRMS (ESI): calculated for C16H27O211B79BrSi [M+H]+ 369.1057, found 369.1062.  
m.p.: 82-84 ˚C.  
Rf = 0.14 (EtOAc:hexane = 1:40).  
 
((4-chlorophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)trimethylsilane 
285c:  
 
Isolated as a white crystalline solid (115.5 mg, 0.356 mmol, 79%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:40), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. Data are consistent with a reported example.ix 
 
1H NMR (600 MHz, CDCl3): δ 7.16 (d, J = 8.6 Hz, 2 H, H2), 7.09 (d, J = 8.6 Hz, 2 H, H3), 
1.95 (s, 1 H, H5), 1.26 (s, 6 H, H8a/H8b), 1.23 (s, 6 H, H8a/H8b), 0.00 (s, 9 H, H6).  
13C NMR (150 MHz, CDCl3): δ 139.6 (C4), 130.0 (C2), 129.2 (C1), 128.0 (C3), 83.3 (C7), 
25.3 (C8a/C8b), 25.0 (C8a/C8b), -1.4 (C6). (C5 broadened by quadrupolar relaxation with 
boron). 
11B NMR (128 MHz, CDCl3): δ 33.2.  
FTIR (νmax, cm-1): 2980 (w), 1487 (m, C=C), 1409 (w), 1392 (w), 1370 (m), 1338 (m), 1315 
(m), 1300 (m), 1265 (m), 1249 (m), 1210 (w), 1167 (w), 1141 (m), 1088 (w), 1050 (w), 1012 
(w), 968 (s), 841 (s).  
HRMS (ESI): calculated for C16H27O211B35ClSi [M+H]+ 325.1562, found 325.1561.  
m.p.: 83-84 ˚C.  
Rf = 0.26 (EtOAc:hexane = 1:20).  
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((4-fluorophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)trimethylsilane 
285d:  
 
Isolated as a colourless oil (98.6 mg, 0.320 mmol, 71%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:50), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. Data are consistent with a reported example.ix 
 
1H NMR (600 MHz, CDCl3): δ 7.12-7.10 (m, 2 H, H2), 6.91-6.88 (m, 2 H, H3), 1.95 (s, 1 H, 
H5), 1.26 (s, 6 H, H8a/H8b), 1.24 (s, 6 H, H8a/H8b), 0.00 (s, 9 H, H6).  
13C NMR (150 MHz, CDCl3): δ 160.1 (d, J = 239.2 Hz, C1), 136.4 (d, J = 3.0 Hz, C4), 
129.7 (d, J = 7.3 Hz, C2), 114.6 (d, J = 20.7 Hz, C3), 83.3 (C7), 25.2 (C8a/C8b), 25.0 
(C8a/C8b), -1.5 (C6). (C5 broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 32.8.  
FTIR (νmax, cm-1): 2979 (w), 1603 (w), 1506 (m), 1469 (w), 1372 (m), 1341 (m), 1248 (m), 
1220 (m), 1140 (m), 1032 (m), 970 (m), 840 (s).  
HRMS (ESI): calculated for C16H27O211BFSi [M+H]+ 309.1857, found 309.1857.  
Rf = 0.48 (EtOAc:hexane = 1:10).  
 
trimethyl(phenyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)silane 285e:  
 
Isolated as a white crystalline solid (87.6 mg, 0.302 mmol, 67%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:30), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. Data are consistent with a reported example.xii 
 
1H NMR (600 MHz, CDCl3): δ 7.22-7.17 (m, 4 H, H2, H3), 7.06-7.03 (m, 1 H, H1), 1.98 (s, 
1 H, H5), 1.26 (s, 6 H, H8a/H8b), 1.24 (s, 6 H, H8a/H8b), 0.00 (s, 9 H, H6).  
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13C NMR (150 MHz, CDCl3): δ 140.9 (C4), 128.8 (C3), 127.9 (C2), 123.5 (C1), 83.2 (C7), 
25.3 (C8a/C8b), 25.0 (C8a/C8b), -1.4 (C6). (C5 broadened by quadrupolar relaxation with 
boron). 
11B NMR (128 MHz, CDCl3): δ 33.2.  
FTIR (νmax, cm-1): 2979 (w), 1600 (w), 1495 (w), 1451(w), 1372 (m), 1349 (m), 1307 (m), 
1269 (m), 1247 (m), 1211 (m), 1140 (m), 1033 (w), 1003 (w), 970 (m), 915 (w), 837 (s).  
HRMS (ESI): calculated for C16H28O211BSi [M+H]+ 291.1952, found 291.1937.  
m.p.: 40-42 ˚C.  
Rf = 0.16 (EtOAc:hexane = 1:30).  
 
4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(trimethylsilyl)methyl)benzonitrile 285f:  
 
Isolated as a white amorphous solid (102.1 mg, 0.326 mmol, 72%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:30 → 1:20), following the general batch 
procedure B for α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.48 (d, J = 8.2 Hz, 2 H, H3), 7.26 (d, J = 8.2 Hz, 2 H, H4), 
2.09 (s, 1 H, H6), 1.27 (s, 6 H, H9a/H9b), 1.24 (s, 6 H, H9a/H9b), 0.01 (s, 9 H, H7).  
13C NMR (150 MHz, CDCl3): δ 147.9 (C5), 131.8 (C3), 129.3 (C2), 119.9 (C1), 107.1 (C2), 
83.6 (C8), 25.3 (C9a/C9b), 25.0 (C9a/C9b), -1.5 (C7). (C6 broadened by quadrupolar 
relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 32.9.  
FTIR (νmax, cm-1): 2978 (m), 2225 (m, CN), 1604 (m), 1500 (w, C=C), 1419 (w), 1345 (m), 
1307 (m), 1250 (m), 1214 (w), 1141 (m), 1033 (m), 970 (m), 852 (s).  
HRMS (ESI): calculated for C17H27O211BNSi [M+H]+ 316.1904, found 316.1910.  
m.p.: 114-116 ˚C.  
Rf = 0.19 (EtOAc:hexane = 1:20).  
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((4-(tert-butyl)phenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl)trimethylsilane 285g:  
 
Isolated as a white amorphous solid (110.7 mg, 0.320 mmol, 71%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:40), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.20 (d, J = 8.4 Hz, 2 H, H4), 7.09 (d, J = 8.4 Hz, 2 H, H5), 
1.94 (s, 1 H, H7), 1.30 (s, 9 H, H1), 1.26 (s, 6 H, H10a/H10b), 1.25 (s, 6 H, H10a/H10b), 
0.00 (s, 9 H, H8).  
13C NMR (150 MHz, CDCl3): δ 146.0 (C4), 137.5 (C3), 128.3 (C5), 124.8 (C6), 83.1 (C9), 
34.3 (C2), 31.6 (C1), 25.3 (C10a/C10b), 25.2 (C10a/C10b), -1.3 (C8). (C7 broadened by 
quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.6.  
FTIR (νmax, cm-1): 2963 (w), 1611 (w), 1513 (w), 1466 (w), 1417 (w), 1364 (m), 1339 (m), 
1308 (m), 1268 (m), 1247 (m), 1213 (w), 1142 (m), 1117 (w), 1084 (w), 1023 (w), 969 (w), 
841 (s).  
HRMS (ESI): calculated for C20H36O211BSi [M+H]+ 347.2578, found 347.2585.  
m.p.: 105-107 ˚C.  
Rf = 0.16 (EtOAc:hexane = 1:40).  
 
trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(4- 
(trifluoromethyl)phenyl)methyl)silane 285h:  
 
Isolated as a white amorphous solid (119.4 mg, 0.333 mmol, 74%) after silica gel column 
chromatography (eluent: CH2Cl2:hexane = 1:5), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
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1H NMR (600 MHz, CDCl3): δ 7.45 (d, J = 8.1 Hz, 2 H, H3), 7.27 (d, J = 8.1 Hz, 2 H, H4), 
2.08 (s, 1 H, H6), 1.28 (s, 6 H, H9a/H9b)), 1.25 (s, 6 H, H9a/H9b), 0.02 (s, 9 H, H7).  
13C NMR (150 MHz, CDCl3): δ 145.8 (d, J = 1.3 Hz, C5), 128.8 (C4), 125.9 (q, J = 32.0 Hz, 
C3), 124.91 (q, J = 269.7 Hz, C2), 124.87 (q, J = 3.8 Hz, C1), 83.5 (C8), 25.2 (C9a/C9b), 
25.0 (C9a/C9b), -1.4 (C7). (C6 broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 32.8.  
FTIR (νmax, cm-1): 2981 (w), 1615 (w), 1514 (w), 1392 (m), 1373 (m), 1321 (s), 1268 (w), 
1249 (w), 1213 (w), 1141 (m), 1115 (m), 1067 (m), 1018 (w), 969 (w), 908 (w), 841 (m).  
HRMS (ESI): calculated for C17H27O211BF3Si [M+H]+ 359.1825, found 359.1839.  
m.p.: 73-75 ˚C.  
Rf = 0.27 (EtOAc:hexane = 1:50).  
 
trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(4-vinylphenyl)methyl)silane 
285i:  
 
Isolated as a white crystalline solid (129.6 mg, 0.410 mmol, 91%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:20), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.26 (d, J = 8.2 Hz, 2 H, H4), 7.13 (d, J = 8.2 Hz, 2 H, H5), 
6.67 (dd, J = 17.6, 10.9 Hz, H2), 5.66 (dd, J = 17.6, 0.8 Hz, 1 H, H1trans), 5.12 (dd, J = 10.9, 
0.8 Hz, 1 H, H1cis) 1.98 (s, 1 H, H7), 1.26 (s, 6 H, H10a/H10b), 1.24 (s, 6 H, H10a/H10b), 
0.01 (s, 9 H, H8).  
13C NMR (150 MHz, CDCl3): δ 141.0 (C3), 137.1 (C6), 133.0 (C2), 128.9 (C5), 125.9 (C4), 
111.8 (C1), 83.2 (C9), 25.3 (C10a/C10b), 25.1 (C10a/C10b), -1.3 (C8). (C7 broadened by 
quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.7.  
FTIR (νmax, cm-1): 2979 (w), 1629 (w), 1608 (w), 1508 (w, C=C), 1426 (w), 1343 (m), 1310 
(m), 1248 (m), 1214 (w), 1141 (m), 1033 (w), 970 (w), 853 (s), 843 (s).  
HRMS (ESI): calculated for C18H30O211BSi [M+H]+ 317.2108, found 317.2111.  
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m.p.: 46-48 ˚C.  
Rf = 0.22 (EtOAc:hexane = 1:20).  
 
trimethyl((4-methyl-3-nitrophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)methyl)silane 285j:  
 
Isolated as a white crystalline solid (124.1 mg, 0.355 mmol, 79%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:20), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.77 (d, J = 1.8 Hz, 1 H, H4), 7.29 (dd, J = 8.0, 1.8 Hz, 1 H, 
H6), 7.14 (d, J = 8.0 Hz, 1 H, H7), 2.51 (s, 3 H, H1), 2.02 (s, 1 H, H8) 1.26 (s, 6 H, 
H11a/H11b), 1.23 (s, 6 H, H11a/H11b), 0.02 (s, 9 H, H9).  
13C NMR (150 MHz, CDCl3): δ 149.1 (C3), 140.8 (C5), 133.5 (C7), 132.1 (C6), 128.4 (C2), 
124.2 (C4), 83.6 (C10), 25.2 (C11a/C11b), 24.9 (C11a/11b), 20.0 (C1), -1.5 (C9). (C8 
broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.0.  
FTIR (νmax, cm-1): 2979 (w), 1526 (s, N-O), 1449 (w), 1410 (w), 1372(m), 1343 (s, N-O), 
1293 (m), 1270 (m), 1250 (m), 1214 (w), 1141 (m), 1036 (w), 971 (w), 849 (s).  
HRMS (ESI): calculated for C17H29O411BNSi [M+H]+ 350.1959, found 350.1971.  
m.p.: 88-90 ˚C.  
Rf = 0.19 (EtOAc:hexane = 1:20).  
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trimethyl((3-nitrophenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)silane 
285k:  
 
Isolated as a white crystalline solid (146.3 mg, 0.436 mmol, 97%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:30), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 8.03 (t, J = 1.9 Hz, 1 H, H2), 7.89 (dd, J = 8.2, 1.4 Hz, 1 H, 
H6), 7.48 (d, J = 7.7 Hz, 1 H, H1), 7.34 (dd, J = 8.0, 7.9 Hz, 1 H, H4), 2.11 (s, 1 H, H7), 1.27 
(s, 6 H, H10a/H10b), 1.23 (s, 6 H, H10a/H10b), 0.02 (s, 9 H, H8).  
13C NMR (150 MHz, CDCl3): δ 148.3 (C5), 143.7 (C4), 134.9 (C3), 128.6 (C2), 123.1 (C6), 
118.8 (C1), 83.6 (C9), 25.2 (C10a/C10b), 24.9 (C10a/C10b), -1.5 (C8).  
11B NMR (128 MHz, CDCl3): δ 32.7. (C7 broadened by quadrupolar relaxation with boron). 
FTIR (νmax, cm-1): 2981 (w), 1524 (s, N-O), 1479 (w), 1392 (w), 1371 (w), 1347 (s, N-O), 
1312 (s), 1274 (m), 1245 (m), 1166 (w), 1139 (m), 1037 (w), 967 (w), 933 (w), 912 (w), 839 
(s). 
HRMS (ESI): calculated for C16H27O411BNSi [M+H]+ 336.1802, found 336.1804.  
m.p.: 105-107 ˚C.  
Rf = 0.34 (EtOAc:hexane = 1:10).  
 
trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(o-tolyl)methyl)silane 285l:  
 
Isolated as a white crystalline solid (113.7 mg, 0.374 mmol, 83%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:30), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. Data are consistent with a reported example.ix 
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1H NMR (600 MHz, CDCl3): δ 7.39 (d, J = 7.7 Hz, 1 H, H5), 7.12-7.09 (m, 2 H, H2, H3), 
6.96 (m, 1 H, H1), 2.22 (s, 4 H, H7, H8), 1.27 (s, 6 H, H11a/H11b), 1.24 (s, 6 H, 
H11a/H11b), 0.02 (s, 9 H, H9).  
13C NMR (150 MHz, CDCl3): δ 139.5 (C4), 134.7 (C6), 130.0 (C5), 128.7 (C3), 125.5 (C3), 
123.5 (C2), 83.2 (C10), 25.3 (C11a/C11b), 25.0 (C11a/C11b), 21.2 (C7), -1.1 (C9). (C8 
broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.5.  
FTIR (νmax, cm-1): 2978 (w), 1602 (w), 1485 (w), 1370 (m), 1338 (m), 1315 (m), 1290 (m), 
1269 (m), 1247 (m), 1213 (w), 1143 (m), 1091 (w), 1030 (m), 970 (m), 850 (s), 839 (s).  
HRMS (ESI): calculated for C17H30O211BSi [M+H]+ 305.2108, found 305.2114.  
m.p.: 41-43 ˚C.  
Rf = 0.45 (EtOAc:hexane = 1:10).  
 
N-(3-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)(trimethylsilyl)methyl)phenyl)acetamide 28m:  
 
Isolated as a pale yellow, waxy solid (98.4 mg, 0.283 mmol, 63%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:3, then MeOH:CHCl3 = 1:50), following the 
general batch procedure A for α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.51 (s, 1 H, NH), 7.37 (dd, J = 8.0, 1.1 Hz, 1 H, H2), 7.14-
7.10 (m, 2 H, H1, H6), 6.91 (d, J = 7.7 Hz, 1 H, H3), 2.13 (s, 3 H, H8), 1.94 (s, 1 H, H9), 
1.24 (s, 6 H, H12a/H12b), 1.22 (s, 6 H, H12a/H12b), -0.01 (s, 9 H, H10).  
13C NMR (150 MHz, CDCl3): δ 168.5 (C7), 141.9 (C5), 137.6 (C4), 128.5 (C2), 124.9 (C3), 
119.8 (C6), 115.5 (C1), 83.2 (C11), 25.2 (C12a/C12b), 25.0 (C12a/C12b), 24.7 (C8), -1.4 
(C10). (C9 broadened by quadrupolar relaxation with boron).  
11B NMR (128 MHz, CDCl3): δ 33.3.  
FTIR (νmax, cm-1): 3301 (br w, N-H), 2979 (w), 1664 (w), 1608 (w), 1553 (w), 1488 (w), 
1436 (w), 1371(m), 1339 (m), 1307 (m), 1247 (m), 1214 (m), 1140 (s), 1022 (w), 969 (w), 
909 (w), 839 (s).  
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HRMS (ESI): calculated for C18H30O311BNSi [M]+ 347.2088, found 347.2104.  
m.p.: 135-137 ˚C.  
Rf = 0.24 (EtOAc:hexane = 1:3).  
 
((3,5-di-tert-butylphenyl)(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 
yl)methyl)trimethylsilane 285n:  
 
Isolated as a white crystalline solid (143.1 mg, 0.356 mmol, 79%) after silica gel column 
chromatography (eluent: CH2Cl2:hexane = 1:6), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.05 (t, J = 1.8 Hz, 1 H, H1), 7.03 (d, J = 1.8 Hz, 2 H, H3), 
1.93 (s, 1 H, H7), 1.30 (s, 18 H, H6), 1.27 (s, 6 H, H10a/H10b), 1.25 (s, 6 H, H10a/H10b), -
0.02 (s, 9 H, H8).  
13C NMR (150 MHz, CDCl3): δ 149.7 (C2), 139.2 (C4), 123.5 (C3), 117.0 (C1), 83.0 (C9), 
34.8 (C5), 31.7 (C6), 25.4 (C10a/C10b), 25.2 (C10a/C10b), -1.4 (C8). (C7 broadened by 
quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.7.  
FTIR (νmax, cm-1): 2963 (m), 1594 (m), 1479 (w), 1390 (w), 1371 (m), 1337 (m), 1309 (m), 
1269 (w), 1247 (m), 1205 (w), 1144 (m), 1040 (w), 973 (w), 948 (w), 849 (s), 841 (s).  
HRMS (ESI): calculated for C24H44O211BSi [M+H]+ 403.3204, found 403.3208.  
m.p.: 110-112 ˚C.  
Rf = 0.35 (EtOAc:hexane = 1:50).  
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trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(2 
(trifluoromethoxy)phenyl)methyl)silane 285o:  
 
Isolated as a colourless oil (141.5 mg, 0.378 mmol, 84%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:40), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.49 (dd, J = 7.8, 1.5 Hz, 1 H, H3), 7.18-7.14 (m, 2 H, H2, 
H5), 7.07-7.04 (m, 1 H, H1), 2.47 (s, 1 H, H8), 1.26 (s, 6 H, H11a/H11b), 1.23 (s, 6 H, 
H11a/H11b), 0.02 (s, 9 H, H9).  
13C NMR (150 MHz, CDCl3): δ 146.5 (C6), 134.2 (C3), 130.8 (C2), 126.1 (C4), 124.6 (C1), 
120.9 (q, J = 255.1 Hz, C7), 120.0 (d, J = 1.2 Hz, C5), 83.4 (C10), 25.1 (C11a/C11b), 25.0 
(C11a/C11b), -1.2 (C9). (C8 broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.7.  
FTIR (νmax, cm-1): 2980 (w), 1605 (w), 1489 (w), 1453 (w), 1373 (m), 1345 (m), 1319 (m), 
1292 (w), 1247 (s), 1225 (m), 1196 (m), 1141 (s), 1082 (w), 1038 (w), 1004 (w), 970 (m), 
924 (w), 837 (s).  
HRMS (ESI): calculated for C17H27O311BF3Si [M+H]+ 375.1775, found 375.1780.  
Rf = 0.34 (EtOAc:hexane = 1:40).  
 
trimethyl((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(thiophen-2-yl)methyl)silane 
285p:  
 
Isolated as a colourless oil (116.1 mg, 0.392 mmol, 87%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:50), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
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1H NMR (600 MHz, CDCl3): δ 6.94 (d, J = 5.2 Hz, 1 H, H1), 6.88 (dd, J = 5.2, 3.2 Hz, 1 H, 
H2), 6.73 (d, J = 3.2 Hz, 1 H, H3), 2.28 (s, 1 H, H5), 1.27 (s, 6 H, H8a/H8b), 1.25 (s, 6 H, 
H8a/H8b), 0.06 (s, 9 H, H6).  
13C NMR (150 MHz, CDCl3): δ 143.0 (C4), 126.8 (C2), 123.1 (C3), 120.6 (C1), 83.5 (C7), 
25.3 (C8a/C8), 25.0 (C8a/C8b), -1.5 (C6). (C5 broadened by quadrupolar relaxation with 
boron). 
11B NMR (128 MHz, CDCl3): δ 32.7 
FTIR (νmax, cm-1): 2979 (w), 1522 (w), 1436 (w), 1371 (m), 1316 (m), 1247 (m), 1204 (w), 
1166 (w), 1142 (m), 1113 (w), 1068 (w), 1032 (w), 968 (w), 840 (s).  
HRMS (ESI): calculated for C14H26O211BSSi [M+H]+ 297.1516, found 297.1520.  
Rf = 0.38 (EtOAc:hexane = 1:20).  
 
methyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)(trimethylsilyl)methyl)benzoate 
285q:  
 
Isolated as a white amorphous solid (94.1 mg, 0.270 mmol, 60%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:40), following the general batch procedure B for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.87 (d, J = 8.4 Hz, 2 H, H4), 7.22 (d, J = 8.4 Hz, 2 H, H5), 
3.87 (s, 3 H, H1), 2.08 (s, 1 H, H7), 1.26 (s, 6 H, H10a/H10b), 1.23 (s, 6 H, H10a/H10b), 
0.00 (s, 9 H, H8).  
13C NMR (150 MHz, CDCl3): δ 167.7 (C2), 147.5 (C3), 129.4 (C4), 128.6 (C5), 125.6 (C6), 
83.4 (C9), 51.9 (C1), 25.3 (C10a/C10b), 25.0 (C10a/C10b), -1.4 (C8). (C7 broadened by 
quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.0.  
FTIR (νmax, cm-1): 2978 (w), 1719 (s, C=O), 1606 (m), 1508 (w), 1435 (m), 1274 (s, C-O), 
1182 (m), 1141 (s, C-O), 1021 (w), 969 (m), 866 (s), 837 (s).  
HRMS (ESI): calculated for C18H30O411BSi [M+H]+ 349.2006, found 349.2018.  
m.p.: 97-99 ˚C.  
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Rf = 0.25 (EtOAc:hexane = 1:20).  
 
(E)-trimethyl(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(p-tolyl)allyl)silane 
285r: 
 
Isolated as a white amorphous solid (89.2 mg, 0.270 mmol, 60%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:50), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.24 (d, J = 8.0 Hz, 2 H, H4), 7.09 (d, J = 8.0 Hz, 2 H, H3), 
6.31 (dd, J = 15.7, 10.9 Hz, 1 H, H7), 6.13 (d, J = 15.7 Hz, 1 H, H6), 2.32 (s, 3 H, H1), 1.68 
(d, J = 10.9 Hz, 1 H, H8), 1.27 (s, 6 H, H11a/H11b), 1.26 (s, 6 H, H11a/H11b), 0.09 (s, 9 H, 
H9).  
13C NMR (150 MHz, CDCl3): δ 136.1 (C2), 135.6 (C5), 129.2 (C3), 128.1 (C6), 126.9 (C7), 
125.5 (C4), 83.1 (C10), 25.11 (C11a/C11b), 25.10 (C11a/C11b), 21.2 (C1), -1.4 (C9).  
11B NMR (128 MHz, CDCl3): δ 33.5.  
FTIR (νmax, cm-1): 2978 (w), 1636 (w), 1513 (w), 1447 (w), 1371 (m), 1354 (m), 1314 (m), 
1297 (m), 1263 (m), 1248 (m), 1214 (w), 1139 (m), 1112 (w), 1018 (w), 970 (m), 856 (m), 
837 (s).  
HRMS (ESI): calculated for C19H32O211BSi [M+H]+ 331.2265, found 331.2267.  
m.p.: 78-80 ˚C.  
Rf = 0.24 (EtOAc:hexane = 1:50).  
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(E)-trimethyl(4-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-2-en-1-
yl)silane 285s:  
 
Isolated as a pale yellow liquid (98.1 mg, 0.297 mmol, 66%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:50), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.29-7.27 (m, 2 H, H2), 7.20-7.17 (m, 3 H, H1, H3), 5.64 
(dd, J = 15.1, 10.7 Hz, 1 H, H7), 5.33 (dt, J = 15.1, 7.0 Hz, 1H, H6), 3.36 (d, J = 7.0 Hz, 2 H, 
H5), 1.50 (d, J = 10.7 Hz, 1H, H8), 1.26 (s, 12 H, H11a/H11b), 0.06 (s, 9 H, H9).  
13C NMR (150 MHz, CDCl3): δ 142.0 (C4), 128.7 (C3), 128.5 (C2), 128.3 (C6), 126.1 (C1), 
125.8 (C7), 83.0 (C10), 39.6 (C5), 25.1 (C11a/C11b), 25.0 (C11a/C11b), -1.5 (C9). (C8 
broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.2.  
FTIR (νmax, cm-1): 2979 (w), 1651 (w), 1604 (w), 1494 (w), 1453 (w), 1355 (m), 1314 (m), 
1261 (m), 1247 (m), 1213 (w), 1140 (m), 1082 (w), 1029 (m), 970 (m), 837 (s).  
HRMS (ESI): calculated for C19H32O211BSi [M+H]+ 331.2265, found 331.2260.  
Rf = 0.12 (EtOAc:hexane = 1:50).  
 
(E)-(3-(4-fluorophenyl)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl)trimethylsilane 285t:  
 
Isolated as a white amorphous solid (99.3 mg, 0.297 mmol, 66%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:50), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
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1H NMR (600 MHz, CDCl3): δ 7.28-7.26 (m, 2H, H3), 6.96-6.93 (m, 2H, H2), 6.26 (dd, J = 
15.7, 10.8 Hz, 1 H, H6), 6.12 (d, J = 15.7 Hz, 1H, H5), 1.67 (d, J = 10.8 Hz, 1 H, H7), 1.26 
(s, 6 H, H10a/H10b), 1.25 (s, 6 H, H10a/H10b), 0.09 (s, 9 H, H8).  
13C NMR (150 MHz, CDCl3): δ 161.5 (d, J = 242.9 Hz, C1), 135.1 (d, J = 3.2 Hz, C4), 
128.9 (d, J = 2.1 Hz, C5), 126.9 (d, J = 7.6 Hz, C3), 126.0 (C6), 115.3 (d, J = 21.2 Hz, C2), 
83.2 (C9), 25.14 (C10a/C10b), 25.12 (C10a/C10b), -1.4 (C8). (C7 broadened by quadrupolar 
relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.0.  
FTIR (νmax, cm-1): 2982 (w), 2957 (w), 1638 (w), 1592 (w), 1509 (m), 1468 (w), 1372 (m), 
1352 (m), 1308 (m), 1265 (m), 1249 (m), 1225 (m), 1159 (m), 1139 (s), 1112 (w), 1079 (w), 
1035 (m), 974 (m), 907 (w), 860 (s), 838 (s).  
HRMS (ESI): calculated for C18H29O211BFSi [M+H]+ 335.2014, found 335.2007.  
m.p.: 102-104 ˚C.  
Rf = 0.16 (EtOAc:hexane = 1:50).  
 
(E)-trimethyl(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-2-en-1-yl)silane 285u:  
 
Isolated as a colourless liquid (81.4 mg, 0.288 mmol, 64%) after silica gel column 
chromatography (eluent: EtOAc:hexane = 1:50), following the general batch procedure A for 
α-trimethylsilyl boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 5.44 (ddt, J = 15.1, 10.5, 1.3 Hz, 1 H, H4), 5.15 (dd, J = 
15.1, 6.9 Hz, H5), 2.00-1.90 (m, 2 H, H3), 1.41 (d, J = 10.5 Hz, 1 H, H6), 1.37-1.30 (m, 2 H, 
H2), 1.23 (s, 6 H, H9a/H9b), 1.23 (s, 6 H H9a/H9b), 0.86 (t, J = 7.4 Hz, 3 H, H1), 0.03, (s, 9 
H, H7).  
13C NMR (150 MHz, CDCl3): δ 127.8 (C4), 126.9 (C5), 82.9 (C8), 35.2 (C3), 25.1 
(C9a/C9b), 25.1 (C9a/C9b), 23.4 (C2), 13.8 (C1), -1.5 (C7). (C6 broadened by quadrupolar 
relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.2.  
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FTIR (νmax, cm-1): 2959 (w), 1651 (w), 1465 (w), 1356 (m), 1314 (m), 1247 (m), 1216 (w), 
1143 (m), 1023 (w), 970 (m), 849 (s), 837 (s).  
HRMS (ESI): calculated for C15H32O211BSi [M+H]+ 283.2265, found 223.2260.  
Rf = 0.28 (EtOAc:hexane = 1:50). 
 
Olefination of α-trimethylsilyl boronic pinacol ester  
 
1-Bromo-4-(4-methoxystyryl)benzene 298: 
The reaction was carried out in dry conditions under an atmosphere of argon. To a mixture of 
α-trimethylsilyl boronic pinacol esters 285a (0.40 mmol, 2.0 equiv.) and p-
bromobenzaldehyde (39.0 mg, 0.20 mmol, 1.0 equiv.) in THF (0.1 mL) was added TBAT 
(10.2 mg, 0.02 mmol, 0.1 equiv.). The reaction mixture was stirred at 85 ˚C for 16 h and 
allowed to cool to room temperature. The reaction was quenched with water (1 mL) and 
concentrated under vacuum. The residue was diluted with EtOAc (10 mL) and washed with 
brine, dried over MgSO4 and concentrated under reduced pressure. The residue was purified 
by silica gel column chromatography (eluent: EtOAc/hexane = 15:85) to provide the olefin 
(22.0 mg, 0.076 mmol, 76% with a E:Z ratio of 44:56) as a yellow oil.  
 
 
Z-isomer 
1H NMR (600 MHz, CDCl3): δ 7.35 (d, J = 8.5 Hz, 2 H, H10), 7.16 (d, J = 8.7 Hz, 2 H, H4) 
7.13 (d, J = 8.5 Hz, 2 H, H9) 6.77 (d, J = 8.8 Hz, 2 H, H3), 6.56 (d, J = 12.3 Hz, 1 H, H7), 
6.42 (d, J = 12.3 Hz, 1 H, H6), 3.80 (s, 3 H, H1). 
13C NMR (150 MHz, CDCl3): δ 159.0 (C2), 136.7 (C8), 131.5 (C5), 130.7 (C7), 130.6 
(C10), 130.3 (C6), 129.4 (C4), 127.6 (C9), 120.8 (C11), 113.9 (C3), 55.5 (C1). 
FTIR (νmax, cm-1): 3421 (w), 3020 (w), 2960 (w), 2837 (m), 1640 (m), 1604 (m), 1574 (m), 
1459 (m), 1400 (w), 1335 (m), 1305 (w), 1254 (m), 1176 (w), 1031 (m), 834 (s).  
HRMS (ESI): calculated for C15H1379BrO [M+H]+ 288.0150, found 288.0153.  
Rf = 0.56 (EtOAc:hexane = 15:85). 
Data are consistent with a reported example.xiii 
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E-isomer 
1H NMR (600 MHz, CDCl3): δ 7.44-7.41 (m, 4 H, H10, H4), 7.32 (d, J = 8.7 Hz, 2 H, H9) 
7.02 (d, J = 16.5 Hz, 2 H, H7) 6.89-6.85 (m, 3 H, H3, H6), 3.80 (s, 3 H, H1). 
13C NMR (150 MHz, CDCl3): δ 159.7 (C2), 136.8 (C8), 131.9 (C5), 130.1 (C7), 129.2 
(C10), 127.7 (C9), 127.6 (C4), 125.5 (C6), 120.8 (C11), 113.9 (C3), 55.5 (C1) 
FTIR (νmax, cm-1): 3421 (w), 3013 (w), 2960 (w), 2837 (m), 1604 (m), 1574 (m), 1459 (m), 
1400 (w), 1335 (m), 1305 (w), 1254 (m), 1176 (w), 1031 (m), 969 (w), 832 (s).   
HRMS (ESI): calculated for C15H1379BrO [M+H]+ 288.0150, found 288.0154.  
Rf = 0.50 (EtOAc:hexane = 15:85). 
Data are consistent with a reported example.xiv 
 
Alkylation reaction of α-trimethylsilyl boronic pinacol esters 
 
General batch procedure C for preparation of alkylated boronic pinacol esters:  
 
The reaction was carried out under dry conditions and an atmosphere of argon. To a mixture 
of α-trimethylsilyl boronic pinacol esters (0.20 mmol, 1.0 equiv.) and cesium fluoride (61 
mg, 0.40 mmol, 2.0 equiv.) in DMA (0.5 mL) was added the solution of the corresponding 
bromide (0.4 mmol, 2.0 equiv.) in DMA (0.5 mL). The reaction mixture was stirred at 65 ˚C 
for 48 h and allowed to cool to room temperature. The reaction was diluted with EtOAc (10 
mL) and washed with aqueous solution of LiCl and brine, dried over MgSO4 and 
concentrated under reduced pressure. The residue was purified by silica gel flash column 
chromatography to afford the desired alkylated boronic pinacol esters.  
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2-[1-(p-methoxyphenyl)-2-phenylethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (300a): 
 
 
Isolated as a colourless liquid (51.4 mg, 0.152 mmol, 76%) after silica gel column 
chromatography (eluent: EtOAc:petroleum ether = 5:95), following the general batch 
procedure C for alkylated boronic pinacol esters. Data are consistent with a reported 
example.ix, xv  
 
1H NMR (600 MHz, CDCl3): δ 7.23-7.13 (m, 7 H, H3, H9, H10, H11), 6.8 (d, J = 8.7 Hz, 2 
H, H4), 3.78 (s, 3 H, H1), 3.11 (dd, J = 9.6, 13.5 Hz, 1 H, H6), 2.92 (dd, J = 7.2, 13.4 Hz, 1 
H, H7), 2.62 (dd, J = 7.2, 10.0 Hz, 1H, H7'), 1.11 (s, 6 H, H13a/H13b), 1.10 (s, 6 H, 
H13a/H13b). 
13C NMR (150 MHz, CDCl3): δ 157.5 (C2), 141.8 (C8), 134.6 (C5), 129.3 (C10), 128.9 
(C4), 128.0 (C9), 125.7 (C11), 113.7 (C3), 83.3 (C12), 55.2 (C1), 39.1 (C7), 24.6 
(C13a/C13b), 24.5 (C13a/C13b). (C6 broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 33.4.  
FTIR (νmax, cm-1): 2978 (w), 2933 (w), 1608 (w), 1582 (w), 1509 (m), 1455 (w), 1362 (m), 
1325 (m), 1244 (m), 1178 (w), 1073 (m), 1037 (w), 968 (w), 855 (w), 831 (w). 
HRMS (ESI): calculated for C21H2811BO3 [M+H]+ 339.2132, found 339.2134.  
Rf = 0.18 (EtOAc:petroleum ether = 5:95). 
 
2-[1-(p-methoxyphenyl)pentyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 300b: 
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Isolated as a colourless liquid (32 mg, 0.106 mmol, 53%) after silica gel column 
chromatography (eluent: EtOAc:petroleum ether = 5:95), following the general batch 
procedure C for alkylated boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.13 (d, J = 8.6 Hz, 2 H, H4), 6.81 (d, J = 8.6 Hz, 2 H, H3), 
3.78 (s, 3 H, H1), 2.24 (t, J = 7.8 Hz, 1 H, H6), 1.80 (td, J = 13.3, 7.9 Hz, 1 H, H7), 1.60 (td, 
J = 13.1, 7.9 Hz, 1 H, H7'), 1.37-1.22 (m, 4 H, H8, H9), 1.21 (s, 6 H, H12a/H12b), 1.20 (s, 6 
H, H12a/H12b), 0.86 (t, J = 7.1, 3 H, H10). 
13C NMR (150 MHz, CDCl3): δ 157.2 (C2), 135.5 (C5), 129.2 (C4), 113.6 (C3), 83.1 (C11), 
55.1 (C1), 32.5 (C8), 31.4 (C7), 24.6 (C12a/C12b), 24.6 (C12a/C12b), 22.7 (C9), 14.0 (C10). 
(C6 broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 32.7.  
FTIR (νmax, cm-1): 2977 (w), 2956 (w), 2926 (w), 1608 (w), 1582 (w), 1509 (m), 1465 (w), 
1360 (m), 1319 (m), 1269 (w), 1244 (m), 1215 (w), 1177 (w), 1142 (m), 1113 (w), 1038 
(m),967 (m), 877 (w), 850 (m), 829 (m).  
HRMS (ESI): calculated for C18H30O311B [M+H]+ 305.2288, found 305.2280.  
Rf = 0.24 (EtOAc:petroleum ether = 5:95). 
 
3-[4-(p-Methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy]-2,3-
dimethyl-2-butanol 300c: 
 
 
Isolated as a colourless liquid (13 mg, 0.032 mmol, 16%) after silica gel column 
chromatography (eluent: EtOAc:petroleum ether = 5:95), following the general batch 
procedure C for alkylated boronic pinacol esters. 
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1H NMR (600 MHz, CDCl3): δ 7.13 (d, J = 8.7 Hz, 2 H, H4), 6.81 (d, J = 8.7 Hz, 2 H, H3), 
3.78 (s, 3 H, H1), 3.34 (t, J = 6.5 Hz, 2 H, H9), 2.86 (s, 1 H, OH), 2.26 (t, J = 7.7 Hz, 1 H, 
H6), 1.88 (dt, J = 13.0, 7.9 Hz, 1 H, H7), 1.65 (dt, J = 13.5, 7.8 Hz, 1 H, H7'), 1.50 (p, J = 6.6 
Hz, 2 H, H8), 1.21 (s, 6 H, H15a/H15b), 1.19 (s, 6 H, H15a/H15b), 1.17 (s, 6 H, H11/H13), 
1.12 (s, 3 H, H11/H13), 1.11 (s, 3 H, H11/H13).  
13C NMR (150 MHz, CDCl3): δ 157.3 (C2), 135.2 (C5), 129.2 (C4), 113.7 (C3), 83.2 (C14), 
78.8 (C10), 75.0 (C12), 61.1 (C9), 55.2 (C1), 30.0 (C8), 29.6 (C7), 24.6 (C15a/C15b), 24.6 
(C15a/C15b), 24.4 (C11/C13), 24.4 (C11/C13), 19.5 (C11/C13), 19.5 (C11/C13). (C6 
broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 32.7.  
FTIR (νmax, cm-1): 3548 (br w, OH), 2978 (w), 2985 (w), 1610 (w), 1510 (m), 1464 (w), 
1390 (w), 1365 (m), 1322 (m), 1245 (m), 1143 (m), 1117 (m), 1065 (w), 1038 (w), 968 (w), 
960 (w), 851 (w), 829 (w). 
HRMS (ESI): calculated for C23H40O511B [M+H]+ 407.2963, found 407.2959.  
Rf = 0.23 (EtOAc:petroleum ether = 5:95). 
 
4-(p-methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-butene 300d:  
 
Isolated as a colourless liquid (38 mg, 0.134 mmol, 67%) after silica gel column 
chromatography (eluent: EtOAc:petroleum ether = 5:95), following the general batch 
procedure C for alkylated boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.14 (d, J = 8.7 Hz, 2 H, H4) 6.82 (d, J = 8.7 Hz, 2 H, H3), 
5.82 (ddt, J = 16.7, 10.1, 6.6 Hz, 1 H, H8), 5.03 (d, J = 16.8 Hz, 1 H, H9trans), 4.93 (d, J = 
10.7 Hz, 1 H, H9cis), 3.78 (s, 3 H, H1), 2.59-2.53 (m, 1 H, H6), 2.00 (dt, J = 6.9, 3.9 Hz, 2 H, 
H7), 1.21 (s, 6 H, H11a/H11b), 1.19 (s, 6 H, H11a/H11b).   
13C NMR (150 MHz, CDCl3): δ 157.4 (C2), 138.2 (C5), 134.6 (C8), 129.2 (C4), 115.0 (C9), 
113.7 (C3), 83.3 (C10), 55.2, 37.0 (C1), 24.6 (C11a/C11b), 24.6 (C11a/C11b). (C6 
broadened by quadrupolar relaxation with boron). 
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11B NMR (128 MHz, CDCl3): δ 32.6.  
FTIR (νmax, cm-1): 2978 (w), 1640 (w), 1608 (w), 1582 (w), 1510 (m), 1465 (w), 1443 (w), 
1360 (m), 1324 (m), 1274 (w), 1245 (m), 1178 (w), 1166 (w), 1142 (m), 1112 (w), 1038 (w), 
996 (w), 869 (w), 829 (w). 
HRMS (ESI): calculated for C17H26O311B [M+H]+ 289.1975, found 289.1974.  
Rf = 0.22 (EtOAc:petroleum ether = 5:95). 
 
2-[1-(p-Chlorophenyl)-2-phenylethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 300e: 
 
Isolated as a colourless liquid (23 mg, 0.068 mmol, 34%) after silica gel column 
chromatography (eluent: EtOAc:petroleum ether = 10:90), following the general batch 
procedure C for alkylated boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.23-7.20 (m, 4 H, H2, H3), 7.16-7.13 (m, 5 H, H8, H9, 
H10), 3.13 (dd, J = 13.3, 9.2 Hz, 1 H, H6), 2.93 (dd, J = 13.7, 7.3 Hz, 1 H, H6'), 2.66 (t, J = 
8.3 Hz, 1 H, H5), 1.13 (s, 6 H, H12a/H12b), 1.12 (s, 6 H, H12a/H12b).  
13C NMR (150 MHz, CDCl3): δ 141.3 (C7), 141.0 (C4), 131.1 (C1), 129.7 (C3), 128.8 (C9), 
128.4 (C2/C10), 128.1 (C2/C10), 125.8 (C8), 83.5 (C11), 38.6 (C6), 24.6 (C12a/C12b), 24.5 
(C12a/C12b).  
11B NMR (128 MHz, CDCl3): δ 32.4.  
FTIR (νmax, cm-1): 2978 (w), 2930 (w), 1609 (w), 1580 (w), 1509 (m), 1464 (w), 1362 (m), 
1325 (m), 1246 (m), 1217 (w), 1141 (m), 1110 (w), 1036 (w), 1006 (m), 968 (w), 853 (w), 
831 (w). 
HRMS (ESI): calculated for C20H25O211B [M+H]+ 343.1636, found 343.1632.  
Rf = 0.38 (EtOAc:petroleum ether = 10:90). 
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2-[2-(p-Iodophenyl)-1-(p-methoxyphenyl)ethyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
300f: 
 
Isolated as a colourless liquid (24 mg, 0.052 mmol, 26%) after silica gel column 
chromatography (eluent: EtOAc:petroleum ether = 10:90), following the general batch 
procedure C for alkylated boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.53 (d, J = 8.2 Hz, 2 H, H10), 7.11 (d, J = 8.0 Hz, 2 H, H4), 
6.90 (d, J = 8.0 Hz, 2 H, H9), 6.80 (d, J = 8.3 Hz, 2 H, H3), 3.78 (s, 3 H, H1), 3.05 (dd, J = 
9.0, 13.6 Hz, 1 H, H7), 2.85 (dd, J = 7.4, 13.6 Hz, 1 H, H7'), 2.55 (t, J = 8.2 Hz, 1 H, H6), 
1.14 (s, 6 H, H13a/H13b), 1.13 (s, 6 H, H13a/H13b). 
13C NMR (150 MHz, CDCl3): δ 157.5 (C2), 141.5 (C8), 137.0 (C10), 134.0 (C5), 131.0 
(C9), 129.3 (C4), 113.8 (C3), 90.8 (C11), 83.4 (C12), 55.2 (C1), 38.5 (C7), 24.6 
(C13a/C13b). (C6 broadened by quadrupolar relaxation with boron). 
11B NMR (128 MHz, CDCl3): δ 32.4.  
FTIR (νmax, cm-1): 2977 (w), 2931 (w), 1609 (w), 1582 (w), 1509 (m), 1484 (w), 1464 (w), 
1362 (m), 1326 (m), 1390 (w), 1245 (m), 1214 (w), 1179 (w), 1141 (m), 1060 (w), 1037 (m), 
1007 (m), 968 (w), 854 (w), 841 (m), 794 (w). 
HRMS (ESI): calculated for C21H27O311BI [M+H]+ 465.1098, found 465.1107.  
Rf = 0.25 (EtOAc:petroleum ether = 10:90). 
 
Coupling of α-trimethylsilyl boronic pinacol esters with hetroaromatic compounds 
 
General procedure D for preparation of silane derivatives:  
 
The reaction was carried out under dry conditions and an atmosphere of argon. To a solution 
of heteroaryl (1.2 equiv.) in THF (0.3 M) at -78 °C was added nBuLi (0.15 mL, 1.6 M in 
hexanes, 1.2 equiv.). The reaction mixture was allowed to cool to room temperature stirred 
for 1 h. The reaction mixture was then cooled to -78 °C and a solution of α-trimethylsilyl 
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boronic pinacol esters (0.2 mmol, 1.0 equiv.) in THF (0.5 M) was added dropwise. The 
mixture was stirred at -78 °C for 2 h. A solution of NBS (1.2 equiv.) in THF (0.3 M) was 
added dropwise. After 1 h at -78 °C, saturated aqueous solution of Na2S2O3 was added and 
the reaction mixture was allowed to warm to room temperature. The reaction mixture was 
diluted with Et2O and water. The layers were separated and the aqueous phase was extracted 
with EtOAc. The combined organic extracts were dried (MgSO4) and concentrated under 
reduced pressure. The residue was purified by silica gel flash column chromatography to 
afford the desired silane derivative.  
 
(furan-2-yl(4-methoxyphenyl)methyl)trimethylsilane 313a: 
 
Isolated as a yellow liquid (92 mg, 0.355 mmol, 71%) after silica gel column chromatography 
(eluent: EtOAc:hexane = 3:97), following the general batch procedure D for alkylated 
boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.34 (dd, J = 1.0, 1.7 Hz, 1 H, H4), 7.11 (d, J = 8.5 Hz, 2 H, 
H9), 6.83 (d, J = 8.5 Hz, 2 H, H1), 6.31 (dt, J = 2.0, 1.0 Hz, 1 H, H2), 6.03 (d, J = 3.2 Hz, 1 
H, H3), 3.79 (s, 3 H, H11), 3.53 (s, 1 H, H5), 0.05 (s, 9 H, H6). 
13C NMR (150 MHz, CDCl3): δ 157.2 (C10), 156.9 (C4), 140.7 (C1), 133.0 (C7), 128.7 
(C8), 113.7 (C9), 110.2 (C2), 105.2 (C3), 55.2 (C11), 37.5 (C5), -2.2 (C6).  
FTIR (νmax, cm-1): 2955 (w), 2835 (w), 1610 (w), 1581 (w), 1508 (m), 1464 (w), 1420 (w), 
1420 (w), 1379 (w), 1300 (w), 1244 (s), 1178 (w), 1098 (w), 1073 (w), 1036 (w), 1011 (w), 
924 (w), 865 (m), 838 (s), 773 (w), 722 (m).  
HRMS (ESI): calculated for C15H20O2Si [M+H]+ 260.1233, found 260.1235.  
Rf = 0.24 (EtOAc:hexane = 3:97). 
 
4-(furan-2-yl(trimethylsilyl)methyl)benzonitrile 313b: 
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Isolated as a yellow liquid (36 mg, 0.140 mmol, 56%) after silica gel column chromatography 
(eluent: EtOAc:hexane = 5:95), following the general batch procedure D for alkylated 
boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.55 (d, J = 7.8 Hz, 2 H, H9), 7.36 (d, J = 1.7, 0.7 Hz, 1 H, 
H8), 7.26 (d, J = 8.2 Hz, 2 H, H1), 6.33 (dt, J = 2.0, 1.0 Hz, 1 H, H2), 6.08 (d, J = 3.2 Hz, 1 
H, H3), 3.68 (s, 1 H, H5), 0.04 (s, 9 H, H6). 
13C NMR (150 MHz, CDCl3): δ 154.7 (C4), 147.1 (C1), 141.4 (C7), 132.1 (C9), 128.2 (C8), 
119.2 (C11), 110.4 (C2), 108.7 (C10), 106.4 (C3), 39.4 (C5), -2.4 (C6) 
FTIR (νmax, cm-1): 2957 (w), 2226 (m, CN), 1605 (m), 1583 (w), 1501 (m), 1415 (w), 1379 
(w), 1251 (m), 1219 (w), 1171 (w), 1146 (w), 1093 (w), 1070 (w), 1012 (m), 925 (w), 847 
(s), 783 (w), 730 (m) 
HRMS (ESI): calculated for C15H17NOSi [M+H]+ 255.1079, found 255.1078.  
Rf = 0.27 (EtOAc:petroleum ether = 5:95). 
 
((4-methoxyphenyl)(thiophen-2-yl)methyl)trimethylsilane 313c: 
 
Isolated as a yellow liquid (17 mg, 0.140 mmol, 21%) after silica gel column chromatography 
(eluent: EtOAc:hexane = 10:90), following the general batch procedure D for alkylated 
boronic pinacol esters. 
 
1H NMR (600 MHz, CDCl3): δ 7.14 (d, J = 8.5 Hz, 2 H, H8), 7.07 (dd, J = 5.3, 1.0 Hz, 1 H, 
H1), 6.93 (dt, J = 5.2, 3.7, 1 H, H2), 6.85 (d, J = 3.2 Hz, 1 H, H3), 6.83 (d, J = 8.9 Hz, 2 H, 
H9), 3.79 (s, 3 H, H11), 3.70 (s, 1 H, H5), 0.06 (s, 9 H, H6). 
13C NMR (150 MHz, CDCl3): δ 157.2 (C10), 156.9 (C4), 140.7 (C7), 128.9 (C8), 126.6 
(C2), 123.9 (C3), 122.4 (C1), 113.7 (C9), 55.2 (C11), 39.3 (C5), -2.1 (C6). 
FTIR (νmax, cm-1): 2954 (w), 1609 (w), 1583 (w), 1509 (s), 1463 (w), 1437 (w), 1301 (w), 
1248 (s), 1179 (m), 1037 (m), 867 (m), 841 (m), 771 (w). 
HRMS (ESI): calculated for C15H17NOSi [M+H]+ 255.1079, found 255.1078.  
Rf = 0.45 (EtOAc:petroleum ether = 10:90). 
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Addition reaction to aldehydes using silanes in the presence of TBAT 
 
General procedure E for preparation of benzyl alcohol derivatives:  
 
The reaction was carried out in dry conditions under an atmosphere of argon. To a mixture of 
silane derivative (0.20 mmol, 1.0 equiv.) and aldehyde (0.40 mmol, 1.0 equiv.) in THF (0.1 
mL) was added TBAT (10.2 mg, 0.02 mmol, 0.1 equiv.). The reaction mixture was stirred at 
75 ˚C for 6 h and allowed to cool to room temperature. The reaction was quenched with 
water (1 mL) and concentrated under vacuum. The residue was diluted with EtOAc (10 mL) 
and washed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
crude residue was purified by silica gel flash column chromatography to afford the desired 
benzyl alcohol derivative.  
 
1-(4-bromophenyl)-2-(furan-2-yl)-2-(4-methoxyphenyl)ethan-1-ol 314a: 
 
Isolated as a yellow liquid (50.7 mg, 0.136 mmol, 68% with a diastereomeric ratio of 1:1.3) 
after silica gel column chromatography (eluent: EtOAc:petroleum ether = 80:20), following 
the general batch procedure E for benzyl alcohol derivatives. 
 
Diastereoisomer (major) 
1H NMR (600 MHz, CDCl3): δ 7.38 (d, J = 8.5 Hz, 2 H, H14), 7.31 (dd, J = 0.6, 1.8 Hz, 1 
H, H1), 7.30 (d, J = 8.5 Hz, 2 H, H7), 7.08 (d, J = 8.3 Hz, 2 H, H13), 6.89 (d, J = 8.22 Hz, 2 
H, H8), 6.21 (dt, J = 1.8, 1.3 Hz, 1 H, H2), 5.95 (d, J = 3.5 Hz, 1 H, H3), 5.27 (dd, J = 7.8, 
2.6 Hz, 1 H, H11), 4.11 (d, J = 7.9 Hz, 1 H, H5), 3.81 (s, 3 H, H10), 2.11 (d, J = 2.9 Hz, 1 H, 
OH).  
13C NMR (150 MHz, CDCl3): δ 159.0 (C9), 154.3 (C4), 141.4 (C1), 141.1 (C12), 131.1 
(C6), 130.0 (C14), 130.1 (C7), 128.1 (C13), 121.4 (C15), 114.1 (C8), 110.2 (C2), 107.3 (C3), 
75.5 (C11), 55.2 (C10), 53.5 (C5).  
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FTIR (νmax, cm-1): 3447 (br w, OH), 2908 (w), 1610 (m), 1585 (w), 1511.0 (s), 1488 (m), 
1463 (m), 1441 (m), 1406 (w), 1304 (w), 1247 (s), 1178 (m), 1146 (w), 1112 (w), 1070 (w), 
1034 (m), 1009 (s), 949 (w), 927 (w), 885 (w), 835 (m), 771 (m), 733(s) 
HRMS (ESI): calculated for C19H16O2Br [M+H]+ 355.0333, found 355.0335.  
Rf = 0.23 (EtOAc:petroleum ether = 4:1). 
 
Diastereoisomer (minor) 
1H NMR (600 MHz, CDCl3): δ 7.43 (dd, J = 1.1, 0.7 Hz, 1 H, H1), 7.33 (d, J  = 8.4 Hz, 2 H, 
H14), 7.01 (d, J = 5.0 Hz, 2 H, H7), 7.00 (d, J = 4.5 Hz, 2 H, H13), 6.74 (d, J = 8.9 Hz, 2 H, 
H8), 6.36 (dt, J = 1.9, 1.3 Hz, 1 H, H2), 6.26 (d, J = 3.2 Hz, 1 H, H3), 5.15 (dd, J = 8.5, 2.7 
Hz, 1 H, H11), 4.18 (d, J = 8.9 Hz, 1 H, H5), 3.75 (s, 3 H, H10), 2.48 (d, J = 3.1 Hz, 1 H, 
OH). 
13C NMR (150 MHz, CDCl3): δ 158.5 (C9), 154.4 (C4), 142.0 (C1), 140.7 (C12), 131.0 
(C6), 130.5 (C14), 129.7 (C7), 128.4 (C13), 121.4 (C15), 113.8 (C8), 110.4 (C2), 107.9 (C3), 
76.6 (C11), 55.2 (C10), 53.5 (C5).  
FTIR (νmax, cm-1): 3447 (br w, OH), 2908 (w), 1610 (m), 1585 (w), 1511.0 (s), 1488 (m), 
1463 (m), 1441 (m), 1406 (w), 1304 (w), 1247 (s), 1178 (m), 1146 (w), 1112 (w), 1070 (w), 
1034 (m), 1009 (s), 949 (w), 927 (w), 885 (w), 835 (m), 771 (m), 733(s) 
HRMS (ESI): calculated for C19H16O2Br [M+H]+ 355.0333, found 355.0334.  
Rf = 0.22 (EtOAc:petroleum ether = 4:1). 
 
4-(2-(4-bromophenyl)-1-(furan-2-yl)-2-hydroxyethyl)benzonitrile 314b: 
 
Isolated as a yellow liquid (39.6 mg, 0.108 mmol, 54% with a diastereomeric ratio of 1:1.8) 
after silica gel column chromatography (eluent: EtOAc:petroleum ether = 80:20), following 
the general batch procedure E for benzyl alcohol derivatives. 
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Diastereoisomer (major) 
1H NMR (600 MHz, CDCl3): δ 7.60 (d, J  = 8.5 Hz, 2 H, H14), 7.45 (d, J = 9.2 Hz, 2 H, 
H8), 7.38 (d, J = 8.5 Hz, 2 H, H7), 7.35 (dd, J = 1.1, 0.6 Hz, 1 H, H1), 7.05 (d, J = 8.3 Hz, 2 
H, H13), 6.25 (dt, J = 1.9, 1.4 Hz, 1 H, H2), 6.01 (d, J = 3.2 Hz, 1 H, H3), 5.39 (dd, J = 7.2, 
3.1 Hz, 1 H, H11), 4.24 (d, J = 7.2 Hz, 1 H, H5), 2.16 (d, J = 3.3 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 152.8 (C4), 143.7 (C6), 142.0 (C1), 140.6 (C12), 132.1 
(C8), 131.3 (C14), 130.1 (C7), 127.8 (C13), 121.8 (C15), 118.7 (C10), 111.1 (C9), 110.5 
(C2), 108.1 (C3), 75.1 (C11), 53.8 (C5). 
FTIR (νmax, cm-1): 3455.2 (br w, OH), 2922 (w), 2364 (w), 2229 (m, CN), 1608 (m), 1592 
(w), 1503 (m), 1487 (m), 1416 (w), 1175 (w), 1146 (w), 1071 (m), 1048 (m), 1010 (s), 946 
(w), 909 (w), 822 (m), 774 (m), 731 (s). 
HRMS (ESI): calculated for C19H15BrNO2 [M+H]+ 368.0286, found 368.0288.  
Rf = 0.11 (EtOAc:petroleum ether = 4:1). 
 
Diastereoisomer (minor) 
1H NMR (600 MHz, CDCl3): δ 7.49 (d, J = 8.4 Hz, 2 H, H14), 7.45 (dd, J  = 1.3, 0.6 Hz, 1 
H, H1), 7.35 (d, J = 8.2 Hz, 2 H, H7), 7.21 (d, J = 8.3 Hz, 2 H, H1), 6.98 (d, J = 8.5 Hz, 2 H, 
H13), 6.40 (dt, J = 1.8, 1.3 Hz, 1 H, H2), 6.32 (d, J = 3.3 Hz, 1 H, H3), 5.19 (dd, J = 8.4, 2.5 
Hz, 1 H, H11), 4.29 (d, J = 8.2 Hz, 1 H, H5), 2.44 (d, J = 3.3 Hz, 1 H, OH).  
13C NMR (150 MHz, CDCl3): δ 152.5 (C4), 143.9 (C6), 142.6 (C1), 139.9 (C12), 132.1 
(C8), 131.4 (C14), 129.5 (C7), 128.2 (C13), 121.9 (C15), 118.6 (C10), 111.0 (C9), 110.6 
(C2), 108.8 (C3), 76.1 (C11), 54.3 (C5). 
FTIR (νmax, cm-1): 3455.2 (br w, OH), 2922 (w), 2364 (w), 2229 (m, CN), 1608 (m), 1592 
(w), 1503 (m), 1487 (m), 1416 (w), 1175 (w), 1146 (w), 1071 (m), 1048 (m), 1010 (s), 946 
(w), 909 (w), 822 (m), 774 (m), 731 (s). 
HRMS (ESI): calculated for C19H15BrNO2 [M+H]+ 368.0286, found 368.0288.  
Rf = 0.10 (EtOAc:petroleum ether = 4:1). 
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4-(2-(furan-2-yl)-1-hydroxy-2-(4-methoxyphenyl)ethyl)benzonitrile 314c: 
 
Isolated as a yellow liquid (42.2 mg, 0.132 mmol, 66% with a diastereomeric ratio of 1:1) 
after silica gel column chromatography (eluent: EtOAc:petroleum ether = 80:20), following 
the general batch procedure E for benzyl alcohol derivatives. 
 
Diastereoisomer (major) 
1H NMR (600 MHz, CDCl3): δ 7.53 (d, J = 8.3 Hz, 2 H, H14), 7.33 (dd, J = 1.2, 0.6 Hz, 1 
H, H1), 7.29 (d, J = 8.7 Hz, 2 H, H13), 7.29 (d, J = 8.7 Hz, 2 H, H7), 6.88 (d, J = 8.7 Hz, 2 H, 
H8), 6.22 (dt, J = 1.8, 1.3 Hz, 1 H, H2), 5.93 (d, J = 3.2 Hz, 1 H, H3), 5.36 (dd, J = 7.3, 2.3 
Hz, 1 H, H11), 4.10 (d, J = 8.0 Hz, 1 H, H5), 3.81(s, 3 H, H10), 2.23 (d, J = 2.8 Hz, 1 H, 
OH).  
13C NMR (150 MHz, CDCl3): δ 159.1 (C9), 153.7 (C4), 147.3 (C12), 141.6 (C1), 130.8 
(C6), 131.1 (C14), 129.9 (C7), 127.4 (C13), 118.9 (C16), 114.2 (C8), 111.2 (C15), 110.5 
(C2), 108.2 (C3), 75.5 (C11), 55.3 (C10), 53.5 (C5). 
FTIR (νmax, cm-1): 3483 (br w, OH), 2933 (w), 2838 (w), 2228 (m, CN), 1610 (m), 1584.4 
(w), 1511 (s), 1464 (w), 1412 (w), 1303 (m), 1247 (s), 1178 (m), 1146 (w), 1111 (w), 1033 
(m), 1012 (m), 910 (w), 840 (m), 782 (m), 729 (s). 
HRMS (ESI): calculated for C19H15BrNO2 [M+H]+ 368.0286, found 368.0288.  
Rf = 0.11 (EtOAc:petroleum ether = 4:1). 
 
Diastereoisomer (minor) 
1H NMR (600 MHz, CDCl3): δ 7.49 (d, J = 8.3 Hz, 2 H, H14), 7.44 (dd, J = 1.2, 0.6 Hz, 1 
H, H1), 7.22 (d, J = 8.3 Hz, 2 H, H13), 6.99 (d, J = 8.7 Hz, 2 H, H7), 6.74 (d, J = 8.7 Hz, 2 H, 
H8), 6.37 (dt, J = 1.8, 1.3 Hz, 1 H, H2), 6.26 (d, J = 3.4 Hz, 1 H, H3), 5.23 (dd, J = 8.3, 2.5 
Hz, 1 H, H11), 4.17 (d, J = 8.6 Hz, 1 H, H5), 3.75 (s, 3 H, H10), 2.60 (d, J = 3.0 Hz, 1 H, 
OH).  
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13C NMR (150 MHz, CDCl3): δ 158.7 (C9), 153.8 (C4), 147.0 (C12), 142.2 (C1), 131.7 
(C6), 129.7 (C14), 129.4 (C7), 127.0 (C13), 118.9 (C16), 113.9 (C16), 111.2 (C8), 110.3 
(C15), 107.6 (C3), 76.6 (C11), 55.2 (C10), 53.6 (C5) 
FTIR (νmax, cm-1): 3483 (br w, OH), 2933 (w), 2838 (w), 2228 (m, CN), 1610 (m), 1584.4 
(w), 1511 (s), 1464 (w), 1412 (w), 1303 (m), 1247 (s), 1178 (m), 1146 (w), 1111 (w), 1033 
(m), 1012 (m), 910 (w), 840 (m), 782 (m), 729 (s). 
HRMS (ESI): calculated for C19H15BrNO2 [M+H]+ 368.0286, found 368.0288.  
Rf = 0.10 (EtOAc:petroleum ether = 4:1). 
 
2-(benzofuran-2-yl)-1-(4-bromophenyl)-2-(4-methoxyphenyl)ethan-1-ol 314d: 
 
Isolated as a yellow liquid (55.7 mg, 0.132 mmol, 44% with a diastereomeric ratio of 1:1.2) 
after silica gel column chromatography (eluent: EtOAc:petroleum ether = 80:20), following 
the general batch procedure E for benzyl alcohol derivatives. 
 
Diastereoisomer (major) 
1H NMR (600 MHz, CDCl3): δ 7.53 (d, J = 7.6 Hz, 1 H, H4), 7.48 (d, J = 8.0 Hz, 1 H, H7), 
7.37-7.16 (m, 4 H, H5, H6, H18), 7.08 (d, J = 8.9 Hz, 2 H, H17), 7.06 (d, J = 8.5 Hz, 2 H, 
H11), 6.74 (d, J = 8.8 Hz, 2 H, H12), 6.68 (s, 1 H, H2), 5.30 (dd, J = 8.6, 2.4 Hz, 1 H, H15), 
4.32 (d, J = 8.6 Hz, 1 H, H9), 3.75 (s, 3 H, H14), 2.52 (d, J = 3.0 Hz, 1 H, OH). 
13C NMR (150 MHz, CDCl3): δ 159.1 (C1), 157.4 (C13), 154.8 (C8), 140.8 (C16), 131.2 
(C10), 130.3 (C18), 129.9 (C11), 128.4 (C17), 128.3 (C3), 123.9 (C6), 122.8 (C5), 121.5 
(C19), 120.8 (C4), 114.1 (C12), 111.1 (C7), 104.8 (C2), 76.3 (C15), 55.2 (C14), 53.8 (C9). 
FTIR (νmax, cm-1): 3426 (br w, OH), 2931 (w), 2837 (w), 1610 (w), 1584 (m), 1512 (m), 
1487 (w), 1454 (m), 1303 (w), 1251 (m), 1178.61 (m), 1104 (w), 1071 (w), 1035 (w), 1010 
(w), 963 (w), 945 (w), 909 (w), 815 (w), 750 (m). 
HRMS (ESI): calculated for C23H20BrO3 [M+H]+ 423.0595, found 423.0596.  
Rf = 0.11 (EtOAc:petroleum ether = 4:1). 
 
7
11
1
2
34
5
6
8
9
19
12
13
18
16
10
17
O
HO
Br
14
15
OMe
3. Development of flow methodolgies using organoboron reagents and diazo compounds 
	 214	
Diastereoisomer (minor) 
1H NMR (600 MHz, CDCl3): δ 7.44-7.40 (m, 2 H, H4, H7), 7.37-7.16 (m, 6 H, H5, H6, 
H17, H17), 7.13 (d, J = 8.6 Hz, 2 H, H11), 6.89 (d, J = 8.5 Hz, 2 H, H12), 6.38 (s, 1 H, H2), 
5.44 (dd, J = 7.4, 2.6 Hz, 1 H, H15), 4.26 (d J = 7.6 Hz, 1 H, H9), 3.81 (s, 3 H, H14), 2.16 (d, 
J = 3.0 Hz, 1 H, OH).  
13C NMR (150 MHz, CDCl3): δ 158.7 (C1), 157.3 (C13), 154.6 (C8), 140.5 (C16), 131.1 
(C10), 129.8 (C18), 129.2 (C11), 128.3 (C17), 128.1 (C3), 123.7 (C6), 122.7 (C5), 121.5 
(C19), 120.7 (C4), 113.8 (C12), 111.0 (C7), 104.4 (C2), 75.1 (C15), 55.2 (C14), 53.8 (C9). 
FTIR (νmax, cm-1): 3426 (br w, OH), 2931 (w), 2837 (w), 1610 (w), 1584 (m), 1512 (m), 
1487 (w), 1454 (m), 1303 (w), 1251 (m), 1178.61 (m), 1104 (w), 1071 (w), 1035 (w), 1010 
(w), 963 (w), 945 (w), 909 (w), 815 (w), 750 (m). 
HRMS (ESI): calculated for C23H20BrO3 [M+H]+ 423.0595, found 423.0596.  
Rf = 0.10 (EtOAc:petroleum ether = 4:1). 
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